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The combined effects of maternal obesity and low vitamin D status have adverse 
implications for maternal and fetal health. The overall aim of this PhD thesis was to 
investigate the association between maternal body weight and vitamin D status 
throughout pregnancy. From the systematic review, this thesis reports that few 
observational studies have assessed vitamin D status across BMI categories. Obese or 
obese class 2 pregnant women had lower vitamin D status compared to non-obese 
pregnant women. Maternal vitamin D status was negatively associated with maternal 
BMI and positively associated with infants vitamin D status. Vitamin D status was 
lower in infants born to obese mothers than infants born to normal weight mothers. 
When we examined data from a previous cohort of pregnant women in Northern 
Ireland (from 2006) who were not taking vitamin D supplements in pregnancy, we 
were able to examine the true association between BMI and vitamin D status in this 
unique cohort. Our results demonstrate that pregnant women with obesity had 
significantly lower vitamin D status than those who were normal weight, this was 
evident particularly during the winter months. There was a high prevalence of vitamin 
D insufficiency (<50 nmol/L) among pregnant women living in Northern Ireland in 
2006. When we assessed the association between BMI and vitamin D status in early 
pregnancy in a cohort that were recruited for the purposes of this PhD work, we found 
that pregnant women with overweight and obesity had significantly lower vitamin D 
status compared to pregnant women of normal weight in early pregnancy despite 62% 
of women reporting to take a vitamin D supplement. Maternal BMI was found to be a 
significant negative predictor of vitamin D status and a high prevalence of vitamin D 
insufficiency still exists among pregnant women living in Northern Ireland in 2017. 
This insufficiency was highest among non-supplement users during winter months. 
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We assessed the effect of supplementation with 10μg vs 20μg vitamin D3/d throughout 
pregnancy on vitamin D status of normal weight, overweight and obese pregnant 
women and on the cord blood of their infants. We report that vitamin D status 
increased throughout the pregnancy in both treatment groups, with a significantly 
higher increase observed in the 20µg group. In the 20µg group, maternal and cord 
vitamin D status reached and maintained sufficiency (≥50 nmol/L) throughout 
pregnancy, even in those who started pregnancy with an insufficient status. In obese 
women who started pregnancy with an insufficient vitamin D status, the related cord 
blood vitamin D status was deficient (<25 nmol/L) in both treatment groups (4). 
Overall, maternal obesity was negatively associated with maternal and infant vitamin 
D status and the current recommendation of 10µg/d is inadequate to reach and 
maintain sufficiency in those who start pregnancy with an insufficient status.   
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Maternal obesity  
Overweight and obesity are increasing in women of childbearing age (National 
Obesity Observatory, 2012), with approximately 60% of women of childbearing age 
(16-44 years) being obese in England and Northern Ireland (Statistics on Obesity, 
England 2017; Health survey Northern Ireland 2016/17). Obesity is recognised as a 
major public health concern during pregnancy (Catalano, 2007). The UK has the 
highest level of maternal obesity in Europe (Poston et al., 2016) with 20% of women 
classified as obese at the first antenatal appointment (Maternity Services, Monthly 
Statistics, 2017); in Northern Ireland this figure is estimated at 17% (Scott-Pillai et al., 
2013). Body mass index (BMI), defined as weight in kilograms divided by height in 
meters squared (kg/m2) is used to categorise individuals into; underweight BMI < 18.5 
kg/m2, normal weight 18.5–24.9 kg/m2, overweight 25.0–29.9 kg/m2, obese class I 
30.0–34.9 kg/m2, obese class II 35.0–39.9 kg/m2 and obese class III ≥ 40 kg/m2 (WHO, 
2000).  
 
Obesity related maternal and infant health risks  
Maternal obesity significantly contributes to adverse pregnancy and birth outcomes 
(Chu et al., 2009) and is associated with short and long-term metabolic dysfunction in 
the mother and her infant (Catalano et al., 2009). 
Maternal risks 
Maternal obesity is associated with an increased risk of hypertensive disorders of 
pregnancy, including preeclampsia and hypertension (Salihu et al., 2012). Pregnant 
women who are overweight or obese are shown to have an increased risk of 
preeclampsia of approximately 2 to 3 fold when compared to women of normal weight 
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(Bodnar et al., 2005). This association between obesity and the risk of preeclampsia 
and hypertension has been reported globally (Mahomed et al., 1998; Hauger et al., 
2008; Persson et al., 2016; El-Chaar et al., 2013; Denison et al., 2014) and a study by 
Jeyabalan, (2013) estimated that 30% of preeclampsia risk is attributable to obesity.  
Ducarme et al. (2007) supports this concept and reported that weight loss prior to 
pregnancy significantly reduced the risk of preeclampsia. The aetiology of 
preeclampsia and gestational hypertension include factors such as insulin resistance, 
genetic predisposition, immunology, poor diet and decreased physical activity (Salihu 
et al., 2012). Furthermore, maternal obesity is associated with an increased risk of 
gestational diabetes mellitus (GDM), which has been defined as either a fasting plasma 
glucose level of ≥5.6 mmol/litre or a 2-hour plasma glucose level of ≥7.8 mmol/litre 
during pregnancy (NICE, 2015). Insulin resistance is increased throughout pregnancy 
by action of the placenta and mothers with obesity have a higher insulin resistance 
(lower insulin sensitivity) than normal weight mothers, which contributes to 
hyperglycaemia and GDM (Korkmaz et al., 2016).  Women who are overweight or 
obese have an increased relative risk of developing GDM by 1.3-3.8 times compared 
with women who are normal weight (Kim et al., 2013). It is also well documented that 
women with GDM are at a higher risk for GDM in future pregnancies (Getahun et al., 
2004), as well as being at an increased risk of developing diabetes later in life (Bellamy 
et al., 2009). Preterm delivery is also considered to be one of the consequences of 
maternal obesity and is defined as a delivery of an infant before 37 gestational weeks 
(Simmons et al., 2010). Women with obesity classes 2 and 3 have an increased risk of 
preterm delivery between 32-36 weeks and <32 weeks, respectively (McDonald et al., 
2010; Torloni et al., 2009). Two retrospective studies of pregnant women in Florida 
and Finland observed an increased risk of preterm delivery (<28 weeks) in obese 
3
women with BMI ≥30 kg/m2 (Salihu et al., 2010; Raisanen et al., 2013). However, 
associations between preterm delivery and overweight (BMI 25-29.9 kgm2) and 
obesity class 1 (BMI 30≤35 kg/m2) are less consistent (Nohr et al., 2007; Torloni et 
al., 2009). The mechanism between preterm delivery and maternal obesity is unknown 
but is believed to be associated with alterations in immune function (Goldenberg et 
al., 2008). Maternal obesity is also a major contributing factor to the increased global 
rates of caesarean section (CS), especially in developed countries (Barry et al., 2009). 
Previous meta-analyses have shown a 2-fold increase in CS in obese women compared 
to normal weight women (Heslehurst et al., 2008; Poobalan et al., 2009) and a study 
by O’Dwyer et al. (2011) reported that maternal obesity in European women is 
associated with an increase in emergency CS in primigravidas and an increase in 
elective CS in multigravidas, compared with women who are normal weight.  
 
Infant risks 
Maternal obesity contributes to short and long-term adverse health effects in the infant. 
Infants born to mothers with obesity have an increased risk of abnormal growth such 
as macrosomia, (defined as birth weight higher than 4000g or 4500g), as well as an 
increased risk of being large for gestational age (LGA), (defined as birth weight higher 
than the 90th centile for gestational age) (Catalano and Shankar, 2017). Studies have 
reported that mothers with obesity have a 2-fold higher risk of giving birth to an LGA 
infant compared to mothers of normal weight (Gaudet et al., 2014). These risk factors 
could be related to insulin resistance as infants of mothers with obesity have higher 
insulin resistance than those of normal weight mothers, with a positive relationship 
shown between maternal pre-pregnancy BMI and fetal insulin resistance (Catalano et 
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al., 2009). Furthermore, children born to mothers with obesity are at a higher risk of 
long-term adverse health outcomes than children born to mothers of normal weight, 
such as cardiovascular disease (Reynolds et al., 2013), type-2 diabetes (Morgan et al., 
2010) and a 3-fold increased risk of childhood obesity (Yu et al., 2013; Taveras et al., 
2009). 
 
Vitamin D metabolism in pregnancy 
Vitamin D is a fat-soluble vitamin involved in calcium and phosphate homeostasis and 
is essential for the maintenance of bone health. Severe vitamin D deficiency causes 
rickets in children and osteomalacia in adults (Bouvard et al., 2011; Christakos et al., 
2011).  There are two forms of vitamin D; D3 (cholecalciferol) which is obtained from 
animal sources or produced from 7-dehydrocholesterol in the skin following exposure 
to ultraviolet B irradiation from sunlight, and D2 (ergocalciferol) which is obtained 
from plant sources. Vitamin D undergoes hydroxylation in the liver by the hydoxylase 
enzyme 25-hydroxylase (CYP27A1) to form 25 hydroxyvitamin D (25(OH)D, the 
status marker of the vitamin) and a further hydroxylation in the kidneys and other 
organs by the enzyme 1-alpha hydroxylase (CYP27B1) to produce the biological 
active form 1,25 dihydroxyvitamin D (1,25(OH)2D). The active form is responsible 
for increasing calcium absorption/resorption from the small intestine, increasing urine 
reabsorption/excretion, regulating parathyroid hormone (PTH) and increasing bone 
mineralisation. Adequate vitamin D is required to maintain homeostasis and calcium 
supply to all tissues and organs in the body, particularly the heart, bone, skeletal 
muscle and brain (Wagner et al., 2012). 
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Vitamin D metabolism is altered during pregnancy to meet the physiological demands 
of the mother and fetus. The conversion of 25(OH)D to 1,25(OH)2D is increased 
approximately 2-fold throughout pregnancy (Hollis et al., 2011). During pregnancy, 
25(OH)D is transferred across the placenta and it has been shown that fetal cord blood 
concentrations of 25(OH)D correlate with maternal 25(OH)D status (Shin et al., 
2010). Whilst, 1,25(OH)2D does not readily cross the placenta (Shin et al., 2010; 
Kaludjerovic et al., 2010), fetal kidneys and placental tissue express CYP27B1 to 
convert 25(OH)D to 1,25(OH)2D within fetal circulation (Adams and Hewison, 2012) 
(Figure 1). In the infant, cord blood concentrations of 25(OH)D and 1,25(OH)2D 
positively correlate (Walker et al., 2011, Eichholzer et al., 2013). Previously it was 
believed that concentrations of calcium for adequate maternal and fetal skeletal 
requirements were maintained owing to an increase in circulating concentrations of 
1,25(OH)2D during pregnancy (Hollis et al., 2011). However, the increase in 
1,25(OH)2D concentrations in early pregnancy is not thought to be linked to calcium 
homeostasis as calcium requirements only significantly increase in the third trimester 
and during lactation (Carneiro et al., 2010).  Approximately 25-30g of calcium is 
transferred from the mother to the fetal skeleton during the last trimester (Kaushal and 
Magon, 2013). The rate of conversion to 1,25(OH)2D in the mother and fetus is 
dependent on 25(OH)D substrate availability and increased CYP27B1 activity in the 
placenta and decidua and is largely independent of calcium homeostasis (Hollis et al., 
2010; Liu and Hewison, 2011; Adams and Hewison, 2012; Hewison et al., 2004). It 
has been reported that pregnant women who develop preeclampsia have abnormal 
expression of CYP27B1, presenting a potential role for 1,25(OH)2D3 as a regulator of 
placentation which is suggestive of a protective mechanism of vitamin D on fetal-
placental development (Kaushal and Magon 2013). Furthermore, it has been reported 
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by Bakacak et al. (2015) that vitamin D is involved in regulating genes in early 
placental development. More recently, vitamin D has also been found to play a role in 
reproduction as well as implantation of the embryo (Heyden and Wimalawans, 2018). 
 
Current recommendations for vitamin D during pregnancy: 
The main source of vitamin D is from sun exposure accounting for approximately 
90%, while the remaining 10% comes from a small range of foods such as liver, egg 
yolks, fatty fish and mushrooms, fortified foods and dietary supplements (Laird et al., 
2010). Cutaneous synthesis of vitamin D is affected by many factors including 
latitude, season, sunscreen use, pollution, weather, age and skin colour. In the UK, 
vitamin D deficiency (<25 nmol/L) is three times more common in winter and spring 
compared to summer and autumn (Hypponen and Power, 2007). Hill et al. (2004) 
reports that latitudes between 51-55°N in Ireland contribute greatly to vitamin D 
deficiency leading to a reliance on foods containing vitamin D during winter and 
autumn, and stores built up from sun exposure in the previous summer. In the UK the 
mean daily intake of vitamin D from food sources for women aged 19-64 years ranges 
from 2.2 to 2.8μg/d (National Diet and Nutrition Survey NDNS,2008/09 to 2011/12, 
(Bates, 2014), well below the currently recommended intakes of 10µg/d for all adults 
including pregnant women (SACN, 2016). Compounding these low intakes, pregnant 
women are advised to reduce intake of some of the naturally containing vitamin D rich 
foods such as liver and fish owing to safety issues and risk of bacterial exposure 




Prevalence of low vitamin D status during pregnancy: 
Vitamin D deficiency and insufficiency among pregnant women have been reported 
worldwide (Dawodu et al., 2012). Studies have reported vitamin D insufficiency 
during pregnancy in European countries (<50 nmol/L) such as Spain (27%) 
(Rodríguez-Dehli et al., 2015) and Poland (24%) (Bartoszewicz et al., 2013).  
Furthermore, in North India (92%) (Singla et al., 2015), and Qatar (48%) (Bener et 
al., 2013). Studies have reported vitamin D deficiency (<25 nmol/L) in various 
populations including Riyadh (68%) (Al-Ajlan et al., 2015) and almost 60% in Tokyo 
(Shiraishi et al., 2014). In the UK, the prevalence of vitamin D deficiency (<25nmol/L) 
among pregnant women living in London was reported to be 47%, 64%, 58% and 13% 
in Asian, Middle Eastern, Black and Caucasian women respectively (Yu et al., 2009). 
Furthermore, approximately 23% of healthy pregnant women living in Glasgow were 
found to be vitamin D deficient (Makgoba et al., 2011). Over 90% of pregnant women 
living in Northern Ireland were vitamin D insufficient and insufficiency was also 
found in women taking vitamin supplements (Holmes et al., 2009).  
 
Consequences of low vitamin D status during pregnancy for mother and infant: 
Recently, a number of studies have reported adverse health outcomes for the mother 
and the infant with vitamin D deficiency during pregnancy (Karras et al., 2013) and 
these outcomes mirror those associated with obesity. 
Maternal risks  
Low vitamin D status in early pregnancy has been observed in women who developed 
pre-eclampsia later in pregnancy and a 50nmol/L decline in vitamin D doubled the 
risk of preeclampsia (Bodnar et al., 2007).  However, these associations have not been 
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supported by randomised controlled trials which have reported no significant effects 
of vitamin D supplementation (110µg/d) on incidence of preeclampsia when 
compared to a lower dose (10µg/d) of vitamin D from early in pregnancy (10-18 
weeks) up to the third trimester (32-38 weeks) (Mirzakhani et al., 2016). However, it 
was noted that having a 25(OH)D concentration of >75 nmol/L throughout pregnancy 
was associated with a lower risk of preeclampsia (Mirzakhani et al., 2016). A meta-
analysis of 6 studies suggested an association between higher vitamin D status and a 
reduced risk of pre-eclampsia, and 4 randomised supplementation studies were 
suggestive of a protective association (Hyppönen et al., 2013). 
 In addition, meta-analyses have shown that low vitamin D status is associated with 
increased incidence of GDM (Aghajafari et al., 2013). In a more recent observational 
study of Chinese pregnant women, vitamin D status at the first prenatal visit was 
significantly lower in women who developed GDM compared with those who did not 
(Xu et al., 2017). Furthermore, supplementation studies have supported the 
associations between vitamin D and GDM. In a randomized, double-blind, placebo-
controlled trial, 90 pregnant women who had at least one risk factor for GDM were 
randomised to receive either 125µg/d of vitamin D/d or placebo until 26 weeks 
gestation, and it was reported that the incidence of GDM was significantly lower in 
the intervention group compared to the control group (Shahgheibi et al., 2016). 
Furthermore, a randomised clinical trial using a dose of 1250µg vitamin D every 2 
weeks from 12 weeks of pregnancy until delivery was found to significantly improve 
insulin resistance compared to other groups who received either 5µg vitamin D daily 
or 1250µg vitamin D monthly (Soheilykhah et al., 2013). In contrast, a recent study 
by Tehrani et al. (2017) found that vitamin D supplementation of 125µg every 2 weeks 
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for 10 weeks among those who had low vitamin D status (<25 nmol/L) at the start of 
the study had no effect on incidence of GDM during pregnancy.  
Vitamin D has also been reported to play a role in obstetric outcomes and low maternal 
vitamin D status (<37.5 nmol/L) at delivery has been shown to be associated with an 
increased risk of CS (Merewood et al., 2009). Furthermore, maternal vitamin D 
deficiency (<30 nmol/L) was reported to result in a 2-fold increased risk of caesarean 
due to prolonged labour in a large cohort of pregnant women in the United States 
(Theresa et al., 2012).  Some studies have also reported associations between maternal 
vitamin D status in early pregnancy and type of delivery however, within a UK study 
no significant differences in mode of delivery according to maternal vitamin D status 
in first trimester were observed (Savvidou et al., 2012). 
Infant risks 
Low maternal vitamin D status has also been linked with a number of adverse 
outcomes in the offspring. Maternal vitamin D deficiency may impair fetal growth and 
result in adverse outcomes including low neonatal birth weight. A recent cross-
sectional study reported that low birth weight neonates (<2500g) were significantly 
more likely to be born to mothers with low vitamin D status compared to normal birth 
weight neonates (>2500g) who were more likely to be born to mothers with higher 
vitamin D status (Khalessi et al., 2015). A positive correlation between maternal 
vitamin D status and neonatal birth weight has also been reported in a Chinese cohort 
(Chen et al., 2015) albeit not all studies have found these associations (Morley et al., 
2006).  
In the long term, children born to mothers who had a low vitamin D status during 
pregnancy are reported to be more likely to suffer from wheezing and asthma 
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(Camargo et al., 2007; Erkkola et al., 2009), type 1 diabetes mellitus and insulin 
resistance (Hypponen et al., 2001; Fronczak et al., 2003) and multiple sclerosis 
(Mirzaei et al., 2011). Furthermore, maternal vitamin D status also contributes to 
skeletal development programming (Sayers et al., 2009) and body composition in 
children (Pasco et al., 2008) by influencing the interaction between osteoblasts and 
adipocytes. Low maternal vitamin D status during late pregnancy is associated with 
reduced whole-body bone mineral content, bone area, and areal bone mineral density 
in children at 9 years old (Javaid et al., 2006). Therefore, it is essential to maintain 
optimal vitamin D status during pregnancy to prevent vitamin D deficiency in the fetus 
and subsequent adverse health outcomes (Wagner et al., 2012, Hollis et al., 2004). 
 
Effect of vitamin D supplementation during pregnancy: 
The effect of vitamin D supplementation during pregnancy on maternal and neonatal 
outcomes using randomised controlled trials (RCT) have been examined in 5 
systematic reviews (De-Regil et al., 2012& 2016, Harvey et al., 2014, Perez-Lopez et 
al., 2015, Thorne-Lyman and Fawzi 2012) and consistently reported that vitamin D 
supplementation in a single or continued dose during pregnancy significantly 
increased maternal vitamin D status at term. A review by Harvey et al. (2014) assessed 
observational and RCT studies and concluded that whilst there was modest evidence 
to support a relationship between maternal vitamin D status and neonatal birth weight, 
bone mass and calcium status, these findings are insufficient to support definite 
clinical recommendations for vitamin D supplementation during pregnancy. A meta-
analysis by Thorne-Lyman and Fawzi (2012) which assessed observational and RCTs 
reported protective effects of vitamin D supplementation on low birthweight and non-
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significant but suggestive effects of vitamin D supplementation on small for 
gestational age and no effect on preterm delivery. A more recent meta-analysis by 
Perez-Lopez et al. (2015) which included 13 RCTs found that vitamin D 
supplementation during pregnancy was associated with increased vitamin D status, 
birth weight and birth length, but was not associated with other maternal and neonatal 
outcomes.  
 
Impact of obesity on vitamin D status for mother and infant 
Research in recent years has reported an inverse association between obesity and 
vitamin D status in many populations (Perez-Lopez et al., 2011, Bartoszewicz et al., 
2013). It is thought that this inverse association may be due to decreased sun exposure 
as obese individual have less outdoor activity and might use more clothing coverage 
than those who are normal weight (Compston et al., 1981; Vanlint, 2013). Another 
potential mechanism is increased sequestration in adipose tissue as vitamin D is a fat 
soluble vitamin (Wortsman et al., 2000).  Studies in which obese and normal weight 
individuals with similar baseline vitamin D status were exposed to UVB irradiation 
for 24 h reported a 57 % lower vitamin D status in obese individuals post-intervention 
compared to the normal weight individuals, highlighting the differences in vitamin D 
synthesis according to weight status (Wortsman et al., 2000). Moreover, it has been 
proposed by Drinic et al. (2012) that volumetric dilution may also result in low 
circulating concentrations of vitamin D in obese individuals. 
A number of studies have been conducted in pregnant cohorts and reported that obese 
or severely obese pregnant women had significantly lower vitamin D status compared 
to non-obese pregnant women (Andersen et al., 2013, Bodnar et al., 2007, Perez-
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Lopez et al., 2011, Perampalam et al., 2011, Bartoszewicz et al., 2013, McAree et al., 
2013, van den Berg et al., 2013, Karlsson et al., 2015). In a cohort of pregnant women 
from Denmark, it was observed that a 5 unit increase in BMI during both winter and 
summer correlated to a lower 25(OH)D of 4.2 nmol/L and 2.85 nmol/L respectively 
(Andersen et al., 2013). However, in a cross-sectional study of pregnant women by 
Pena et al. (2015) the authors noted that vitamin D status was not significantly 
influenced by obesity, despite the obese pregnant women and their neonates having 
significantly higher incidence of vitamin D deficiency, albeit this was not significantly 
different when compared to non-obese pregnant women and their infants.  
The fetus is completely reliant on the maternal vitamin D status and supply (Hollis & 
Pittard, 1984) and whilst neonatal vitamin D status is highly correlated with maternal 
vitamin D status (Dror et al., 2011, El Rifai et al., 2014, Godang et al., 2014), obesity 
significantly weakens this correlation (Pena et al., 2015). Neonates of obese mothers 
had significant lower vitamin D in cord blood than neonates of normal weight mothers 
and the author suggested that obese women and their neonates are at high risk of 
vitamin D deficiency even when the mothers regularly use prenatal vitamins 
containing vitamin D (Bodnar et al., 2007). Jami et al. (2013) have suggested that a 
higher dose of vitamin D supplementation is required for obese pregnant women than 
normal weight pregnant women. It has been observed that normal weight pregnant 
women transfer more vitamin D across the placenta to the fetus than obese pregnant 
women, even when maternal 25(OH)D concentrations did not differ. Indeed, vitamin 
D deficiency during pregnancy is recognized as a serious concern for pregnant women 
especially if they are obese and have dark skin (McAree et al., 2013, Dijkstra et al., 
2007, Finer et al., 2012, Bodnar et al., 2007).  
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Independent of each other obesity and low vitamin D status during pregnancy lead to 
adverse consequences for the mother and their infants. However, the combined effect 
of both obesity and low vitamin D status among healthy women during pregnancy is 
poorly documented and the incidence of both during pregnancy may contribute to 
increased adverse health outcomes for the mother and their infants. Vitamin D status 
during pregnancy has been previously investigated but few studies have considered 
the potential implications of obesity. In addition, whilst the effect of vitamin D 
supplementation during pregnancy on vitamin D status has been assessed, maternal 
body weight has not been taken into account. Furthermore, the effect of vitamin D 
supplementation during pregnancy among normal weight, overweight and obese 
pregnant women and their infant has not yet been investigated.   
The influence of maternal obesity on vitamin D status is an important public health 
consideration with potential short and long-term adverse health consequences for both 
the mother and her infant. Therefore, the overall aim of this thesis is to assess the 
association between maternal body weight and vitamin D status throughout 
pregnancy.  
 
This aim has been addressed through the completion of several chapters as follows: 
1- The association between maternal obesity and vitamin D status of mothers and 
infants: a systematic review (Chapter 2)  
Aim: To explore current knowledge on the association between maternal obesity and 
vitamin D status of the mother and their infants cord blood through a systematic review  
2- The association of overweight and obesity on vitamin D status during 
pregnancy using data from the FASSTT Study (Chapter 3) 
14
Aim: To investigate the association between BMI and maternal vitamin D status and 
to investigate for associations between vitamin D status and neonatal birth outcomes.  
3- The association between maternal body weight and vitamin D status in early 
pregnancy (Chapter 4) 
Aim: To assess and compare maternal vitamin D status between normal weight, 
overweight and obese pregnant women in early pregnancy  
4- The effect of supplementation of 10μg vs 20μg vitamin D3/d on vitamin D 
status in normal weight, overweight and obese pregnant women (Chapter 5) 
Aim: To assess the effect of supplementation of 10μg vs 20μg vitamin D3/d throughout 
pregnancy on vitamin D status of normal weight, overweight and obese pregnant 
women and on the cord blood of their infants. 
5- Discussion (Chapter 6) 
Aim: To discuss and interpret the overall association between maternal obesity and 
vitamin D status and the association between maternal and neonatal health and to 
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 Figure1. Diagram of vitamin D metabolism in pregnancy (adapted from Barnes et al., 2006). 
During pregnancy, maternal vitamin D obtained from sun exposure or through diet is hydroxylated in the liver by the hydoxylase enzyme 25-
hydroxylase (CYP27A1) to form 25 hydroxyvitamin D (25(OH)D, the status marker of the vitamin) before undergoing a further hydroxylation step 
in the kidneys by the enzyme 1-alpha hydroxylase (CYP27B1) in response to parathyroid hormone (PTH) to form the biologically active form 1,25 
dihydroxyvitamin D (1,25(OH)2D).  1,25(OH)2D binds to vitamin D receptors (VDR) on target organs (small intestine, bone, ,muscle, placenta, 
immune system) to and produces the appropriate biological response increase calcium absorption. Any unused vitamin D is converted to various 
metabolites and excreted in the faeces or urine. During pregnancy, maternal 25(OH)D crosses the placenta to the fetus and is the only source of 
vitamin D.  Whilst 1,25(OH)2D does not as readily cross the placenta, the placental tissue and fetal kidneys express CYP27B1 to enable conversion 
of 25(OH)D to 1,25 (OH)2D to meet fetal physiological demands to maintain calcium homeostasis for fetal bone development. PTH-related peptide 
(PTHrP) produced in fetal parathyroid glands and placental tissues and increases placental synthesis of 1,25(OH)2D. PTHrP could mediate the 




The association between maternal obesity and vitamin D status of 




Maternal obesity is becoming increasingly common and significantly contributes to 
adverse pregnancy and birth outcomes. Vitamin D insufficiency is another established 
risk factor in pregnancy and is linked with health consequences similar to those 
associated with obesity. 
The association between maternal obesity and low vitamin D status is an important 
public health consideration. The aim of this systematic review is to explore current 
knowledge on the association between maternal obesity and vitamin D status of 
mothers and their infants cord blood. 
Literature searches were conducted using Ovid MEDLINE, PubMed, Web of science 
and Cochrane library databases. Papers published from 1 January 1980 to 17 June 
2018 following PRISMA guidelines were included in the search. Inclusion criteria 
were: articles reporting quantitative body composition measures or categories of BMI 
and vitamin D status (as 25(OH)D concentrations), data from any study design, 
published in the English language and including data on healthy pregnant women and 
their infants. Two randomised clinical trials and 58 observational studies were 
included in this review. 
As evidenced by our findings, few observational studies have assessed vitamin D 
status across BMI categories. Obese or obese class 2 pregnant women had lower 
vitamin D status compared to non-obese pregnant women. Maternal vitamin D status 
was positively associated with infants vitamin D status but was negatively associated 
with maternal BMI. Vitamin D status was lower in infants born to obese mothers than 
infants born to normal weight mothers; this difference was related to factors such as 
maternal vitamin D status, maternal obesity, maternal age and infant adiposity. 
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Maternal obesity was negatively associated with maternal and infant vitamin D status. 
Advice on vitamin D supplementation during pregnancy may need to be based on pre-




Maternal obesity (defined as body mass index (BMI) ≥30 kg/m2) is becoming 
increasingly common and significantly contributes to adverse pregnancy and birth 
outcomes (Chu et al., 2009). The prevalence of maternal overweight and obesity across 
Europe is estimated at 30-37% (European perinatal health report, 2010). In the UK, 
20% of women are classified as obese at their first antenatal appointment (Maternity 
Services Monthly Statistics, 2017). Obesity-related consequences during pregnancy 
include increased risk of gestational diabetes (GDM), preeclampsia, hypertension, 
caesarean section (CS), preterm delivery and low birth weight (Scott-Pillai et al., 
2013).  
Vitamin D insufficiency during pregnancy has been associated with adverse health 
consequences similar to those of obesity (McAree, 2013), and there is a high 
prevalence of low vitamin D status in many populations globally (Dawodu et al., 
2012).  During pregnancy, there are increased calcium demands for fetal bone growth 
and development (Ponsonby et al., 2010) and the fetus relies solely on the mother for 
its supply of vitamin D to meet these demands. Furthermore, obesity is a recognised 
risk factor for hypovitaminosis D in the general population (Vimaleswaran et al., 
2013) as well as during pregnancy (Bodnar et al., 2007; Karlsson et al., 2015). Indeed, 
Andersen et al., (2013), reported that a 5 kg/m2 increase in BMI was associated with 
a decrease in vitamin D status of 3.7 nmol/L in pregnant women. 
Although limited in number, some epidemiological studies have shown that obese 
pregnant women have a significantly lower vitamin D status than non-obese women 
(Bodnar et al., 2007; Karlsson et al., 2015; McAree et al., 2013), and it has been shown 
that obese pregnant women transfer less vitamin D to the infant than normal-weight 
47
pregnant women even when maternal vitamin D status is the same (Josefson et al., 
2013). In addition, Karlsson et al., (2014) reported that, despite having a higher dietary 
vitamin D intake and similar supplement use, obese pregnant women had lower 
vitamin D status in the first trimester compared with normal weight women.  Several 
potential mechanisms explaining low vitamin D status in obese pregnant women have 
been postulated including increased sequestration in adipose tissue and owing to 
volumetric dilution (Parikh et al., 2004; Gallagher et al., 2013). 
The association between maternal obesity and low vitamin D status in the mother and 
their infants is an important public health consideration but one that is poorly 
understood. The aim of this systematic review is to explore current knowledge on the 
association between maternal obesity and vitamin D status of the mother and their 





A systematic search strategy was developed and electronic literature searches were 
conducted using Ovid MEDLINE (www.gateway.Ovid.com), PubMed 
(www.PubMed.org), Web of science (www.webofknowledge.com) and Cochrane 
library (www.cochranelibrary.com) to identify papers published between 1 January 
1980 (Date of first publication of maternal vitamin D status) to 17 June 2018 following 
PRISMA guidelines. 
Inclusion criteria were: articles reporting quantitative body composition measures or 
qualitative categories of BMI and vitamin D status (as 25(OH)D concentrations), data 
from any study design, published in the English language and including data on 
healthy pregnant women and their infants. 
Searches were conducted using the following combinations of keywords or Medical 
Subject Heading (MeSH) phrases truncation where appropriate: Obes* OR BMI OR 
Body mass index AND Vitamin D OR 25-hydroxy vitamin D OR 25(OH)D OR 
Cholecalciferol OR calciferol OR calcifediol AND Pregnan* OR Maternal OR 
Mothers OR women. In a secondary search, bibliographies of selected articles were 
also examined for additional studies which may not have been identified by previous 





Selection criteria  
After duplicate articles were removed and filter applied, two independent reviewers 
(BM, AMcG) screened the titles and abstracts to select only those studies that met the 
inclusion criteria. The full texts of all articles were obtained before reviewing for 
eligibility. Articles were further excluded at this stage if they reported data: 1) from 
blood samples taken after delivery; 2) from non-pregnant women only; 3) from non-
healthy pregnant women; 4) without 25(OH)D concentrations; 5) where BMI and 
25(OH)D measurements were not matched appropriately; 6) where BMI was not 
measured; 7) within a literature review; 8) not presented as required or unable to be 
calculated as (mean±SD); 9) from abstract only or from protocol or 10) from cohorts 
that were repeated in another publication. 
Where possible, data were obtained from the control (healthy) pregnancy group of 
studies investigating unhealthy populations and included within the review. 
Manuscript authors were contacted if data were not presented in a useful format (for 
example, if data were presented only in figures or data presented as median and range).   
 
Quality assessment  
The quality of final articles was assessed using 2 quality assessment tools for 
observational studies and RCT (Newcastle-Ottawa Scale, Cochrane methodology) 
based on 5 areas (overall quality, cohort selection, methods, results and risk of bias), 
with each area containing questions relevant to the quality of the article. Scores were 
given for each area as +1 for addressing the issue appropriately, -1 for not addressing 
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the issue and 0 if it was unclear.  Studies were defined as being of satisfactory quality 
if they scored ≥ 7 and were therefore deemed suitable for inclusion. 
 
Data extraction 
Data extracted from the articles were compiled into Microsoft Office Excel 2016 data 
files. Information extracted included study design, geographic location, sample size, 
biomarker of 25(OH)D status, 25(OH)D measurement methods used and BMI data, 
and then categorised based on (WHO BMI classification) for individual paper. Study 
populations were defined into trimesters (first, second and third) according to 
gestational age (first trimester (≤12 weeks), second trimester (13-26 weeks) and third 
trimester (27-40 weeks)). Quantitative data (mean ±SD) for vitamin D status as 
25(OH)D concentrations were extracted as nmol/L, and conversion from ng/ml  to 
nmol/L was carried out where appropriate (ng/ml * 2.5). Quantitative data for BMI 
were extracted as kg/m2. Where available, dietary vitamin D intake was also recorded, 
albeit it was not possible to assess the impact of dietary data within the scope of this 
review. Vitamin D intake was extracted as µg/d and conversion from IU/d to µg/d was 
carried out where appropriate (1 IU= 40µg). 
The accuracy of the extracted data was checked and approved by an independent third 






Vitamin D status and BMI data are presented as mean ±SD and classified into 4 levels 
of sufficiency:  deficiency (25(OH)D <25 nmol/L), insufficiency (25-50 nmol/L), 
sufficiency (50-75 nmol/L) and optimal (≥75 nmol/L) (SACN, 2016). In addition, 
BMI data were categorised into 3 groups: normal weight (18.5-24.9 kg/m2), 
overweight (25-29.9 kg/m2) and obese (≥30 kg/m2) (WHO, 2004). 
For ease interpretation, data have been presented in 2 ways within this review; 1) by 

















Figure 1. PRISMA Flow Diagram of the systematic literature search and article selection.  
*Filter criteria: Published from 01 January 1980 to 17 June 2018, human studies, female and English language. 
N= 1840 records after duplicates 
removed 
N=1840 records screened  
N=596 initial screen title and 
abstract 
 
N= 178 Full text obtained and 
assessed for eligibility  
 
N=60 
Data extraction included in 
the review 
 
N= 1244 recodes excluded 
after filter* applied 
N= 418 of initial screen 
title and abstract excluded 
 
N= 118 of Full text obtained 
excluded, with reasons 
 Blood sample taken after 
delivery n=7 
 Non- pregnant women n=14 
 Non-healthy pregnant women 
n=14 
 25(OH)D not measured n=25 
 BMI not matched with 
25(OH)D n=17 
 BMI not measured n=12 
 Literature review n=10 
 Data not presented as required 
n=14 
 Only abstract or protocol n= 3 
 Cohort data repeated in 




































Identification of studies 
A total of 2052 records were identified from the initial searches.  After the removal of 
duplicates and filters were applied, a total of 596 records were screened by title and 
abstract with 418 of these papers excluded as they did not fit the inclusion criteria, 
leaving a total of 178 full-text articles which were obtained and assessed for eligibility.  
Of these 178 articles, 118 were excluded for reasons as outlined in Figure 1. 
From this point forward the numbers within brackets e.g. (42, 36, 17) etc refer to the 
studies numbered within Tables 1-4. Data extracted for the purposes of this review 
were from 58 observational studies (Table 1, 2), and 2 randomised clinical trials (Table 
3) and are presented in order of trimester of pregnancy. 
The population of this review were pregnant women across all three trimesters. Within 
trimesters, findings are discussed in subsections of deficiency, insufficiency and 
sufficiency. A range of observational studies were included in this review and included 
prospective studies, retrospective analysis, cohort studies, case-control and cross-
sectional studies. Measures of BMI were reported to be taken either pre-pregnancy or 
throughout pregnancy. The majority of the analyses for 25(OH)D used serum samples 
and a variety of different methods including 1.5% used immunodiagnostic system 
(IDS), 1.5% used enzyme immunoassay (EIA), 5% used high performance liquid 
chromatography (HPLC), 10% used chemiluminescence immunoassay (CLIA), 14% 
used radioimmunoassays (RIA), 20.5% used electrochemoluminiescent Immunoassay 
(ECLIA), 22 % used enzyme linked immunosorbent assays (ELISA) and the gold 
standard 25.5% used liquid chromatography tandem mass spectrometry (LC-MS/MS). 
54
However, 2 studies (Hanieh et al., 2015; Valkama et al., 2018) did not report the 
methods used. 
When studies were assessed according to trimester of pregnancy, a total of 14 reported 
vitamin D status in the first trimester, 5 studies covered a period between first and 
second trimesters, 21 studies were conducted during the second trimester, 4 covered a 
period between the second and third trimesters and 24 studies were conducted in the 
third trimester. 
The studies reported in this review included 20 prospective studies, 1 retrospective 





The association between maternal BMI and vitamin D status during pregnancy 
according to trimester 
First trimester 
A total of 14 studies in this review reported vitamin D status in the first trimester of 
pregnancy (Table 1, a).  
 
Deficiency 
Only 1 study reported vitamin D deficiency (<25 nmol/L) (13.3 ±4.3nmol/L) at this 
time-point in a cohort of pregnant women from Saudi Arabia where the mean BMI 
was overweight albeit no significant associations were reported between BMI and 
vitamin D status. Although this study was conducted in a sunny country, the time of 




The majority of studies (8, 23, 25, 33, 34, 39, 47) which assessed vitamin D status in 
the first trimester reported insufficient vitamin D status (25-50 nmol/L). These studies 
were from different regions, had a range of BMIs and were assessed across different 
seasons; seasonality was considered the most influential factor affecting vitamin D 
status. In a large cross-sectional study conducted in Malaysia, where the city climate 
is consistently hot and humid throughout the year, insufficient vitamin D status was 
observed among 396 normal weight pregnant women in first trimester. Increased 
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dietary vitamin D intake from food was found to reduce the prevalence of vitamin D 
insufficiency, and 55% of pregnant women were reported to meet the Malaysian 
Recommended Nutrient Intakes (RNI), of 5µg/d. In over half of those pregnant women 
who reportedly met the RNI, insufficient vitamin D status was observed (8). In 
addition, among 500 Korean pregnant women recruited prospectively during the year, 
the mean BMI was categorised as normal and the mean vitamin D status insufficient, 
which was related to a low daily vitamin D intake of 2.8µg/d (33). Furthermore, a 
study in London  retrospectively analysed 346 blood samples collected from pregnant 
women at their initial booking visit and reported insufficient vitamin D status, with an 
independent association found between BMI and vitamin D, with obese pregnant 
women (BMI ≥ 30kg/m2) having significantly lower vitamin D status than non-obese 
pregnant women. Seasonal variations were apparent with 30% of pregnant women 
having a lower vitamin D status between January and March compared to between 
July and September (23). A negative association was reported between BMI in the 
first trimester and maternal vitamin D status among 158 control pregnant women 
recruited in a case -control study (25). In another study based in London among 995 
pregnant women, it was reported that maternal vitamin D status in the first trimester 
decreased with increasing BMI and vitamin D status increased in summer (34). 
Insufficient vitamin D status was reported among overweight pregnant women living 
in Amsterdam with low level of education, albeit 55% of sampling in this study was 
done during the winter months (39). Although insufficient vitamin D status was 
reported in 301 Pakistani pregnant women (47), information on vitamin D dietary 
intake and season of sample collection was not available. Furthermore, none of these 





Four out of fourteen studies (27, 31, 40, 43) reported sufficient vitamin D status (>50 
nmol/L) during the first trimester of pregnancy and included populations from 
Southampton (UK) (27), Boston (USA) (31), South-western Sweden (40) and Warsaw 
(Poland) (43). In the Southampton prospective study where the mean BMI was 
classified as overweight, 37% of pregnant women reported taking vitamin D 
supplements and supplementation use was correlated with vitamin D status.  It was 
also reported that higher weight gain during pregnancy was associated with reduced 
25(OH)D concentrations (27). In Warsaw, 80% of all pregnant women reported taking 
multivitamins containing vitamin D in the first trimester and overweight pregnant 
women had significantly lower vitamin D status than normal weight women in both 
winter and summer. In contrast to other studies, there was no significant difference in 
vitamin D status between winter and summer time, suggesting that high supplement 
use prevented seasonal variations in status (43). In a case-control study of pregnant 
women living in Boston Massachusetts, healthy pregnant women who were 
categorised as normal weight in the first trimester had sufficient vitamin D status and 
vitamin D status was inversely associated with BMI. However, there was no 
information reported about time of sampling (season) or vitamin use (31). In a multi-
ethnic population-representative Swedish cohort of 1829 pregnant women in the first 
trimester where vitamin D status was sufficient, the mean BMI was classified as 
normal weight, 43% of pregnant women reported taking vitamin D supplements and 




Between first and second trimesters 
Few studies (2, 9, 48, 49, 50) assessed vitamin D status during pregnancy at a time, 
which fell between first and second trimesters.  
 
Insufficiency  
Insufficient vitamin D status was reported among women who were classified as being 
obese and obese class 2 pre-pregnancy compared to non-obese in Canada, with vitamin 
D status being inversely correlated with pre-pregnancy BMI (48). This was also 
observed in a cohort carried out across all seasons in North Carolina, when women 
classified as being overweight pre-pregnancy had insufficient vitamin D status (50).  
 
Sufficiency 
Vitamin D status was sufficient among all BMI groups in 2 studies albeit information 
on diet or vitamin D supplementation use was not reported in one study (2), whilst a 
study conducted in Pittsburgh, USA reported high regular use of multivitamins or 
prenatal vitamins during pregnancy (9). Almost optimal vitamin D status has been 
observed in normal weight and overweight pregnant women and sufficient vitamin D 
status in obese women, even where there was no variation in season of sampling 






A total of 21 studies assessed vitamin D status during the second trimester (Table 1, 
b). 
Deficiency 
Three of these studies reporting a high prevalence of vitamin D deficiency (13, 35, 
36). In 30 Turkish pregnant women used as a control in a controlled cross-sectional 
study, deficient vitamin D status was reported and the mean BMI during second 
trimester was 26.1 kg/m2, classified as overweight (13). In addition, a prospective 
study conducted in North India among 304 pregnant women, observed a high rate of 
vitamin D deficiency (92%), with high BMI during second trimester being a negative 
predictor of low vitamin D status in this cohort (36). These findings are similar to 
those in a Japanese pregnant cohort, which reported that higher pre-pregnancy BMI 
was negatively associated with vitamin D status (35). In contrast to the Turkish and 
Indian studies, the study on Japanese women reported a mean daily dietary vitamin D 
intake of 6.3µg/d, with 14% reportedly taking vitamin D supplements, whilst dietary 
intake and supplement use was not reported in the other studies.  
 
Insufficiency 
Insufficient vitamin D status in the second trimester was reported in 4 studies. Firstly, 
in a cross-sectional study of 1695 Chinese pregnant women where the mean BMI 
during second trimester was categorised as normal, vitamin D status was negatively 
correlated with BMI and body weight (37). This finding was not reported in multi-
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ethnic population study in Norway, where the mean pre-pregnancy BMI was normal 
(52) or in a large prospective observational study of 370 Chinese pregnant women, 
where the mean pre-pregnancy BMI was normal (42). In a Korean pregnant cohort 
vitamin D status reportedly increased from first trimester to second trimester however, 
it was still considered insufficient and information was not reported on supplement 
use or the seasons of blood sampling. After the first visit women were advised to 
engage in outdoor physical activity and eat variety of foods specially fortified milk, 
which may explained the increase in vitamin D status (33). 
 
Sufficiency 
The majority of studies carried out during the second trimester reported sufficient 
vitamin D status (1, 6, 15, 18, 21, 28, 29, 36, 42, 43, 46) although these studies were 
conducted in sunny countries and in women who had a normal BMI. One Australian 
cohort of obese pregnant women where the mean vitamin D status was considered 
sufficient, it was noted that increased BMI during second trimester in winter and 
spring was a significant predictor of vitamin D deficiency (15). Furthermore, in a 
cross-sectional study of 201 pregnant women, whilst mean vitamin D status was 
considered sufficient and the mean BMI during second trimester classed as 
overweight, 59% reported no supplement use, with only 12 participants achieving a 
dietary intake of 10µg/d. The authors reported that ethnicity, season, BMI and 
supplement use were significant predictors of vitamin D status in the second trimester 
(29). In Chinese pregnant women where the mean BMI was normal, 73% of pregnant 
women reported regularly use vitamin D supplements, along with reports of seasonal 
variation in vitamin D status in pregnant women in second trimester (42).  
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In studies conducted in Europe (Warsaw, Amsterdam, Izmir, New Zealand) sufficient 
vitamin D status during the second trimester was reported. In the Karlsson et al., 
(2013) study normal weight women were reported to have a sufficient vitamin D status 
with obese women almost reaching sufficiency (58.2 and 49.7 nmol/L, respectively); 
while dietary vitamin D intake (7.9 vs. 8.2 µg/d) and supplement use (44% vs. 47%) 
were not significantly different between the 2 groups (46). Furthermore, a study of 50 
normal weight pregnant women living in Warsaw reported sufficient vitamin D status, 
albeit 70% of the cohort reported regular use of vitamin D supplements (43). Sufficient 
vitamin D status was also reported in a large prospective cohort conducted in New 
Zealand (1710 pregnant women) where the mean BMI in second trimester was 
classified as normal, blood sampling was carried out across all seasons  and over half 
of women reporting consumption of vitamins contain vitamin D (51). Studies in 
second trimester that have reported the overall mean of vitamin D status as sufficient 
suggest that vitamin D deficiency is more likely if sampling occurred in winter, if 
women had a higher pre-pregnancy BMI or were not regularly users of vitamin D 
supplements (21, 6). 
Sufficient vitamin D status in the second trimester was also reported in United States, 
in small sample size of 36 obese pregnant women living in Pittsburgh compared to 
optimal vitamin D status reported in non-obese pregnant women however, there was 
no association observed between obesity and vitamin D (38). Furthermore, in a cross-
sectional study of 193 pregnant women where the mean BMI was categorised as 
overweight, a high vitamin D intake from supplements of 8.3µg/d was reported (28). 
Moreover, sufficient vitamin D status was also reported in 658 pregnant women living 
Seattle and Tacoma with a normal mean BMI (18). Vitamin D data on supplement use 
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and dietary intake were not reported in these studies (18, 38) and none of these studies 
reported on season of sampling (18, 28, 38). 
Optimal levels of vitamin D (≥75 nmol/L) in the second trimester has been achieved 
in some studies around the world (7, 17, 38, 41, 42) with the mean BMI category of 
most of these cohorts being normal weight. This was the case in 498 pregnant women 
living in Seattle, 114 pregnant women living in Tacoma, 93 non-obese pregnant 
women living in Pittsburgh and 637 Chinese pregnant women. A high rate of vitamin 
D supplement use of 92% and 73 % was reported in Tacoma and in China respectively 
(41, 42) however, no information was reported on supplement use or season of 
sampling in other cohorts (17, 38). Vitamin D status in the second trimester was 
inversely associated with maternal adiposity as estimated by pre-pregnancy BMI, were 
the mean BMI of healthy control pregnant women was normal weight (41). Only 1 
study of 537 overweight Canadian pregnant women in the second trimester showed a 
significant relationship between maternal vitamin D status and dietary intake from 
(diet, supplements) where the mean vitamin D intake diet and supplements was 
20.3µg/d (7). 
 
Between the second and third trimesters 
Four studies (32, 53, 54, 55) assessed vitamin D status during pregnancy at a time, 






Insufficient vitamin D status was reported in a large cohort of Chinese pregnant 
women where the mean BMI was categorised as normal weight, it has been reported 
that pregnant women who were overweight before pregnancy had significantly lower 
vitamin D status than non-overweight. Chinese pregnant women were non-
supplements users of calcium and vitamin D as it was one of exclusion criteria 
however, there was a seasonal variation in maternal vitamin D status (55). 
 
Sufficiency 
Sufficient vitamin D status was reported among healthy control pregnant women in 
these cohorts where the mean BMI was categorised as normal weight, except Turkish 
women who were classified as obese. However, all Turkish pregnant women were 
non-supplements users of calcium and vitamin D as it was one of exclusion criteria in 
this study whereas, 30% of Hungarian pregnant women were taking vitamin D 
supplements and 44% of the samples were taken in spring and summer (32, 54). In 
addition, optimal vitamin D status was reported in Indian pregnant women and there 
was a statistically significant negative linear correlation between vitamin D status and 
BMI with a 26% rate of obesity in the control group (53).  
 
Third trimester 
Twenty-four studies assessing vitamin D status in the third trimester are included in 




Six studies reported insufficient vitamin D status in third trimester (11, 19, 24, 33, 56, 
57), 3 studies reported the mean pre-pregnancy BMI being as normal weight (11, 24, 
57) one included 95 pregnant women living in Sweden, another 60 pregnant women 
living Greece and finally 767 pregnant women living in Maastricht. It was reported 
that the main determinates of vitamin D status in the third trimester were season and 
use of vitamin D supplements, as the mean vitamin D intake from supplements was 
5.8µg/d and from diet was 6.1µg/d (11) and the mean estimated vitamin D intake from 
food only was 10.5µg/d which is higher than many countries (24). However, none the 
pregnant women living in Greece were taking vitamin D supplements, and supplement 
usage was not reported in the Maastricht cohort; the author explained the insufficient 
vitamin D status could be related to reduced adherence to vitamin D supplementation 
or seasonal variations (57). 
Insufficient vitamin D status was reported among pregnant women in the third 
trimester who were classified as overweight (19, 33, 56), including among 202 
pregnant women living in Norway, 500 Korean pregnant women and among 70 Greek 
pregnant women. There was no significant association reported between early 
maternal BMI and vitamin D status in third trimester (19, 56). None of Greek pregnant 
women were taking a vitamin D supplement and there was no information on 
supplement use reported in either studies. Vitamin D status varied significantly with 
season in Norway however, season was not a factor in Greece as the study was 





The majority of the studies (3, 5, 9, 10, 12, 16, 20, 27, 40, 43, 45, 46, 52) reported 
sufficient vitamin D status in third trimester of pregnancy around the world. Five 
studies reported the mean BMI of pregnant women in early pregnancy (5, 16, 43, 46, 
17), 2 studies reported the mean before early pregnancy BMI (20, 52) and 1 study 
reported the mean BMI of pregnant women in third trimester (45) where the mean 
BMI of these cohorts were classified as being normal weight. Most of these studies 
reported vitamin D supplement use in 31%- 88% of pregnant women (5, 16, 20, 40, 
43, 45, 46) but one study, conducted in multi-ethnic population in Norway of 719 
pregnant women, did not report vitamin D supplementation. However, vitamin D 
status increased from insufficient status in second trimester to sufficient status in third 
trimester; this increase might be related to recommending vitamin D supplementation 
after the first visit; no information was reported on seasons of sampling (52). In a 
representative Swedish cohort of 1829 pregnant women, 17% of women travelled to 
regions with latitudes <35 ̊ in the third trimester. No significant association was 
observed in gestational weight gain and BMI with change in vitamin D status (40) 
however, other studies did not report on these associations. 
Within The Southampton Women’s Survey (SWS), a prospective cohort study, two 
studies assessed vitamin D status in third trimester and reported sufficient vitamin D 
status despite only 22% of women reporting supplement use and the mean pre-
pregnancy BMI being classified as overweight (10, 27). 
Two studies reported sufficient vitamin D status in the third trimester and the mean 
pre-pregnancy BMI or BMI in third trimester was considered as obese (3, 12). Among 
206 pregnant women was living in Oakland, where the mean vitamin D intake from 
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prenatal vitamins was 19µg/d, 71% of pregnant women reported daily supplement use. 
It has been reported that maternal vitamin D was significantly associated with pre or 
early pregnancy BMI (12). This was also observed among 40 healthy control pregnant 
women however, no information on supplement use or the season of sampling was 
available (3).  
Sufficient vitamin D status in the third trimester was reported for 384 pregnant women 
from different BMI groups from a prospective cohort conducted in Pittsburgh, Magee 
USA, where the majority of pregnant women used multivitamins or prenatal vitamins 
regularly during the last 3 months of pregnancy (9).  
Optimal vitamin D status in third trimester was reported in 5 studies from different 
geographical locations (14, 22, 26, 44, 58). In a cross sectional study of 38 normal 
weight and 23 obese pregnant women living in Chicago, both groups reported prenatal 
vitamin use and no significant difference was reported in vitamin D status between 
normal weight and obese pregnant women (26). Two studies reported optimal vitamin 
D status where the mean pre-pregnancy BMI was overweight in 37 and 40 healthy 
pregnant women who were used as controls in case control studies which were 
conducted in Ontario, Canada and in South Carolina respectively (22, 44). In the 
Canadian cohort the mean vitamin D from dietary intake (food and supplement) was 
14.4µg/d, while this study was conducted in wintertime to minimize the sun light 
influence (22), no information reported on season of sampling and vitamin D 
supplement use in South Carolina study (44). A study comprising 910 pregnant 
women living in Singapore where the mean BMI in the third trimester was overweight, 
reported optimal vitamin D status with a high rate of participants taking vitamin D 
supplementation 74% during pregnancy, the climate of the region is sun-rich all year 
round (58).  
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Optimal vitamin D status in third trimester was reported among 135 Egyptian pregnant 
women living Cairo, where the mean maternal BMI in the third trimester was 
classified as obese. Pregnant women were not taking any form of calcium or vitamin 
D supplements during the last 3 months of pregnancy in this study. Maternal vitamin 
D status had significant negative correlations with BMI and maternal age, and 
significant positive correlations with fish consumption and skin exposure (14).  
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The association between maternal BMI and vitamin D status during pregnancy 
according to study type 
 
Prospective studies 
A total of 20 prospective studies reported vitamin D status in different trimesters and 
BMI categories (Table 2, a). Vitamin D deficiency (<25 nmol/L) was only observed 
in 1 prospective study conducted in North India among pregnant women, in which 
92% of pregnant women were classified as vitamin D deficient and BMI during second 
trimester was a negative predictor of vitamin D status (36). 
Insufficient vitamin D status (25-50 nmol/L) was reported in 7 prospective studies, 
during the first trimester where the mean BMI was classified as normal weight and 
overweight in two populations (London and Pakistan) (34, 47). These studies reported 
that maternal vitamin D status in the first trimester decreased with increasing BMI and 
vitamin D status increased in summer (34); none of these studies reported information 
on vitamin use (34, 47). During the second and third trimesters, insufficient vitamin D 
status was reported among pregnant women who had pre-pregnancy BMI categorised 
as normal weight (42, 57). The authors suggested that the insufficient vitamin D status 
could be related to reduced adherence to vitamin D supplementation or owing to 
seasonal variation (57). Insufficient vitamin D status was also reported among 
Norwegian pregnant women in the third trimester who were classified as overweight, 
and the authors reported seasonal fluctuations in vitamin D status (19). Whilst these 
prospective studies assessed vitamin D status and measured BMI, the researchers did 
not investigate potential associations between vitamin D status and BMI (42, 57) and 
in 1 study where these associations were examined, no significant associations were 
69
found (19). Furthermore, insufficient vitamin D status has been observed across all 
trimesters of pregnancy in obese pregnant women compared to normal weight who 
had sufficient vitamin D status despite obese women reporting higher dietary intakes. 
Percentage fat mass in addition to BMI has also been shown to be negatively 
associated with vitamin D status in all trimesters of pregnancy (46). In a cohort of 
Korean pregnant women recruited prospectively throughout the year, the mean BMI 
was categorised as normal and vitamin D status reportedly increased as pregnancy 
progressed albeit concentrations were still considered insufficient at all time-points; 
season of sampling was not taken into consideration. The rise in vitamin D status may 
be owing to advice given on increasing outdoor physical activity and consumption of 
fortified milk (33). 
Sufficient vitamin D status (>50 nmol/L) has been reported in most prospective studies 
included in this review (9, 10, 16, 18, 21, 27, 38, 46, 49, 51, 52). Four studies had 
assessed vitamin D status at more than one time-point during pregnancy and reported 
sufficient vitamin D status (27, 9, 52, 46, 49). During the first and third trimesters in 
the Southampton prospective study where the mean BMI was classified as overweight, 
37% of pregnant women reported taking vitamin D supplements and supplementation 
use was correlated with vitamin D status. In this study it was also reported that higher 
weight gain during pregnancy was associated with reduced 25(OH)D concentrations 
(27). These findings are comparable to studies conducted in Pittsburgh and Finland 
where sufficient vitamin D status was observed among all BMI groups in all trimesters 
but obese women had significantly lower vitamin D status compared to non-obese 
women (9, 49). In both studies, vitamin D status did not change as pregnancy 
progressed (27, 9). In addition, in a multi-ethnic population study in Norway, where 
the mean pre-pregnancy BMI was normal, vitamin D status increased from insufficient 
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status in second trimester to sufficient status in third trimester; albeit this increase is 
most likely due to increased use of vitamin D supplementation following 
recommendations at the first visit. No information was reported on associations 
between maternal BMI and vitamin D status or on seasons of sampling (52).  
Sufficient vitamin D status was also reported in 7 prospective studies which assessed 
vitamin D status at one time point during pregnancy in women classified as normal 
weight (18, 21, 51) and 1 study reported significant negative associations between pre-
pregnancy BMI and vitamin D status (21).  
A small study conducted in Pittsburgh, USA reported significantly lower vitamin D 
status in obese compared to non-obese pregnant women but found no significant 
association between BMI and vitamin D status (38). Similar null associations between 
BMI and vitamin D status in third trimester have been reported in a Southampton 
population but were not investigated in Vietnam populations (10, 16). 
Optimal vitamin D status (≥75 nmol/L) was observed during the second and third  
trimesters in 3 prospective studies (7, 38, 58) of pregnant women who had a mean 
BMI classified as overweight (7, 58). The high vitamin D status observed was most 
likely owing to high dietary intakes (as high as 20.3µg/d in Canada) (7) or high vitamin 
D supplement use (58). It has been reported that pregnant women who had vitamin D 
status (≥75 nmol/L) had lower BMI (58).  
Three prospective studies assessed vitamin D status in cord blood (9, 19, 47) and 
reported insufficient vitamin D status in both the mother and in cord blood samples 
(19, 47), with maternal status significantly predicting cord blood status (19). In 1 
study, vitamin D status in cord blood was significantly higher in neonates born to non-
obese mothers compared to those born to obese mothers, possibly owing to lower 
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maternal vitamin D status in obese mothers (9). Furthermore, in this study, it was 
observed that an increase in BMI from 22 to 34 weeks gestation, resulted in a 2.1-fold 
increase in neonatal vitamin D deficiency (9). 
 
Retrospective analysis 
A study in London retrospectively analysed 346 blood samples collected from 
pregnant women at their initial booking visit and reported insufficient vitamin D status 
(Table 2, b), with an independent association found between BMI and vitamin D 
status. Obese pregnant women (BMI ≥ 30kg/m2) had significantly lower vitamin D 
status than non-obese pregnant women and seasonal variations were apparent with 
30% of pregnant women having a lower vitamin D status between January and March 
compared to between July and September, irrespective of body weight (23). 
 
Cohort studies 
A total of 6 cohort studies reported vitamin D status of pregnant women within 
different trimesters and across BMI categories and are included in this review (Table 
2, c). None of these studies reported vitamin D deficiency (<25 nmol/L) whilst, 
insufficient vitamin D status (25-50 nmol/L) was reported in 2 of the cohort studies of 
pregnant women with mean pre-pregnancy BMI classified as overweight (39, 50). 
However, there was no association reported between maternal BMI and vitamin D 
status (39, 50). Furthermore, insufficient vitamin D status was reported in a large 
cohort of Chinese pregnant women and it was found that those women who were 
overweight before pregnancy had significantly lower vitamin D status than normal 
weight women (55). 
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Sufficient vitamin D status (>50 nmol/L) has been reported in 4 cohort studies within 
different BMI categories (15, 39, 40, 43), and one study reported that increasing BMI 
was a significant negative predictor of vitamin D status (15). Furthermore, in a multi-
ethnic population-representative Swedish cohort of 1829 pregnant women with mean 
BMI classified as normal weight, vitamin D status increased from first to third 
trimester albeit status at both trimesters was within range of sufficiency. This increase 
was related to factors such as dietary vitamin D intake, vitamin D supplementation 
and travel to regions with latitudes <35 ̊. There were no significant associations 
between gestational weight gain or BMI and change in vitamin D status (40). In 
Warsaw, a cohort study of pregnant women with normal BMI reported sufficient 
vitamin D status across all trimesters of pregnancy, with overweight pregnant women 
having significantly lower vitamin D status than normal weight women in both winter 
and summer. In contrast to other studies, there was no significant difference in vitamin 
D status between winter and summer time, suggesting that high supplement use 
prevented seasonal variations in status (43). 
 
Case-control studies 
There are 12 case-control studies included in this review, where vitamin D status of 
the healthy control group has been reported from each study (Table 2, d). Vitamin D 
deficiency (<25 nmol/L) was observed only in one study among Turkish pregnant 
women in the second trimester where the mean BMI was classified as overweight, 
however, there was no association reported between maternal BMI and vitamin D 
status (13). Insufficient vitamin D status (25-50 nmol/L) was observed in 2 healthy 
control pregnant women groups, firstly during the first trimester where the mean BMI 
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of women was classified as being overweight and secondly at the time between the 
first and second trimesters where the mean pre- pregnancy BMI was classified as being 
obese and obese class 2. Both of these studies reported a significant negative 
association between maternal BMI and maternal vitamin D status (25, 48). 
The majority of case-control studies included in this review reported sufficient vitamin 
D status (>50 nmol/L) in healthy control groups of pregnant women within different 
trimesters across BMI categories (3, 5, 31, 32, 45, 48, 54), with some studies reporting 
significant negative associations between BMI and vitamin D status (31, 48) whilst 
others did not find these associations (32, 54). Other studies did not investigate links 
between maternal BMI and vitamin D status despite having measured both parameters 
(3, 5, 45). 
Optimal vitamin D status (≥75 nmol/L) was observed among healthy control pregnant 
women in some studies around the world (22, 41, 44) and reported significant inverse 
associations between vitamin D status and BMI in normal weight pregnant women 
(41). In comparison, studies where the mean pre-pregnancy BMI was overweight (22, 
44), and higher dietary intakes (from food and supplements) were reported, no 
significant correlations was found between maternal BMI and vitamin D status (22) 
or were not investigated (44). 
Only 1 case-control study reported vitamin D status of cord blood samples, and 
reported that neonates born to healthy control mothers had sufficient vitamin D status 




A total of 19 cross-sectional studies included in this review reported vitamin D status 
within different trimesters and across BMI categories (Table 2, e). Two studies 
reported deficient vitamin D status (<25 nmol/L) during the first and second trimester 
among Saudi pregnant women where the mean BMI was overweight and among 
Japanese pregnant women with mean pre-pregnancy BMI considered normal.  
However, pre-pregnancy BMI was positively correlated with vitamin D status in the 
Japanese study but not significantly associated in Saudi study (4, 35).  
Insufficient vitamin D status (25-50 nmol/L) was observed in 6 cross-sectional studies 
of pregnant women (8, 11, 24, 29, 37, 56). A cross-sectional study conducted in 
Malaysia, where the city climate is consistently hot and humid throughout the year, 
reported insufficient vitamin D status among normal weight pregnant women in first 
trimester. Increased dietary vitamin D intake from food was found to reduce 
prevalence of vitamin D insufficiency. However, pre-pregnancy BMI in this study was 
not significantly associated with hypovitaminosis D (8). Two studies conducted during 
the second trimester of pregnancy also reported insufficient vitamin D status despite 
being from two different populations (China and Australia) and different BMI 
groupings (normal weight and obese/obese class 2 pregnant women). Both studies 
reported significant negative correlations between BMI and vitamin D status (29, 37). 
Furthermore, insufficient vitamin D status has also been observed during second and 
third trimesters in pregnant women of normal weight and overweight BMI, although 
no significant associations were found between BMI and vitamin D status (11, 56) or 
was not investigated (24).  
The majority of cross-sectional studies included in this review reported sufficient 
vitamin D status (>50 nmol/L) within all trimesters across different BMI categories 
(1, 2, 6, 12, 20, 28, 29, 30). Three studies included a range of BMI categories (normal 
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weight, overweight, obese) and reported sufficient vitamin D status across pregnancy 
and found that vitamin D status was inversely correlated with early pregnancy or pre-
pregnancy BMI (2, 29, 30). Similar associations between BMI and vitamin D status 
were also reported in 2 studies which recruited pregnant women with a mean BMI 
classified as overweight and obese (28, 12). In contrast, 3 studies where the mean BMI 
was classified as normal, did not investigate the associations between maternal BMI 
and vitamin D status (1, 6, 20). 
Optimal vitamin D status (≥75 nmol/L) was observed in the second and third trimesters 
across BMI categories (14, 17, 26, 53). One study of Indian pregnant women where 
the mean BMI was classified as normal, reported a statistically significant negative 
linear correlation between vitamin D status and BMI with a 26% rate of obesity in the 
control group (53). However, not all studies have found significant associations 
between BMI and vitamin D status (17, 26).  
Vitamin D status of cord blood has been measured in 5 cross sectional studies (12, 14, 
24, 26, 56). Insufficient vitamin D status was reported in cord blood samples of 
neonates born to normal weight or overweight mothers who had insufficient vitamin 
D status (24, 56) and also among cord samples of neonates born to obese mothers who 
had sufficient or optimal vitamin D status (12, 14). It has been observed that neonates 
of obese mothers have significantly lower cord vitamin D status compared to neonates 
of normal weight mothers despite similar maternal vitamin D status concentrations at 
the end of pregnancy (26). Overall, maternal and cord vitamin D status are determined 
by season of delivery, vitamin D dietary intake, skin pigmentation, supplement use 
and BMI (12, 14, 26). 
 
76
Vitamin D supplementation during pregnancy 
Only 2 RCT studies met the inclusion criteria for this review (1, 2) (Table 3). The first 
one from Kashan, Iran, had two groups of pregnant women who were recruited in the 
second trimester (n=24 in each group); the treatment group received 10µg/d vitamin 
D3 supplement and the control group received a placebo supplement for 9 weeks. The 
mean BMI of both groups was classified as overweight and there were no significant 
differences in dietary intake between the two groups. Following supplementation, 
vitamin D status was significantly higher in the treatment group compared to the 
placebo group and supplementation was reported to have beneficial effects on 
metabolic status including a decrease in high-sensitivity C- reactive protein and insulin 
concentrations. BMI was not considered in any analysis for this RCT (1). In the second 
RCT from Cork, Ireland, 3 groups of pregnant women (n= 48 in each group) at 14 
gestational weeks were recruited, with the treatment groups receiving supplements 
containing 10µg/d vitamin D3 or 20µg/d vitamin D3 and with the control group 
receiving a placebo  from 14 weeks gestation until delivery. The mean BMI of the 
10µg/d vitamin D3 group and placebo group was classified as overweight while 
20µg/d vitamin D3 group was classified as normal weight and there were no significant 
differences in dietary intake or vitamin D status at baseline between the three groups. 
After supplementation, vitamin D status at 24 and 36 weeks gestation increased in all 
groups with a significantly higher increase in the treatment groups than placebo, the 
increase in vitamin D status observed in the placebo group was attributed to seasonal 
variability and the larger increase in the 20µg group may well have been due to the 
normal BMI, where normal weight participants are known to have a higher response 
to vitamin D supplementation then their overweight or obese counterparts. No 
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association was observed between maternal BMI at baseline and maternal vitamin D 
at baseline or change of vitamin D status after intervention (2).  
 
Vitamin D status in cord blood 
Some observational studies (9, 12, 14, 19, 22, 24, 26, 47, 56) did assess vitamin D 
status in cord blood samples (Table 1, d) and reported that neonates of obese mothers 
have significantly lower cord vitamin D status compared to neonates of normal weight 
mothers (26). It has been observed that an increase in BMI from 22 to 34 weeks 
gestation, results in a 2.1-fold increase in neonatal vitamin D deficiency (9). Overall, 
maternal and cord vitamin D status are determined by season of delivery, vitamin D 
dietary intake, skin pigmentation, supplement use and BMI (12, 14, 26). In a 
Norwegian study in overweight women in early pregnancy, no significant association 
between maternal BMI and cord blood vitamin D status was reported despite there 
being a strong positive association between maternal vitamin D status and cord blood 
vitamin D status (19). Three studies, 2 in Greece and 1 in Pakistan reported that both 
the mother and neonate had insufficient vitamin D status; vitamin D status in mothers 
was not significantly higher than the neonates (24, 47, 56). In addition, it has been 
observed that neonates born to a mother who had deficient vitamin D status during 
pregnancy had significantly lower vitamin D status compared with neonates born to 
mothers who had sufficient vitamin D status during pregnancy (24). 
 
Overall summary of studies divided the study cohort based on BMI categories 
A total of 13 studies were included in this review which divided the study cohort based 
on BMI categories even if the association between maternal BMI and vitamin D was 
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not the main aim of the research; 6 studies reported data from the first trimester, 3 
studies from second trimester, 4 studies which considered between first and second 
trimesters and 3 studies at third trimester. Only 2 study assessed vitamin D status in 
cord blood samples according to maternal BMI categorised by studies (Table 4).  In 
this review, we have assessed the association between maternal BMI and vitamin D 
status during pregnancy within each trimester and classified status as deficiency, 
insufficiency and sufficiency. Obese or obese class 2 pregnant women in these studies 
had insufficient vitamin D status compared to non-obese (2, 9, 23, 29, 30, 39, 43, 46, 
48). Only 2 studies reported optimal vitamin D status in normal weight and overweight 
pregnant women and sufficient vitamin D status in obese women, 1 in Pittsburgh with 
small participant numbers and where the BMI was measured pre-pregnancy and 
prenatal vitamin use was common in this population, however, no information 
reported on season of sampling (38). The other study was conducted in Finland, no 
significant difference was observed for the season of blood collection and no 
information was reported on supplement use (49). In a cross-sectional study among 
1345 pregnant women living in Denmark, it was reported that a 5 unit increase in BMI 
was associated with a 25(OH)D lowering of 4.2 nmol/L and 2.8 nmol/L in winter and 
summer months, respectively (2). Across the first trimester, 25(OH)D concentrations 
during pregnancy were inversely correlated with maternal BMI (30, 43). Maternal 
BMI in the second trimester was a significant predictor of vitamin D status in a study 
of 201 Caucasian pregnant women living in Australia (29).  
Furthermore, in a prospective pregnancy cohort study conducted in 398 pregnant white 
and black women, neonates of obese mothers had significantly lower 25(OH)D 
concentrations compared to neonates of lean mothers (49.9 vs. 56.2 nmol/L; P < 0.05) 
after adjustment for ethnicity, season, gestational age, multivitamin use, physical 
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activity, and maternal age. The authors concluded that obese women and their 
neonates are at a high risk of vitamin D deficiency despite maternal prenatal vitamin 
use (9). Moreover, a sufficient vitamin D status in the first trimester was reported in a 
prospective pregnancy cohort of Pakistani pregnant women where the cohort was 
divided into 3 groups in the first trimester BMI (underweight, normal weight and 
overweight), no information was reported on time of sampling (season) or vitamin use 
(47).  
 
Strengths and limitations of this review 
To the authors’ knowledge this is the first systematic review to explore current 
knowledge on the association between maternal obesity and vitamin D status of the 
mother and their infants. Whilst there are some systematic reviews investigating 
associations between vitamin D status and effect of supplementation during pregnancy 
on maternal and infant health outcomes, the association between obesity and vitamin 
D status was not considered in these analyses (Thorne-Lyman and Fawzi, 
2012;Harvey et al., 2014;Faustino et al., 2015). The majority of the studies included 
in this review were observational studies, highlighting the need for RCTs to assess the 
association between maternal obesity and maternal and child vitamin D status. Owing 
to the heterogeneity of the studies included in this review, a meta-analysis of the data 
was not possible and assessment of the magnitude of effect of BMI on vitamin D status 
could not be elucidated. However, we have adhered as much as possible to guidelines 





Evidence shows that obese or obese class 2 pregnant women have consistently lower 
vitamin D status compared to non-obese pregnant women in studies across the globe 
and maternal BMI is negatively associated with maternal vitamin D status. As infant 
vitamin D stores are directly related to maternal stores, studies report that vitamin D 
status is lower in infants born to obese mothers compared to infants born to normal 
weight mothers. As maternal obesity was negatively associated with maternal and 
infant vitamin D status, with potential implications for both maternal and child health, 
public health advice on vitamin D supplementation during pregnancy should consider 
the implications of pre-pregnancy BMI.   
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11 wk 1st 
trimester 




CS 502 Spanish 
Mediterranean 
sea coast  





11 -14 wk 1st 
trimester 
67.8 ± 8.5                            ECLIA N/A N/A  
30 Perez-Lopez, 
2011 
CS 307 Spanish 
Mediterranean 
sea coast  




11 -14 wk 1st 
trimester 







CS 132 Spanish 
Mediterranean 
sea coast  




11 -14 wk 1st 
trimester 





CS 63 Spanish 
Mediterranean 
sea coast  




11 -14 wk 1st 
trimester 
60.6 ±10.0 ECLIA BMI ≥ 30 
kg/m2 
Obese  
31 Powe,  
2010 
CCS 131 Boston, USA            
42.3601° N, 
71.0589° W 
N/A 11.6 ± 3.0 wk     1st 
trimester 
72.0 ± 2.0 LC-MS/MS   24.4 ± 4.5 Normal 
weight 
 










12-14 wk                                                                        1st
trimester 











11–13 wk 1st 
trimester 














11–13 wk 1st 
trimester 













11–13 wk 1st 
trimester 
55.9 ± 14.6  LC-MS/MS 26.1 ± 1.6 Overweight Women 
had 
Elective   
C- section 
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39 Gerrit van den 
Berg,  
2013 
Cohort study 372 Amsterdam, 







~12 wk 1st 
trimester 
49.8 ± 23.7                     ELISA BMI >25 
kg/m2  **                                                                                                                  
Overweight  
39 Gerrit van den 
Berg,  
2013 
Cohort study N/A Amsterdam, 







~12 wk 1st 
trimester 
58.3± 24.1  ELISA BMI >25 
kg/m2 ** 
Overweight  
39 Gerrit van den 
Berg,  
2013 
Cohort study N/A Amsterdam, 







~12 wk 1st 
trimester 
62.6 ± 27.5     ELISA BMI >25 
kg/m2 ** 
Overweight  
39 Gerrit van den 
Berg,  
2013 
Cohort study 1902 Amsterdam, 







~12 wk 1st 
trimester 
63.6 ± 39.8  ELISA BMI <25 




39 Gerrit van den 
Berg, 
2013 
Cohort study N/A Amsterdam, 







~12 wk 1st 
trimester 
71.5± 28.4 ELISA BMI <25 




39 Gerrit van den 
Berg,  
2013 
Cohort study N/A Amsterdam, 











ELISA BMI <25 

















10.8 ± 2.0 wk 1st 
trimester 














(April 1 – 
September 
30) 
1st trimester     1st 
trimester 
































11.5 ± 1.5 wk   1st 
trimester 
49.7 ± 11.5                                                                          CLIA  33.9 ± 3.3 Obese  















40.9 ± 32.3 ELISA 22.4 ± 4.6 Normal 
weight 
All women 















43.7 ± 30.7 ELISA 17.2 ± 1.0  Normal 
weight 
 















38.3 ± 29.4 ELISA 20.9 ± 1.3  Normal 
weight 
 















42.4 ± 36.3 ELISA 27.3 ± 4.0 Overweight  
 Observational studies of vitamin D status in the first & second trimesters 
2 Andersen, 
2013 







8-16 wk 1st & 2nd 
trimester 
59.7 LC-MS/MS <18.5    













8-16 wk 1st & 2nd 
trimester 
66.6 LC-MS/MS 18.5–24.9 













8-16 wk 1st & 2nd 
trimester 
62.6 LC-MS/MS 25–29.9 












8-16 wk 1st & 2nd 
trimester 
56.7 LC-MS/MS 30–34.9 











8-16 wk 1st & 2nd 
trimester 
52.1 LC-MS/MS >35  














4–22 wk 1st & 2nd 
trimester 
62.8(55.0, 

































4–22 wk 1st & 2nd 
trimester 
55.9 (48.7, 
64.2) *     





CCS 1002 Quebec  
52° 56' N  
73° 32' W 
Halifax  
44° 38' N  
63° 34' W   
Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 







CCS 311 Quebec  
52° 56' N  
73° 32' W 
Halifax  
44° 38' N  
63° 34' W   
Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 





CCS 124 Quebec  
52° 56' N  
73° 32' W 
Halifax  
44° 38' N  
2002–2010 12-15 wk 1st & 2nd 
trimester 
48.2 ± 16.5 CLIA 30-<35 
kg/m2** 
Obese   
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CCS 84 Quebec  
52° 56' N  
73° 32' W 
Halifax  
44° 38' N  
63° 34' W   
Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 













2008-2014 7-18 wk 1st & 2nd 
trimester 













2008-2014 7-18 wk 1st & 2nd 
trimester 











2008-2014 7-18 wk 1st & 2nd 
trimester 
64 ± 24 N/A 30-<35 
kg/m2 









2008-2014 7-18 wk 1st & 2nd 
trimester 
57 ± 22 N/A ≥35  
kg/m2 
Obese 













13.2 ± 5.5 wk 1st & 2nd 
trimester 
41.1 ± 14.2 IDS 27.4 ±7.0** Overweight  
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).      
CS- cross section, CCS-case control study, N/A not available, wk- week gestational.  
* n 9 study vitamin D presented as mean (95% CI)   
 ** Pre-pregnancy BMI 
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1 Allen,  
2013  






18 wk     2nd 
trimester 
55.0 ± 17.1  ELISA 22.6 ± 4.4   Normal 
weight 
 
1 Allen,  
2013  






18 wk  2nd 
trimester 
58.6 ± 16.3 ELISA 21.8 ± 3.7 Normal 
weight 
 
6 Mehmet Bal,  
2016 







24-28 wk 2nd 
trimester 


















95.3 ± 25.0              LC-MS/MS  26.0 ± 5.0 Overweight  
13 Daglar,  
2016 












22.7 ± 18.2         ELISA 26.1 ± 5.2               Overweight  















71.0 ± 47.9 ECLIA 31.2 ± 13.5 Obese  
17 Huang,  
2014 
CS 498 Seattle, 







At or prior 
to 20 wk 
2nd 
trimester 








658 Washington.    
Seattle,    
Tacoma   
47.6062° N, 
122.3321° W  
        
1996 to 
2008 
At or prior 
to 20 wk 
2nd 
trimester 
72.7 ± 21.0                                                                                                        LC-MS/MS 23.8 ±5.4**        Normal
weight 















60.4 ± 0.7 ELISA  22.9 ± 3.7 Normal 
weight 
 
28 Ozias,  
2014 







14 ± 4 wk      2nd 
trimester 
56.7 ± 33.2                     EIA 27.0 ±5.0**  Overweight  
29 Perampalam, 
2011 
CS 100 Australia –  







24-28 wk 2nd 
trimester 
61.3 ± 23.4                                                  ECLIA 27.3 ± 5.7                                                          Overweight  
29 Perampalam, 
2011 
CS 33 Australia –  







24-28 wk 2nd 
trimester 
65.9 ± 28.8    ECLIA 16.0 - 24.9  






CS 44 Australia –  







24-28 wk 2nd 
trimester 
61.6 ± 21.2   ECLIA 25.0- 29.9 




CS 15 Australia –  







24-28 wk 2nd 
trimester 
53.4 ± 17.2   ECLIA 30.0- 34.9 




CS 8 Australia –  







24-28 wk 2nd 
trimester 
60.7 ± 21.9    ECLIA ≥35.0  
















24-28 wk 2nd 
trimester 
69.5 ± 26.9   RIA 28.3 ± 5.8                  Overweight  
29 Perampalam, 
2011 








24-28 wk 2nd 
trimester 
62.8 ± 24.3  RIA 16.0- 24.9 














24-28 wk 2nd 
trimester 
58.9 ± 30.1 RIA 25.0- 29.9 












24-28 wk 2nd 
trimester 
49.0 ± 17.4 RIA 30.0- 34.9 












24-28 wk 2nd 
trimester 
49.1 ± 25.0 RIA ≥35.0  














20-22 wk 2nd 
trimester 











19- 23 wk 2nd 
trimester 











19- 23 wk 2nd 
trimester 












19- 23 wk 2nd 
trimester 














12–16 wk 2nd 
trimester 
20.9 ± 4.5   ELISA  21.8 ± 3.4  Normal 
weight 
 
37 Tao,  
2012 
CS 1695 Shanghai, 
China         
31.2304° N, 
121.4737° E 
1 July 2008 
to 30 June 
2009 




43.9 ± 28.6                                                   ECLIA 22.5 ± 3.1             Normal 
weight 
 















ELISA  <25 kg/m2** Normal 
weight 
 















ELISA 25.0-29.9  
kg/m2** 
Overweight  















ELISA ≥30  
kg/m2** 
Obese  
41 Zhang,  
2008 
CCS 114 Tacoma, 








~16 wk  
2nd 
trimester 
75.2 ± 24.2  ELISA 23.3 ±3.8**  Normal 
weight 
 















16–20 wk 2nd 
trimester 
41.4 ± 6.5                                                                                 ECLIA 20.2 ±2.5**                                                                Normal
weight 
 















16–20 wk 2nd 
trimester 



















16–20 wk 2nd 
trimester 





















trimester   
2nd 
trimester 















trimester   
2nd 
trimester 















trimester   
2nd 
trimester 
49.7 ± 18.9   CLIA 33.9 ± 3.3#  Obese  




1710 New Zealand 
40.9006° S, 
174.8860° E 
2005-2008 15 wk 2nd 
trimester 













15.4 3.5 2nd 
trimester 
50.0 ± 27.0 RIA 24·5±4·8** Normal 
weight 
 
 Observational studies of vitamin D status in the second & third trimesters 
32 Parildar,  
2013 





24-32 wk 2nd &3rd 
trimester 
57.25± 25   ELISA  25.9± 4.4  Obese  
109
53 Siddiqi,  
2018 







24-28 wk 2nd &3rd 
trimester 
80.8 ± 21.0 CLIA 23.9 ± 2.6 Normal 
weight 
 
54 Tänczer,  
2017 








24-28 wk 2nd &3rd 
trimester 
67.3 ± 24.5 CLIA 24.3±4.4 Normal 
weight 
 
55 Zhao,  
2017 








23-28 wk 2nd & 3rd 
trimester 
37.7  ± 14.1 CLIA 21.4 ±2.6** Normal 
weight 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).      
CS- cross section, CCS-case control study, N/A not available, wk- week gestational.  
* n 38,40 studies vitamin D and BMI presented as mean (95% CI)  
 ** Pre-pregnancy BMI 
# BMI from first-trimester   
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Mean ± SD  
Vitamin 

















N/A 38.5 ± 1.43  
wk     
3rd 
trimester 
59.2 ± 14.8                                                                        ECLIA 30.6 ± 3.72 Obese  
5 Abedi,   
2013 










57.3 ± 28.4  ELISA 23.6 ± 3.5# Normal 
weight 
 










37–42 wk 3rd 
trimester 














37–42 wk 3rd 
trimester 
61.2 (52.0, 72.0)*   ELISA 25–29.9 
kg/m2 ** 
Overweight  










37–42 wk 3rd 
trimester 
60.2 (51.0, 71.2)*   ELISA ≥30 
kg/m2 ** 
Obese  






UK,    






34 wk  3rd 
trimester 











 35–37 wk 3rd 
trimester 
 47·4 ± 18·1  CLIA 22·5 ** Normal 
weight 
 
12 Dror,  
2011 










due date.  
3rd 
trimester 
74.2 ± 34.0  RIA 32.1 ±8.7**  Obese  
14 El Rifai,  
2014 










38.6 ± 5.0 
3rd 
trimester 
81.5 ± 53.5                                                 ELISA 31.8 ±5.0 Obese  















32 Wk 3rd 
trimester 
70.6 ± 22.2 N/A 19.9 ± 2.0# Normal 
weight 
 










30–32 wk 3rd 
trimester 
45.0 ± 17.0 RIA 
 
26.6 ± 3.8 Overweight  
20 Gunduz,  
2016 








36 wk 3rd 
trimester 

























93.2 ± 19. 2 RIA  27.2 ±7.2** Overweight  
24 Karras,  
2013 
CS 60 Thessaloniki, 













 44.7 ± 33.0  LC-MS/MS 22.2 ±3.3**  Normal 
weight 
 
26 Josefson,  
2013 
CS 38 Chicago,  
41° N  




n= 33   115.12     HPLC 22.0 ±1.8** Normal 
weight 
 
26 Josefson,  
2013 
CS 23 Chicago 41° 
N  




n= 15     124.6                             HPLC 35.5 ±4.1** Obese  












34 wk  3rd 
trimester 
64.8 ± 30.4 RIA  25.2 ±4.6** Overweight  










32-34 wk 3rd 
trimester 















33.4 ± 1.9 3rd 
trimester 






















trimester        
3rd 
trimester 





CCS 40 South 









91.5 ± 27.4    RIA  29.2 ±2.6**    Overweight  
45 Ullah,  
2013 
















































47.7 ± 18.3  CLIA  33.9 ± 3.3# Obese  
56 Karras,  
2018 








38.8 ± 0.2 3rd 
trimester 














34–36 wk 3rd 
trimester 
44·4 ± 18·2 ELISA 23·8±3·9** Normal 
weight 
 






N/A 26-28 wk 3rd 
trimester 












28.8 1.4 3rd 
trimester 
59.0 ± 29.0 RIA 24·5±4·8** Normal 
weight 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).      
CS- cross section, CCS-case control study, N/A not available, wk- week gestational.  
** Pre-pregnancy BMI 



































N, 79.9959° W 











N, 79.9959° W 









N, 79.9959° W 
1997 to 2001 49.9 (42.8, 58.2)* ELISA ≥30  
kg/m2 ** 
Obese  









to January 2008 
43.7 ± 23 RIA 32.1 ± 8.7 ** Obese  
14 El Rifai, 
2014 
CS 135 Cairo University, 




to May 2013 





202 Norway, Oslo     
59.9139° N, 
10.7522° E 
2001 to 2008 31 ± 18 RIA  26.6 ± 3.8# Overweight  
22 McManus, 
2014 
CCS 37  London, 
Ontario, Canada 
latitude of 49°N. 













CS 60 Thessaloniki, 






39.7 ± 34  LC-
MS/MS 





CS 35 Chicago, which 
is at latitude 41° 
North  
Summer births 




68.6  HPLC  






CS 23 Chicago, which 
is at latitude 41° 
North  
Summer births 




52  HPLC 35.5+4.1** Obese  






N, 67.0011° E 
January 2012 to 
May 2014 





CS 70 Thessaloniki, 
Greece 40.6401° 
N, 22.9444° E 
April 2014 until 
October 2015 
40.8 ± 2.5 RIA 29.6 ± 0.7 Overweight  
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).      
CS- cross section, CCS-case control study, N/A not available, wk- week gestational.  
* n 9 study vitamin D presented as mean (95% CI)  
 ** Pre-pregnancy BMI 
# BMI from first-trimester 
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Table 2, a: Prospective studies 














































34 wk  3rd trimester 64.8 ± 30.4 RIA  25.2±4.6** Overweight 
 
33 Park,  
2014 






















796 London, UK 
51.5074° N, 
0.1278° W 
01-Mar-06 11–13 wk 1st trimester 47.6 ± 11.7                                                                               LC-
MS/MS 







111 London, UK 
51.5074° N, 
0.1278° W 
01-Mar-06 11–13 wk 1st trimester 45.0 ± 14.2 LC-
MS/MS 






88 London, UK 
51.5074° N, 
0.1278° W 
01-Mar-06 11–13 wk 1st trimester 55.9 ± 14.6  LC-
MS/MS 
26.1 ± 1.6 Overweight Women 
had 
Elective   
C- section 
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9.78 ± 2.30 
wk 
1st trimester 40.9 ± 32.3 ELISA 22.4 ± 4.6 Normal 
weight 
All women 









9.54 ± 2.40 
wk 
1st trimester 43.7 ± 30.7 ELISA 17.2 ± 1.0  Normal 
weight 
 









 9.79 ± 
2.25 wk 
1st trimester 38.3 ± 29.4 ELISA 20.9 ± 1.3  Normal 
weight 
 









 9.92 ± 
2.30 wk 













79.9959° W  
1997 to 
2001 
4–22 wk 1st & 2nd trimester 62.8(55.0, 











79.9959° W  
1997 to 
2001 











79.9959° W  
1997 to 
2001 
4–22 wk 1st & 2nd trimester 55.9 (48.7, 
64.2) *     








37–42 wk 3rd trimester 67.3 (58.8, 









37–42 wk 3rd trimester 61.2 (52.0, 








37–42 wk 3rd trimester 60.2 (51.0, 
71.2)*   







Cord Cord 56.2 (49.7, 
63.6) *                                                        

















Cord Cord 49.9 (42.8, 
58.2)* 






43 Helsinki, Finland 
60.1699° N, 
24.9384° E 







34 Helsinki, Finland 
60.1699° N, 
24.9384° E 






84 Helsinki, Finland 
60.1699° N, 
24.9384° E 






58 Helsinki, Finland 
60.1699° N, 
24.9384° E 















2nd trimester 95.3 ± 25.0              LC-
MS/MS  





658 Washington.    
Seattle,    





At or prior 
to 20 wk 
2nd trimester 72.7 ± 21.0                                                                                                        LC-
MS/MS 

































At ≤20 wk 2nd trimester 88.5 (81.3- 
96.3)* 













At ≤20 wk 2nd trimester 77.8 (63.1-
96.0)* 






























up to 2012 
















up to 2012 















up to 2012 





1710 New Zealand 
40.9006° S, 
174.8860° E 
2005-2008 15 wk 2nd trimester 72.9 ± 27.0 LC-
MS/MS 



























































34–36 wk 3rd trimester 44·4 ± 
18·2 
ELISA 23·8±3·9** Normal 
weight 
 




N/A 26-28 wk 3rd trimester 81.3 ± 27.2 LC-
MS/MS 


















80 Western Sweden 






11.9 ± 1.0  
wk 












11.5 ± 1.5 
wk   






trimester   







trimester   















3rd trimester 47.7 ± 18.3  CLIA  33.9 ±3.3# Obese 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).      
N/A not available, wk- week gestational.  
* n 9 study vitamin D presented as mean (95% CI)  
 ** Pre-pregnancy BMI 
# BMI from first-trimester   
123





































































LC-MS ≥30 kg/m2 Obese 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).     
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Table 2, c: Cohort studies  
          





































~12 wk 1st 
trimester 
49.8 ± 23.7                     ELISA BMI >25 
kg/m2  **                                                                                                                  
Overweight Low 
education










~12 wk 1st 
trimester 














~12 wk 1st 
trimester 














~12 wk 1st 
trimester 
63.6 ± 39.8  ELISA BMI <25 















~12 wk 1st 
trimester 
71.5± 28.4 ELISA BMI <25 





39 Gerrit van den 
Berg,   
2013  
N/A Amsterdam, 






~12 wk 1st 
trimester 
69.1± 27.0 ELISA BMI <25 












(October 1 –– 
March 31) 
and summer 





trimester     
1st 
trimester 








trimester   
2nd 
trimester 







trimester        
3rd 
trimester 















71.0 ± 47.9 ECLIA 31.2 ± 13.5 Obese 
 
55 Zhao,  
2017 






23-28 wk 2nd & 3rd 
trimester 











and 2014 (24 
February–13 
June). 










33.4 ± 1.9 3rd 
trimester 











July 2009 to 
December 
2011 
13.2 ± 5.5 
wk 
1st & 2nd 
trimester 
41.1 ± 14.2 IDS 27.4±7.0** Overweight 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).     
N/A not available, wk- week gestational.  
** Pre-pregnancy BMI 
# BMI from first-trimester 
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Table 2, d: Case-control studies 

































158 Glasgow, UK           
55.8642° N, 
4.2518° W 
N/A  ~12.5 wk 1st 
trimester 
47.6 ± 26.7  LC-
MS/MS 
25.2 ± 4.0 Overweight 
 
31 Powe,  
2011 
131 Boston, USA            
42.3601° N, 
71.0589° W 
N/A 11.6 ± 3.0 
wk     
1st 
trimester 
72.0 ± 2.0 LC-
MS/MS  





1002 Quebec   
52° 56' N  
73° 32' W  
Halifax    
44° 38' N   
63° 34' W   
Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 







311 Quebec   
52° 56' N  
73° 32' W  
Halifax    
44° 38' N   
63° 34' W   
Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 






124 Quebec   
52° 56' N  
73° 32' W  
Halifax    
44° 38' N   
63° 34' W   
Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 






84 Quebec   
52° 56' N  
73° 32' W  
Halifax    
44° 38' N   
63° 34' W   
Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 





























~16 wk  2nd 
trimester 













24-28 wk 2nd &3rd 
trimester 










24-32 wk 2nd &3rd 
trimester 









N/A 38.5 ± 1.43  
wk     
3rd 
trimester 
59.2 ± 14.8                                                                        ECLIA 30.6 ± 3.72 Obese
 
5 Abedi,  
2013 




























93.2 ± 19. 
2 















29 ± 1.17 wk 3rd 
trimester 
91.5 ± 27.4    RIA  29.2±2.6**    Overweight 
 












62.1 ± 2.5  ECLIA 18.9 ± .02     Normal 
weight 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).     
N/A not available, wk- week gestational.  
** Pre-pregnancy BMI 





Table 2, e: Cross sectional studies 


















































sea coast  
36° N, 2° W 
May 2009 to 
April 2010 







sea coast  
36° N, 2° W 
May 2009 to 
April 2010 










sea coast  
36° N, 2° W 
May 2009 to 
April 2010 









sea coast  
36° N, 2° W 
May 2009 to 
April 2010 




4  Al-Ajlan, 
2015  













2010 to April 
2012. 




<18.5    












2010 to April 
2012. 
















2010 to April 
2012. 















2010 to April 
2012. 















2010 to April 
2012. 















1989 to 1991 18 wk     2nd trimester 55.0 ± 17.1  ELISA 22.6 ± 4.4   Normal 
weight 
 






1989 to 1991 18 wk  2nd trimester 58.6 ± 16.3 ELISA 21.8 ± 3.7 Normal 
weight 
 
6 Mehmet Bal, 
2016  





24-28 wk 2nd trimester 63.5 ± 23.2 LC-
MS/MS  

































24-28 wk 2nd trimester 65.9 ± 28.8    ECLIA 16.0 - 24.9  













24-28 wk 2nd trimester 61.6 ± 21.2   ECLIA 25.0- 29.9 












24-28 wk 2nd trimester 53.4 ± 17.2   ECLIA 30.0- 34.9 












24-28 wk 2nd trimester 60.7 ± 21.9    ECLIA ≥35.0 













24-28 wk 2nd trimester 69.5 ± 26.9   RIA 28.3 ± 5.8                  Overweight All women 
29 Perampalam, 
2011 







24-28 wk 2nd trimester 62.8 ± 24.3  RIA 16.0- 24.9 













24-28 wk 2nd trimester 58.9 ± 30.1 RIA 25.0- 29.9 













24-28 wk 2nd trimester 49.0 ± 17.4 RIA 30.0- 34.9 












24-28 wk 2nd trimester 49.1 ± 25.0 RIA ≥35.0 






284 Tokyo, Japan    
35.6895° N, 
139.6917° E 
June 2010 to 
July 2011 





157 Tokyo, Japan    
35.6895° N, 
139.6917° E 
June 2010 to 
July 2011 






127 Tokyo, Japan    
35.6895° N, 
139.6917° E 
June 2010 to 
July 2011 




37 Tao,  
2012 
1695 Shanghai, 




30 June 2009 
21.0 ± 6.2 
wk 
2nd trimester 43.9 ± 28.6                                                   ECLIA 22.5 ± 3.1             Normal 
weight 
 
17 Huang,  
2014 
498 Seattle, 
Washington.         
47.6062° N, 
122.3321° W 
April 2009 to 
December 
2010 
At or prior 
to 20 wk 












24-28 wk 2nd &3rd 
trimester 









July 2008 to 
July 2011 












due date.  





Cord Cord 43.7 ± 23 RIA 32.1±8.7**  Obese 
 
14 El Rifai, 
2014 









38.6 ± 5.0 













2013 and July 
1, 2013 





38 Chicago,  
41° N  
N/A 39.8± 1.1 wk 3rd trimester n= 33   
115.12    















23 Chicago  
41° N  
N/A 39.8 ± 1.0 
wk 
3rd trimester n= 15     
124.6                             
 HPLC 35.5±4.1** Obese 
 
  






Cord Cord 52  HPLC 35.5±4.1** Obese 
 
134












Cord Cord 40.8 ± 2.5 RIA 29.6 ± 0.7 Overweight 
 
24 Karras,  
2013 
60 Thessaloniki, 
Greece                
40.6401° N, 
22.9444° E 







3rd trimester  44.7 ± 33.0  LC-
MS/MS 







Cord Cord 39.7 ± 34  LC-
MS/MS 
22.4±4.3**   Normal 
weight 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).     
N/A not available, wk- week gestational.  
** Pre-pregnancy BMI 

































mean ± SD 
Vitamin 
D method  
BMI 
(kg/m2) 




RCT Pregnant women, 
with 10 µg 
 vitamin D3  
supplements 







10 µg/d vitamin 
D3  for 9 wk 
Run-in period                     
2.8 ± 0.9            
throughout the 
study      
2.9 ± 0.9 
25 wk  baseline 
44.5± 3.25       
HPLC BMI 
baseline                
26.8 ±  3.9 
         
34wk 9 weeks 
53.7± 4.5  
 
BMI at end                       
28.0 ±  3.9 
1 Asemi, 
2013 
RCT Pregnant women, 
with placebo  







Placebo for 9 
wk 
Run-in period            
2.8 ± 0.7              
throughout the 
study   
  2.9 ± 0.8       
25WK  baseline 14.5 
± 1.2  
HPLC BMI 
baseline,                   
27.4 ±  4.0 
         
34WK 9 weeks 
13.3 ± 1.1      
 
BMI at end                     
28.8 ±  3.7     
2 Callaghan, 
2018 
RCT Pregnant women, 
with 20 µg 
vitamin D3 
supplements 







20 µg vitamin 
D3 from 14 wk 
until delivery 
Form diet and 
supplement 11.4 
± 5.0 
14 wk  58.0 ± 22.9 LC-MS/MS 24.5 ± 3.1 
    
44 
    
24 wk 92.8 ± 22.1 
  
    
44 
    
36 wk 100.6 ± 23.3 
  
    
32 
    




RCT Pregnant women, 
with 10 µg 
vitamin D3 
supplements 







10 µg vitamin 
D3 from 14 wk 
until delivery 
Form diet and 
supplement 10.5 
± 5.4 
14 wk 49.6 ± 19.6 LC-MS/MS 26.8 ± 5.1 
    
40 
    
24 wk 81.9 ± 27.8 
  
    
37 
    
36 wk 96.0 ± 29.2 
  
    
33 
    







BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).     










RCT Pregnant women, 
with placebo  







0 µg vitamin D3 
from 14 wk 
until delivery 
Form diet and 
supplement 10.6 
± 5.2 
14 wk 57.2 ± 24.5 LC-MS/MS 25.7 ± 4.3 
    
43 
    
24 wk 63.6 ± 25.0 
  
    
40 
    
36 wk 71.4 ± 24.3 
  
        32         cord 39.2 ± 16.3     
137





















Mean ± SD  
Vitamin 
D method  
BMI 
(kg/m2) 












2010 to April 
2012 
8-16 wk 1st & 2nd 
trimester 












2010 to April 
2012 
8-16 wk 1st & 2nd 
trimester 












2010 to April 
2012. 
8-16 wk 1st & 2nd 
trimester 










2010 to April 
2012 
8-16 wk 1st & 2nd 
trimester 










2010 to April 
2012 
8-16 wk 1st & 2nd 
trimester 














1997 to 2001 4–22 wk 1st & 2nd 
trimester 













1997 to 2001 4–22 wk 1st & 2nd 
trimester 












1997 to 2001 4–22 wk 1st & 2nd 
trimester 
55.9 (48.7, 64.2) *     ELISA ≥30  
kg/m2** 
Obese  








1997 to 2001 37–42 wk 3rd 
trimester 













1997 to 2001 37–42 wk 3rd 
trimester 











1997 to 2001 37–42 wk 3rd 
trimester 
60.2 (51.0, 71.2)*  ELISA ≥30  
kg/m2** 
Obese  





















1997 to 2001 Cord   Cord 53.8 (46.2, 62.8)* ELISA 25–29.9 
kg/m2** 
Overweight  























































29 ± 10.9 LC-MS  ≥30  
kg/m2 
obese  
26 Josefson,  
2013 
CS 38 Chicago,  
41° N  













CS 23 Chicago  
41° N  




n= 15     124.6                             HPLC 35.5±4.1** Obese 
26 Josefson, 
2013 
CS 35 Chicago, 
which 
is at latitude 







Cord  Cord  68.6  HPLC 22.0+1.8**  Normal weight 
26 Josefson, 
2013 
CS 23 Chicago, 
which 
is at latitude 







Cord  Cord  52   HPLC 35.5+4.1** Obese 
29 Perampalam, 
2011 
CS 100 Australia –  






 24-28 wk 2nd 
trimester 




CS 33 Australia –  






 24-28 wk 2nd 
trimester 
65.9 ± 28.8    ECLIA 16.0–24.9 






CS 44 Australia –  






 24-28 wk 2nd 
trimester 
61.6 ± 21.2   ECLIA 25.0–29.9 





CS 15 Australia –  






 24-28 wk 2nd 
trimester 
53.4 ± 17.2   ECLIA 30.0–34.9 




CS 8 Australia –  






 24-28 wk 2nd 
trimester 
 60.7 ± 21.9    ECLIA ≥35.0  














 24-28 wk 2nd 
trimester 












 24-28 wk 2nd 
trimester 
62.8 ± 24.3  RIA 16.0–24.9 














 24-28 wk 2nd 
trimester 
58.9 ± 30.1 RIA 25.0–29.9 












 24-28 wk 2nd 
trimester 
49 ± 17.4 RIA 30.0–34.9 












 24-28 wk 2nd 
trimester 
49.1± 25 RIA ≥35.0  






CS 307 Spanish 
Mediterranea
n sea coast  
36° N, 2° W 
 
May 2009 to 
April 2010 
11 -14 wk 1st 
trimester 








CS 132 Spanish 
Mediterranea
n sea coast  
36° N, 2° W 
 
May 2009 to 
April 2010 
11 -14 wk 1st 
trimester 





CS 63 Spanish 
Mediterranea
n sea coast  
36° N, 2° W 
 
May 2009 to 
April 2010 
11 -14 wk 1st 
trimester 
60.68±10.03 ECLIA ≥ 30  
kg/m2 
Obese  
38 Laura, 2013 Prospective 
cohort study 





At ≤20 wk 2nd 
trimester 





38 Laura, 2013 Prospective 
cohort study 





At ≤20 wk 2nd 
trimester 
77.8 (63.1-96.0)* ELISA 25.0-29.9 
kg/m2** 
Overweight  
38 Laura, 2013 Prospective 
cohort study 





At ≤20 wk 2nd 
trimester 
69.9 (59.0-82.9)* ELISA ≥30  
kg/m2** 
Obese  
39 Gerrit van 
den Berg, 
2013 
Cohort study 372 Amsterdam, 






~12 wk 1st 
trimester 
 
49.8 ± 23.7                     
ELISA >25  
kg/m2 **                                                                                                                   
Overweight  
39 Gerrit van 
den Berg, 
2013 
Cohort study N/A Amsterdam, 






~12 wk 1st 
trimester 
58.3 ± 24.1  ELISA >25  
kg/m2 **    
Overweight  
39 Gerrit van 
den Berg, 
2013 
Cohort study N/A Amsterdam, 






~12 wk 1st 
trimester 
62.6 ± 27.5      ELISA >25  
kg/m2**     
Overweight  
142
39 Gerrit van 
den Berg, 
2013 
Cohort study 1902 Amsterdam, 






~12 wk 1st 
trimester 
63.6 ± 39.8  ELISA  <25  




39 Gerrit van 
den Berg, 
2013 
Cohort study N/A Amsterdam, 






~12 wk 1st 
trimester 
71.5 ± 28.4 ELISA  <25  




39 Gerrit van 
den Berg, 
2013 
Cohort study N/A Amsterdam, 






~12 wk 1st 
trimester 
69.1 ± 27.0 ELISA <25  






Cohort study 13/39 Warsaw, 




(October 1 – 
– March 31) 
and summer 




trimester     
1st 
trimester 





Cohort study 14/42 Warsaw, 




(October 1 – 
– March 31) 
and summer 


















April 2009 to 
November 
2012 




                                                  
64.2 ± 18.3  











April 2009 to 
November 
2012 
11.5 ± 1.5 
wk   
1st 
trimester 










April 2009 to 
November 
2012 















April 2009 to 
November 
2012 
11.5 ± 1.5 
wk   
2nd 
trimester 


































47.7 ± 18.3  CLIA  33.9 ± 3.3# Obese  









to May 2014 
9.78 ± 2.30 1st 
trimester 













to May 2014 
9.54 ± 2.40 1st 
trimester 
43.7 ± 30.7 ELISA 17.2 ± 1.0  Underweight  









to May 2014 
 9.79 ± 2.25 1st 
trimester 
38.3 ± 29.4 ELISA 20.9 ± 1.3  Normal 
weight 
 









to May 2014 
 9.92 ± 2.30 1st 
trimester 
42.4 ± 36.3 ELISA 27.3 ± 4.0 Overweight  









to May 2014 






CCS 1002 Quebec 52° 
56' N / 73° 32' 
W and 
Halifax 44° 
38' N , 63° 34' 
W  , Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 







CCS 311 Quebec 52° 
56' N / 73° 32' 
W and 
Halifax 44° 
38' N , 63° 34' 
W  , Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 





CCS 124 Quebec 52° 
56' N / 73° 32' 
W and 
Halifax 44° 
38' N , 63° 34' 
W  , Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 
48.2 ± 16.5 CLIA 30-<35 
kg/m2** 
Obese   
48 Woolcott, 
2016 
CCS 84 Quebec 52° 
56' N / 73° 32' 
W and 
Halifax 44° 
38' N , 63° 34' 
W  , Canada 
2002–2010 12-15 wk 1st & 2nd 
trimester 
45.7 ± 15.4 CLIA ≥35  
kg/m2** 
Obese 










2008-2014 7-18 wk 1st & 2nd 
trimester 













2008-2014 7-18 wk 1st & 2nd 
trimester 











2008-2014 7-18 wk 1st & 2nd 
trimester 
64 ± 24 N/A 30-<35  
kg/m2 










2008-2014 7-18 wk 1st & 2nd 
trimester 
57 ± 22 N/A ≥35  
kg/m2 
Obese 
 class 2 
 
BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 (m2) (WHO).     
CS- cross section, CCS-case control study, N/A not available, wk- week gestational.  
** Pre-pregnancy BMI 




The association of overweight and obesity on vitamin D status during 


















Maternal obesity and vitamin D deficiency in pregnancy are both global public health 
issues and obesity is a recognised risk factor for low vitamin D status. Sufficient 
maternal vitamin D status (25 hydroxyvitamin D (25(OH)D) concentration) is 
essential for optimal fetal bone growth and development. The aim of this study was to 
investigate the association between BMI and maternal vitamin D status. Data and 
samples from a previous study (FASSTT trial) were used for analysis. Pregnant 
women without pregnancy complications, aged 18 to 35 years, having a singleton 
pregnancy and not taking vitamin D supplements were included. Anthropometric 
measures were recorded at approximately 14 weeks gestation. Non-fasting blood 
samples were collected at 14 and 36 weeks gestation and analysed for total serum 
25(OH)D, using liquid chromatography tandem mass spectrometry. Data from 216 
pregnant women (135 normal weight, 57 overweight, 24 obese) were available for 
analysis. Pregnant women with obesity had significantly lower median (IQR) vitamin 
D status when compared to women of normal weight at 14 weeks (32.1 (18.7, 61.3) vs 
46.1 (30.3, 63.4) nmol/L; P=0.038) but not at 36 weeks gestation (34.6 (19.7, 55.6) vs 
42.1 (27.5, 65.9) nmol/L; P= 0.370) respectively. At both 14 and 36 weeks gestation, 
60% of participants were classified as vitamin D deficient (25(OH)D <25nmol/L) or 
insufficient (25(OH)D 25-50nmol/L); with 37.5% and 41.7% of pregnant women with 
obesity classified as deficient at 14 weeks and 36 weeks gestation compared to 15.6% 
and 17.5% of normal weight women respectively. When examined in relation to 
seasonality, pregnant women with obesity had significantly lower vitamin D status 
during winter months when compared with women who were normal weight or 
overweight. Without vitamin D supplementation, there was a high prevalence of 
vitamin D deficiency/insufficiency in pregnant women in Northern Ireland. Maternal 
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obesity influences on vitamin D status, particularly in early pregnancy and during the 






















Maternal obesity (BMI >30kg/m2) is becoming increasingly prevalent and 
significantly contributes to adverse pregnancy and birth outcomes (Chu et al., 2009; 
Heslehurst et al., 2011; Yu et al., 2013). Currently in the UK, 20% of women are 
classified as obese at their first antenatal appointment (Maternity Services, 2017). 
Obesity during pregnancy increases the risk of metabolic dysregulation, development 
of gestational diabetes mellitus (GDM) (Martin et al., 2015; Athukorala et al., 2010), 
pre-eclampsia (Sohlberg et al., 2012) and large-for-gestational age neonates (Wang et 
al., 2015). These conditions may be related to a decrease in insulin sensitivity in 
pregnant women with obesity (Catalano et al., 2010). Furthermore, maternal obesity 
has been associated with a higher prevalence of post-term delivery (Halloran et al., 
2012) and an increased need for induction of labour (Wolfe et al., 2011) contributing 
to longer duration and poorer progress in labour (Norman et al., 2012) and further 
exacerbating the likelihood of assisted delivery. The rate of induction failure increases 
progressively with increasing BMI (Wolfe et al., 2011) and pregnant women with 
obesity are 36.8% more likely to deliver via caesarean section (CS) (Dzakpasu et al., 
2014). Low maternal vitamin D status (measured as 25-hydroxyvitamin D (25(OH)D) 
concentrations) is also a risk factor for pre-eclampsia (Robinson et al., 2013) and 
GDM (Wagner et al., 2012), as vitamin D plays an important role in glucose 
homeostasis and insulin resistance (Sung et al., 2012). Studies have also reported an 
association between low maternal vitamin D status, preterm delivery and 
hypertension, both factors also associated with higher BMI (Wagner et al., 2012; 
Dawodu et al., 2011). Furthermore, maternal vitamin D deficiency (25(OH)D < 25 
nmol/L) has been significantly correlated with low neonatal birth weight and impaired 
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growth and bone development in the fetus (Khalessi et al., 2015; Robinson et al., 2011; 
Aghajafari et al., 2013) and throughout life (Javaid et al., 2006).  
Vitamin D is synthesised in the skin following sunlight exposure, and with the UK’s 
geographical latitude this synthesis is non-existent for 6 months of the year (SACN, 
2016). Food sources of vitamin D are limited and include fatty fish, egg yolks, liver, 
mushrooms and fish-liver oils (Holick, 2007&2008) and dietary intakes of these foods 
can be further reduced during pregnancy (Food Standards Agency, 2008). In the UK, 
the mean daily intake of vitamin D from food sources for women aged 19-64 years 
ranged between 2.2 and 2.8μg/d (National Diet and Nutrition Survey NDNS, 2008/09 
to 2011/12, Bates, 2014), well below the currently recommended intake of 10µg/d for 
all adults including pregnant women (SACN, 2016).  
Obesity has been shown to be a risk factor for low vitamin D status (Vimaleswaran et 
al., 2013; Earthman et al., 2012) with proposed mechanisms including sequestration 
of this fat-soluble vitamin within adipose tissue (Holick et al., 2011; Hossein-nezhad 
et al., 2013), volumetric dilution or an overall reduction in vitamin D synthesis through 
reduced sun exposure (Drincic et al., 2012; Pourshahidi 2015).  Furthermore, it has 
been shown from the previous chapter (systematic review) that maternal obesity 
negatively influences both maternal and fetal vitamin D status. Pregnant women with 
obesity have significantly lower 25(OH)D concentrations compared to non-obese 
women (McAree et al., 2013) and a twofold increase in vitamin D deficiency has been 
observed in pregnant women and their infants as maternal BMI increased from 22 to 
34 kg/m2 (Bodnar et al., 2007).  
Sufficient maternal vitamin D status is essential; the fetus is solely dependent on the 
mother’s vitamin D supply during pregnancy (Dror et al., 2010). It has been observed 
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that vitamin D concentrations in cord blood samples of infants born to mothers with 
obesity were significantly lower than those born to mothers of normal weight (Bodnar 
et al., 2007). Furthermore, it has been suggested that pregnant women who are of a 
normal weight  transfer more vitamin D across the placenta than pregnant women with 
obesity, even when maternal concentrations of 25(OH)D are equivalent (Josefson et 
al., 2013). The association between increasing BMI and vitamin D status in UK 
pregnant women needs to be defined. Therefore, the primary aim of this study was to 
investigate the association between BMI and maternal vitamin D status. A secondary 






Data and samples from a previous trial (Folic Acid Supplementation in the Second and 
Third Trimesters (FASSTT)), which took place from September 2005 to December 
2006 and carried out within the Nutrition Innovation Centre for Food and Health 
(NICHE) at Ulster University, were used for the current analysis. The methodology of 
the original FASSTT study is described in detail elsewhere (McNulty et al., 2013). In 
brief, pregnant women aged 18 to 35 years, in the first trimester of pregnancy, without 
pregnancy complications and having a singleton pregnancy, who attended antenatal 
clinics at the Causeway Hospital, Coleraine United Kingdom, were recruited to the 
study and followed up until delivery. For the duration of the study, participants were 
asked to refrain from taking dietary supplements. 
Ethical approval for the original study was granted by the Office for Research Ethics 
Committees Northern Ireland (05/Q2008/21) and written informed consent was 
obtained from each participant. For the current analysis, ethical approval was granted 
by the National Research Ethics Committee (14/0002). 
Recruitment and initial sampling commenced in the first trimester at approximately 
14 weeks gestation. Weight (kg) and height (cm) were measured at 14 weeks gestation 
by the researcher at the antenatal clinic and Body Mass Index (BMI; kg/m2) was 
calculated and categorised according to WHO classifications as normal weight (18.5-
24.9 kg/m2), overweight (25.0-29.9 kg/m2) or obese (≥30.0 kg/m2). In addition, 
information on age, parity, socio demographics, gestation duration, smoking habits 
and alcohol consumption were recorded. Following delivery, mode of delivery and 
infant characteristics including birth weight (g) (classified as low birth weight (<2500 
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g) or macrosomia (>4000 g)) (WHO, 2004), length (cm) and head circumference (cm) 
were recorded. Apgar scores were collected from maternal notes and paediatric charts; 
Apgar score is a test generally done at one and five minutes after birth to assess the 
health of new born children with scores between 7 and 10 classified as reassuring, 4 
to 6 as moderately abnormal, and ≤3 regarded as critically low and requiring additional 
medical care (ACOG, 2014). 
 
Blood sample analysis 
Non-fasting blood samples were collected at 14 and 36 weeks’ gestation by 
venepuncture into an evacuated tube by a trained phlebotomist. All samples were 
coded anonymously with each participant being allocated a unique identification 
number. Collected samples were kept chilled and processed (centrifugation at 3000 
rpm for 15 minutes) within 3 hours of collection and serum aliquots were stored at -
80°C until batch analysis.  
Vitamin D status was measured in serum samples from both 14 and 36 weeks time 
points by quantifying and summing 25-hydroxyvitamin D2 (25(OH)D2) and 25-
hydroxyvitamin D3 (25(OH)D3) to give total 25-hydroxyvitamin D (25(OH)D) 
concentrations using a fully validated method (Chromsystems Instruments and 
Chemicals GmbH, Gräfelfing, Germany; MassChrom 25-OH-Vitamin D3/D2) and 
liquid chromatography-tandem mass spectrometry (API 4000; AB SCIEX, 
Washington, DC, USA). Samples were batch analysed in the Biochemistry 
Department of St James's Hospital Dublin, Ireland, a laboratory which participates in 
the Vitamin D External Quality Assessment Scheme (DEQAS). Vitamin D status was 
classified into categories of sufficiency according to SACN guidelines and defined as 
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either deficient (25(OH)D ≤25nmol/L); insufficient (25-50nmol/L) or sufficient 
(25(OH)D ≥50nmol/L) (SACN, 2016). 
 
Dietary intake 
During the second trimester of pregnancy, participants completed a four-day estimated 
food diary to assess dietary intake. Mean daily nutrient intakes were analysed using 
WISP (version 3.0; Tinuviel Software). 
 
Data analysis 
Statistical analysis was performed using SPSS (Statistical Package for the Social 
Sciences software, Version 22; IBM). Normality tests (Kolmogorov-Smirnov) were 
conducted and non-normally distributed data were log transformed as appropriate to 
approximate normality. A one-way ANOVA test was used to assess differences in 
maternal 25(OH)D concentrations (at 14 weeks and 36 weeks gestation) between the 
normal weight, overweight and obese categories. Paired samples T-tests were 
conducted to assess differences in 25(OH)D concentrations between 14 weeks and 36 
weeks gestation within each of the BMI categories. Samples were collected between 
September 2005 and December 2006 and categorised by season; winter samples were 
defined as those collected: December-February, Spring samples as: March-May, 
Summer samples as: June-August and Autumn samples as: September- November. 
Chi-Square tests of association were used to assess associations between vitamin D 
status categories and other categorical variables including season of sampling, 
smoking and alcohol consumption. Bivariate correlations were carried out between 
25(OH)D concentrations (at 14 weeks and 36 weeks gestation) and age, BMI, parity, 
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smoking and gestational age at delivery. In addition, bivariate correlation analysis was 
carried out between vitamin D status (at 14 weeks and 36 weeks gestation) and infant 
characteristics (weight, length and head circumference, Apgar score), controlling for 
BMI, age, parity, season and smoking during pregnancy. Multivariate-adjusted 
multiple regression models were used to assess determinants of vitamin D status at 
each time-point (14 weeks and 36 weeks gestation) and included BMI, age, parity, 
season, smoking during pregnancy and vitamin D intake. Data are presented as median 





Samples and data from 216 pregnant women were available for this analysis, the 
median age of participants at enrolment was 28 years. At enrolment, median BMI was 
23.9 (19.5, 32.5) kg/m2 with 62.5% of women classified as normal weight, 26.4% 
overweight and 11.1% obese. There was no significant difference in maternal age, 
parity, gestational age at delivery or dietary vitamin D intakes across BMI categories 
(Table 1).  
 
Infant characteristics 
Data from 208 infants were available for the current analysis. There were no observed 
differences in infant birth weight, length or head circumference across maternal BMI 
categories. Normal weight mothers were significantly more likely to deliver a baby of 
normal weight compared to mothers who were overweight or obese (Table 1). Apgar 
scores at one minute did not significantly differ according to maternal BMI category; 
however, five minute Apgar scores were significantly lower in infants born to mothers 
with obesity compared to those born to normal weight mothers (9 (5, 9) vs. 9 (9, 9), 
P= 0.043) (Table 1). 
 
Vitamin D status 
A total of 216 and 122 maternal samples were available for measurement of vitamin 
D status at 14 and 36 weeks gestation respectively. In the total group, median (5th, 95th 
percentile) 25(OH)D concentration at 14 weeks was 43.8 (17.5, 102. 6) nmol/L and at 
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36 weeks was 37.8 (15.3, 109.5) nmol/L, concentrations considered as insufficient 
(<50 nmol/L). At 14 weeks gestation, 18%, 42.6% and 39.4% of pregnant women 
were classified as deficient, insufficient and sufficient respectively and 23.8%, 37.7% 
and 38.5% were classified as deficient, insufficient and sufficient respectively at 36 
weeks gestation.  
Vitamin D status was significantly lower in pregnant women with obesity compared 
those of normal weight at 14 weeks gestation but not at 36 weeks gestation (Table 2).  
Within BMI categories, there was no significant difference in vitamin D status as 
pregnancy progressed from 14 to 36 weeks gestation (Table 2). Figures 2a and 2b 
show the percentage of pregnant women categorised as vitamin D deficient, 
insufficient and sufficient within each BMI category. More women with obesity were 
defined as deficient at 14 weeks and 36 weeks compared to women of a normal weight, 
although values were only significantly different at 14 weeks P=0.025. Differences in 
vitamin D status at 14 weeks gestation between the three BMI categories were 
observed in winter but not at any other season: pregnant women with obesity had 
significantly lower vitamin D status (19.3 (16.7, 32.2) nmol/L) when compared with 
those of a normal weight (36.7 (27.6, 57.1) nmol/L) or overweight (41.6 (27.9, 57.0) 
nmol/L), P=0.013). There were no significant differences in vitamin D status between 
BMI categories during any season at 36 weeks gestation. 
At 14 weeks gestation, season was a significant predictor of vitamin D status in both 
unadjusted and adjusted regression models. At 36 weeks gestation, season remained 




This study shows a high prevalence (60%) of vitamin D insufficiency (<50 nmol/L) 
among all pregnant women living in Northern Ireland, irrespective of their BMI at 14 
weeks and 36 weeks gestation. Vitamin D deficiency (<25 nmol/L) at 14 and 36 weeks 
gestation was 18% and 23.8% respectively and insufficiency (25-50 nmol/L) was 
found in 42.6% and 37.7% respectively. These results are similar to a previous study 
of healthy Caucasian pregnant women in Northern Ireland (Holmes et al., 2009) where 
it was reported that vitamin D insufficiency was prevalent during pregnancy. Other 
studies at similar latitudes confirm that low vitamin D status is a problem in pregnant 
women with up to 50% of women being classified as insufficient in the first trimester 
and deficiency ranging from 11- 28%, with higher levels of deficiency observed in 
wintertime (Haggarty et al., 2013; Kiely et al., 2016).  Differences in vitamin D status 
between studies can depend on several factors such as season of blood sample, dietary 
intake, supplement use and the method used for the measurement of vitamin D (Wahl 
et al., 2012; Hilger et al., 2014). In addition, there is debate over the appropriate cut-
offs used to categorise vitamin D status and this could account for variations in 
categorising deficiency and insufficiency. In the current analysis the most recent 
SACN cut-offs for defining deficiency/insufficiency have been used, whereas in USA 
The Institute of Medicine uses slightly higher cut-offs of <30 nmol/L for deficiency.  
Research has shown that maternal obesity and low vitamin D status is frequently 
associated with having negative consequences for both the mother and the child 
(Bodnar et al., 2007; Bener et al., 2013). Obesity is also known to negatively impact 
on vitamin D status and of interest in this study, we found that while pregnant women 
with obesity had significantly lower vitamin D status than those of a normal weight in 
the first trimester particularly in the winter months, this was not observed in the third 
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trimester. Similar findings have been reported by Karlsson et al. (2015). However, 
other studies have shown that pregnant women with obesity are more likely to be 
vitamin D insufficient than those of a normal weight across all trimesters (Bodnar et 
al., 2007; Andersen et al., 2013). In the general population, obesity is thought to 
influence vitamin D status through sequestration in fat tissue. In pregnancy, this may 
be further exacerbated by physiological changes such as weight gain and 
haemodilution (Drincic et al., 2012) which in turn may influence vitamin D status. A 
lower weight gain during pregnancy has been observed in women with obesity 
compared to those of normal weight (Sunsaneevithayakul et al., 2014). Lower vitamin 
D status in obese individuals could be related to volumetric dilution (Drincic et al., 
2012). However, haemodilution and weight gain during pregnancy affect vitamin D 
status for both normal weight and obese pregnant women (Karlsson et al., 2015), with 
the precise mechanism still poorly understood. Adequate vitamin D status during 
pregnancy is necessary through increased fetal demand for calcium (approximately 
25–30 g) and vitamin D status of the fetus is directly correlated with maternal status 
(Dror et al., 2011; El Rifai et al., 2014; Godang et al., 2014). Pregnant women with 
obesity have been shown to have a reduced placental transfer of 25(OH)D compared 
to women of a normal weight with the same prenatal vitamin D status (Josefon et al., 
2013), which may indicate a less efficient transfer of vitamin D across the placenta in 
maternal obesity. This finding supports the contention that obesity reduces the 
bioavailability of vitamin D (Wortsman et al., 2000). Unfortunately, cord blood 
samples were not available for vitamin D analysis in the current study. 
Vitamin D metabolism changes during pregnancy to meet the physiological demands 
of the developing fetus. The concentrations of the active hormonal form 1,25(OH)2D3 
in pregnant women at 12 weeks gestation have been reported to be triple those of non-
160
pregnant women (Hollis et al., 2011), probably via increases in intestinal calcium 
absorption and immune adaptation to the presence of the fetus (Karras et al., 2017). In 
order to produce and increase 1,25 (OH) 2D3, there must be enough substrate vitamin 
D available (Hollis et al., 2013). It has been reported previously that in maternal 
obesity, women are at risk of lower substrate of vitamin D compared to normal weight 
women (Bodnar et al., 2007; Andersen et al., 2013); in the current analysis we 
observed that pregnant women with obesity had a lower vitamin D status than those 
of normal weight, particularly in winter months. Therefore, those with maternal 
obesity are at risk of vitamin D deficiency and insufficiency particularly in winter 
months and adequate vitamin D status during pregnancy is essential to prevent risks 
associated with vitamin D deficiency and insufficiency.   
Dietary intake from food alone is not adequate to prevent vitamin D deficiency, 
particularly during the winter months when the sun exposure is limited; in this study 
dietary intake of vitamin D was 1.92μg/d, which is lower than reported in recent 
NDNS survey for women, and also was lower than in European pregnant women 
(Karlsson et al., 2014). Compounding these low intakes, pregnant women are advised 
to reduce intake of some of the naturally containing vitamin D rich foods such as liver 
and fish owing to safety issues and risk of bacterial exposure (The National Health 
Service, 2012; Food Standards Agency, 2008).  
Obesity prior to or during pregnancy has been shown to contribute to increased risk of 
adverse birth outcomes such as large-for-gestational age infants (Wang et al., 2015; 
Schummers et al., 2015). In the current study, mothers who were overweight and obese 
were less likely to deliver babies of normal weight (> 2500g < 4000g) compared to 
mothers who were normal weight. Furthermore, infants born to mothers with obesity 
performed less well on the Apgar score at 5 minutes, indicating a negative impact of 
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obesity during pregnancy on infant health. Zhu et al., 2015, also reported that maternal 
obesity was associated with lower Apgar score at 5 minutes.  
This study has several strengths in that vitamin D status was assessed by measuring 
25(OH)D concentrations using the gold-standard method of LC-MS/MS (Institute of 
Medicine, 2010) at two time points during pregnancy. Furthermore, blood sampling 
occurred across all seasons and data were available on dietary intake of vitamin D. 
Pregnant women in this study did not consume dietary supplements containing vitamin 
D removing this as a confounding factor and making this one of the only studies where 
the true association between maternal obesity and vitamin D status can be studied. It 
must be acknowledged that only one measure of pregnancy weight was obtained, 
therefore, we were unable to examine the influence of gestational weight gain on 
maternal vitamin D status. Furthermore, body composition changes may be more 
useful as it has also been shown that fat mass may be a better predictor of vitamin D 
status than BMI (Salehpour et al., 2012).  In the FASSTT trial there was a high dropout 
rate from 14-36 weeks, although our findings did not differ when analysis was 
conducted with and without dropouts.  
Conclusion 
In early pregnancy, women with obesity had significantly lower vitamin D status than 
those who were normal weight, this was evident particularly during the winter months. 
There was a high prevalence of vitamin D insufficiency at 14 and 36 weeks gestation 
among pregnant women living in Northern Ireland who were not taking a vitamin D 
supplement. These findings are particularly relevant in the context of the current 
maternal obesity epidemic and for those who do not adhere to the government 
recommendations on vitamin D supplementation during pregnancy.   
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Gestation at Booking Visit(wk)  
Gestation at Second blood 
sample(wk) 
 
Gestation at Labour (delivery) (wk) 
Smoking n (%)      
                        Smoker 
                        Non smoker 
Alcohol consumption n (%) 
                        Yes  
                         No 
Dietary intake of vitamin D(μg/d) 
 
Infant Characteristics     
Birth weight(gm) 
 
          Low birth weight n(%) 
          Normal weight n(%) 
          Macrosomia n(%) 
 
Birth length(cm) 
Head circumference (cm) 
*Apgar 
                     1 minute 
                     5 minutes 
n=216 
28 (19, 34) 
64 (51, 89) 
1.64 (1.52, 1.75) 
23.87 (19.47,32.47) 
1 (0, 3) 
 
13 (10, 18) 
36 (34, 37) 
 
 







1.92 (1.28, 3.19) 
 
N=208 






51 (47, 55.5) 
34.5 (32, 37) 
 
9 (7, 9) 
9 (9, 9) 
n=135 
27 (19, 34) 
60 (50, 70)a 
1.65 (1.54, 1.75) 
22.53 (19.12,24.74)a 
1 (0, 3) 
 
13 (10, 18) 
36 (34, 37) 
 
 
















51 (47, 55.5) 
34.5 (32, 37) 
 
9 (7, 9) 
9 (9, 9)a 
n=57 
29 (21, 34) 
73 (62, 89)b 
1.65 (1.52, 1.78) 
26.81 (25.14,29.42)b 
1 (0, 3) 
 
13 (11, 17) 
36 (34, 37) 
 
 







1.76 (1.38, 2.92) 
 
N=57 






51 (46.9, 56) 
35 (31.9, 36) 
 
9 (5, 9) 
9 (8, 9) 
n=24 
29 (19, 33) 
85 (64, 128)c 
1.60 (1.27, 1.73) 
32.07 (30.05,50.18)c 
1 (0, 3) 
 
13 (10, 18) 
36 (29, 37) 
 
 







1.53 (1.05, 2.76) 
 
N=23 






51 (37.2, 55.5) 
34 (31, 38) 
 
9 (4, 9) 


































Maternal characteristics recorded at enrolment. 
Data are presented as Median (5th, 95th Percentile) 
BMI – body mass index according to WHO categorised as normal weight 18.50-24.99 / overweight ≥25.00 / obese ≥30.00 kg/m2. 
Apgar score is a test generally done at one and five minutes after birth to assess the health of new born children immediately after birth, Scores 7 and above are generally normal,  
4 to 6 fairly low, and 3 and below are generally regarded as critically low. 
Birth weight defined by WHO - Low birth weight<2500 g and macrosomia> 4000g. 
Differences between the BMI categories were assessed by one-way ANOVA or Chi-squared test as appropriate.  P< 0.05 considered significant.  Columns with different superscript  
letters are significantly different from each other
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P-value obtained from one-way ANOVA test assess differences in 25(OH)D concentration between BMI categories at each time-point 
P*-value obtained from paired sample test to assess difference in 25(OH)D concentration between 14 and 36 weeks gestation within each BMI category        





























46.1 (30.3, 63.4)a 
 
 
43 (28.6, 63.8) 
 
 
32.1 (18.7, 61.3)b 
 
 









42.1 (27.5, 65.9) 
 
 
36.0 (20.1, 67.6) 
 
34.6 (19.7, 55.6) 
P*   0.143 0.483 0.290  
180
 












                                                          
                                                        *Winter: December-February, Spring: March-May, Summer: June-August, Autumn: September- November 
  
Model               Unadjusted 
                 25(OH)D 








                               Adjusted 
25(OH)D 
   14 weeks                     36 weeks  
 
Beta              P  Beta             P Beta           P                 Beta P 
BMI -0.104           0.129 -0.201       0.026 -0.125        0.348               -0.116         0.345               
Parity 0.092            0.302 -0.141       0.242 0.067         0.633              -0.130          0.304 
Season* 0.275          <0.0001 0.448    <0.0001 0.303         0.027               0.349         0.007 
Smoking during pregnancy 0.105           0 .123 0.318    <0.0001 0.134         0.354               0.163         0.212 
Age 0.106            0.119 0.185        0.041 0.090         0.533               0.175        0.179 


































Maternal BMI bas been shown to be inversely correlated with vitamin D status (25-
hydroxyvitamin D (25(OH)D) concentrations) during pregnancy. Pregnant women 
with obesity and with vitamin D deficiency are at risk of many adverse health 
outcomes in pregnancy.  
The aim of this study was to examine differences in maternal vitamin D status across 
normal weight, overweight and obese pregnant women in early pregnancy.  
Data collected at baseline from a double-blind randomised vitamin D intervention 
study (MO-VITD) were used. Pregnant women without pregnancy complications, 
aged >18 years and having a singleton pregnancy were recruited between January 
2016 and August 2017 at antenatal clinics in the Western Health and Social Care Trust, 
Northern Ireland. Non-fasting blood samples were collected at 12 weeks gestation and 
analysed for total serum 25(OH)D, using liquid chromatography tandem mass 
spectrometry. Data from 239 pregnant women (80 normal weight, 79 overweight, 80 
obese) were included in the current analysis. The mean ± SD 25(OH)D concentration 
of all pregnant women at 12 weeks gestation was 52.0 ± 21.6 nmol/L. Pregnant women 
classed as obese or overweight were found to have significantly lower 25(OH)D 
concentrations compared to women of normal weight (48.8 ± 20.3 vs 49.8 ± 20.4 vs.  
57.5 ± 23.1 nmol/L, P=0.019; obese, overweight, normal weight respectively). A total 
of 45% of all pregnant women were found to be either vitamin D deficient (25(OH)D 
<25nmol/L; 13%) or insufficient (25-50 nmol/L; 32%) in early pregnancy. BMI was 
significantly negatively correlated with 25(OH)D concentrations (r=-0.168; P=0.009). 
BMI (β=-0.165; P=0.006), season (β=0.220; P=<0.0001), supplement use (β=-0.268; 
P<0.0001) and a sun holiday within the previous 6 months (β=-0.180; P=0.010) were 
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significant predictors of 25(OH)D concentrations. In early pregnancy, 62% of 
pregnant women reported using a supplement containing vitamin D and 38% reported 
no supplement use. Supplement users had a significantly higher 25(OH)D 
concentration than non-supplement users in all BMI categories but overall, 37% of 
supplement users were still classified as vitamin D insufficient. Vitamin D status was 
significantly lower in winter months compared to summer months. In early pregnancy, 
especially during winter months, pregnant women with obesity, particularly non-




The prevalence of maternal obesity is increasing, with one in five women of 
reproductive age in the UK being classed as obese (Poston et el., 2016; Devlieger et 
al., 2016). The UK now has the highest level of maternal obesity in Europe (Poston et 
al., 2016), with 20% of all UK women and 17% of pregnant women in Northern 
Ireland classified as obese at the first antenatal appointment (Maternity Services, 
Monthly Statistics, 2017; Scott-Pillai et al., 2013). In 2010, the European Perinatal 
Health Report noted that the levels of overweight or obesity in pregnant women in 
Poland, France and Slovenia ranged from 25.6% to 27.8%. The majority of other 
European countries have reported maternal overweight and obesity rates of between 
30–37%, with Scotland having the highest prevalence of 48.4%, of which 20.7% were 
classified as obese (EURO-PERISTAT Project, 2010). Maternal obesity is associated 
with increased risk of maternal and perinatal mortality and morbidity, including 
gestational diabetes mellitus (GDM), pre-eclampsia, caesarean section (CS) and birth 
complications (Poston et al., 2016; Sarwer et al., 2006). 
The adverse effects of maternal obesity are similar to those associated with vitamin D 
deficiency during pregnancy. Maternal vitamin D deficiency is considered a global 
public health concern, with approximately 23% of pregnant women observed classed 
as vitamin D deficient in the UK (Makgoba et al., 2011) and more than 90% of 
pregnant women in Northern Ireland have been shown as vitamin D insufficient 
(Holmes et al., 2009). Vitamin D (calciferol) is a fat-soluble vitamin, with a classical 
role in the homeostasis of calcium and phosphate for the protection and maintenance 
of bone health. In addition, vitamin D is involved in skeletal and non-skeletal functions 
(Wacker and Holick, 2013). There are two forms of vitamin D; D3 (cholecalciferol) 
which is obtained from animal sources or produced from 7-dehydrocholesterol in the 
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skin following exposure to ultraviolet B irradiation from sunlight and D2 
(ergocalciferol) which is obtained from plant sources. Vitamin D requires 
hydroxylation in the liver to form 25 hydroxyvitamin D (25(OH)D) in response to 
circulating parathyroid hormone (PTH) concentration and a further hydroxylation in 
the kidneys and other organs to form the biologically active form 1,25 
dihydroxyvitamin D (1,25(OH)2D) (Holick, 2007). Circulating 25(OH)D 
concentration is the most reliable biomarker for the measurement of vitamin D status 
and the Institute of Medicine (IOM) has defined serum 25(OH) D concentrations 
greater than 50 nmol/L as sufficient for bone health (Institute of Medicine, 2010). The 
cut-off point for deficiency has been defined as <25 nmol/L (SACN, 2016) or 
<30nmol/L (Institute of Medicine, 2011) and some researchers have argued that 
concentrations as high as >75 nmol/L are necessary for functions of vitamin D beyond 
bone health (Holick et al., 2011).  
Exposure to ultraviolet B-light irradiation from the sun is the main source of vitamin 
D, accounting for approximately 90%, while the remaining 10% comes from a small 
range of foods such as liver, egg yolks, fatty fish and mushrooms (Laird et al., 2010). 
Factors such as latitude, season, sunscreen use, pollution, weather, age, skin colour 
and body composition are known to limit vitamin D synthesis from UVB light. During 
at least 6 months, over the winter period in countries at high latitudes such as the UK 
and Ireland, the intensity of UVB exposure from sunlight is not sufficient to support 
vitamin D synthesis (Institute of Medicine, 2011; Macdonald et al., 2011). Obesity has 
been shown to influence vitamin D status, since vitamin D is fat-soluble and thus may 
remain hidden within the adipose tissue of overweight and obese individuals (Holick 
et al., 2011; Holick et al., 2007; Hossein-nezhad et al., 2013). 
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Pregnant women are considered at risk of vitamin D deficiency. Hypovitaminosis D 
during pregnancy has been highlighted in many different geographic regions and 
latitudes globally (Dawodu et al., 2012). In addition, obesity during pregnancy is 
thought to further increase the risk of both maternal and infant vitamin D deficiency 
as vitamin D status during pregnancy has been shown to be inversely correlated with 
maternal BMI (Perez-Lopez et al., 2011; Bartoszewicz et al., 2013). Some studies 
report that obese or severely obese pregnant women have lower vitamin D status 
compared to non-obese women (Andersen et al., 2013; Bodnar et al., 2007; McAree 
et al., 2013; Perampalam et al., 2011; Perez-Lopez et al., 2011; Bartoszewicz et al., 
2013; Van den Berg et al., 2013; Karlsson et al., 2015). In a large cohort of 1345 
pregnant women living in Denmark, it was reported that a 5-unit increase in BMI was 
associated with a 25(OH)D lowering of 4.2 nmol/L and 2.8 nmol/L in winter and 
summer months, respectively (Andersen et al., 2013). The fetus is solely reliant on an 
adequate maternal supply of vitamin D (Hollis et al., 1984) and neonatal vitamin D 
status has been shown to be highly correlated with maternal status (Dror et al., 2011; 
El Rifai et al., 2014; Godang et al., 2014). Furthermore, It has been shown that 
neonates of obese mothers had significantly lower vitamin D status in cord blood 
compared to neonates of normal weight mothers (Bodnar et al., 2007; Karras et al., 
2013) despite maternal 25(OH)D did not differ (Josefson et al., 2013). Due to the high 
levels of both obesity and vitamin D deficiency in pregnancy, the interplay between 
maternal BMI and vitamin D warrants further investigation.  
The aim of this study was to examine differences in maternal vitamin D status across 





This study investigated pregnant women recruited to the ‘Association between 
Maternal Body Weight and Vitamin D Status (MO-VITD) Study', which was carried 
out within the Nutrition Innovation Centre for Food and Health (NICHE) at Ulster 
University and Western Health and Social Care Trust (WHSCT) in Northern Ireland. 
Pregnant women (n=240, with equal numbers of normal weight, overweight and 
obese) were recruited between January 2016 and August 2017 during their first 
antenatal visit. At the booking appointment (approximately 9-10 weeks gestation), all 
pregnant women in the WHSCT area received an information sheet from their health 
care provider (HCP) with a detailed study outline and contact details of the lead 
researcher if any further details were required. The HCP also verbally informed the 
potential participant about the study. At the hospital clinic when women attended for 
their 12-week antenatal scan, the researcher was present to answer any further 
questions and to take written informed consent form eligible participants.  
The inclusion criteria were: pregnant women who were at least 12 weeks gestation, 
aged ≥18 years, BMI ≥18.5 kg/m², without current pregnancy related complications 
and having a singleton pregnancy. Exclusion criteria included, aged <18 years, BMI 
<18.5 kg/m2, participants with multiple pregnancy, those currently involved in another 
research study, participants with a history of gastrointestinal, hepatic, renal, vascular 
or haematological disorders. In addition, participants who have had in vitro 
fertilisation (IVF) treatment, participants with a history of NTD affected pregnancies 
and pregnant women with active thyroid disease (e.g., Graves, Hashimoto or 
thyroiditis) were also excluded. 
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All participants provided written informed consent according to the Declaration of 
Helsinki. The study was reviewed by the Biomedical Sciences Ethics Filter 
Committee, Ulster University (Reference:15/0041) and approved by Office for 
Research Ethics Committees (ORECNI) (Reference:15/NI/0068) and by Western 
Health and Social Care Trust (WHSCT) (Reference:WT14/49). The study was 
registered at ClinicalTrials.gov ID: NCT02713009. 
 
Lifestyle and anthropometric information 
All participants completed a Health and Lifestyle Questionnaire at the first antenatal 
visit, which recorded information on age, social demographics, medication use, 
supplementation use and sun exposure, including sun bed use, sunbathing habits, and 
whether participants had been on a sun holiday within the previous 6 months. In 
addition, details from maternal notes were recorded including weeks gestation, parity, 
blood pressure, smoking and previous miscarriage. 
At the first antenatal visit, anthropometric and body composition measurements were 
taken, included height (using a stadiometer), weight, fat mass (kg) and fat free mass 
(kg)(using TANITA, MC-780MA scale). BMI (kg/m2) was calculated as weight (kg) 
divided by height2 (m2) (World Health Organisation, 2004). All measurements were 
carried out by trained researchers in a private environment within the clinic setting.  
 
Blood sample analysis 
Non-fasting blood samples were collected from all participants at the first antenatal 
visit (8-17 gestation weeks) by a fully trained phlebotomist. A total of 20 ml (2x8ml 
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serum tubes and 1x4ml plasma tube) of blood was collected and kept chilled until 
processed (centrifugation at 3000 rpm for 15 minutes) within 3 hours of collection.  
Plasma and serum aliquots were stored at -80°C until batch analysis. Blood samples 
for n=239 participants were available for analysis. One participants withdrew from the 
study (personal reasons) and withdrew consent for blood sample analysis. Stored 
serum samples were used and vitamin D analysis was performed using liquid 
chromatography tandem mass spectrometry (LC-MS/MS) by quantifying and 
summing 25-hydroxyvitamin D2 (25(OH)D2) and 25-hydroxyvitamin D3 (25(OH)D3) 
to give total 25-hydroxyvitamin D (25(OH)D) concentrations (Chromsystems 
Instruments and Chemicals GmbH, Gräfelfing, Germany; MassChrom 25-OH-
Vitamin D3/D2 andAPI 4000 LC-MS/MS; AB SCIEX, Washington, DC, USA). 
Vitamin D status was classified into categories of sufficiency according to SACN 
guidelines and defined as deficient (25(OH)D <25nmol/L); insufficient (25-
50nmol/L) or sufficient (25(OH)D>50nmol/L) (SACN, 2016). Plasma intact PTH 
concentrations were measured, using a commercially available enzyme-linked 
immunosorbent assay (MD Biosciences Inc., Minnesota, USA). Samples were batch 
analysed in the Biochemistry Department of St James's Hospital (Dublin, Ireland). 
Serum concentrations of calcium and albumin were measured using an automated 
clinical chemistry system (Ilab 650 Clinical Chemistry System, WERFEN). Albumin-
adjusted calcium was calculated using the following formulae: 
Adjusted calcium = measured total calcium+0.02(40-albumin) 
Or for albumin greater than 45g/L: 




The statistical analyses were performed using SPSS (Statistical Package for the Social 
Sciences software, Version 22; IBM). Data were assessed for normality using 
Kolmogorov-Smirnov test. Data were presented as mean ± SD. One-way analysis of 
variance (ANOVA) was used to assess differences in maternal 25(OH)D 
concentrations between BMI categories and independent-samples t-test was used to 
assess differences in maternal 25(OH)D concentrations between supplement users and 
non-users. Chi-Square tests were performed to determine associations between the 
category of vitamin D sufficiency and other categorical variables including smoking, 
education level, material status, parity, medication use, dietary supplement use, recent 
sun holiday, sunbed use and season. Bivariate correlations were performed between 
25(OH)D concentrations and age, body composition measures, biochemical measures 
and blood pressure. In addition, multivariate-adjusted multiple regression models were 
used to assess determinants of vitamin D status. Results were considered significant 





Samples and data from 239 pregnant women were available for this analysis. Mean ± 
SD age of participants at recruitment was 29.5 ± 5.2 years and length of gestation was 
12.8 ± 1.4 weeks. Overall mean ± SD BMI was 27.9 ± 5.5 kg/m2 and participants were 
equally distributed across the BMI categories (n=80 normal weight, n=79 overweight 
and n=80 obese). There was no significant difference in maternal demographic factors 
between the three BMI categories. As expected, body weight, BMI, and all body 
composition measures were significantly different across BMI categories. In addition, 
systolic blood pressure was significantly higher in the obese mothers compared to 
normal weight mothers (Table 1). 
 
Vitamin D status 
Overall the mean ± SD of 25(OH)D concentration of the cohort was 52.0 ± 21.6 
nmol/L, a level considered sufficient (>50 nmol/L). In the cohort as a whole, 13.4%, 
31.8% and 54.8% of pregnant women were classified as vitamin D deficient, 
insufficient and sufficient respectively.  
25(OH)D concentrations were significantly lower in pregnant women with obesity and 
overweight compared to women of normal weight (48.8 ± 20.3 vs. 49.8 ± 20.4 vs. 57.5 
± 23.1 nmol/L, P=0.019; obese, overweight, normal-weight respectively) (Table 2). 
Almost two-thirds of participants reported using a vitamin D containing supplement 
and these supplement users had a significantly higher 25(OH)D concentration than 
non-supplement users in the cohort as a whole and in all BMI categories. Among 
supplement users, the 25(OH)D concentration was significantly lower in pregnant 
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women with obesity and overweight compared to women of normal weight (54.4 ± 
18.3 vs. 54.4 ± 17.2 vs. 62.4 ± 16.7 nmol/L, P=0.019; obese, overweight, normal-
weight respectively); this difference was not observed in non-supplement users (Table 
2). 
There was no significant difference in the percentage of participants with vitamin D 
deficiency, insufficiency and sufficiency across the BMI categories in the cohort as a 
whole or when comparing supplement users and non-supplement users (Figure 1). 
Overall 25(OH)D concentrations during winter and summer months was 49.0 ± 22.4 
vs. 55.7 ± 20.0 nmol/L respectively, with status significantly lower in winter months 
(P=0.017). The 25(OH)D concentration of overweight pregnant women was 
significantly lower in winter months compared to summer months 45.4 ± 20.0 vs. 54.9 
± 20.0 nmol/L, P= 0.038 (Figure 2). During winter months pregnant women with 
obesity and overweight had significantly lower 25(OH)D concentrations compared to 
their normal weight counterparts, however this difference was not observed in summer 
months.  
In non-supplement users, 25(OH)D concentrations during winter and summer was 
significantly lower compared to supplement users. In winter months, 25(OH)D 
concentrations of non-supplement users with obesity was significantly lower than 
supplement users with obesity (32.8 ± 18.9 vs. 51.6 ± 19.4 nmol/L P=0.004) (Table 
3).  
There was a significant negative correlation between 25(OH)D concentrations and 
maternal fat mass (r= -0.212; P= 0.001) and a significant positive correlation between 
vitamin D status and maternal age (r= 0.181; P= 0.005) (Figure 3). 
195
In early pregnancy, BMI, season, age, supplement use, sun holiday and sun 
bed/bathing were significant predictors of 25(OH)D concentrations in unadjusted 
regression models. After adjustment BMI (β=-0.165; P=0.006), season (β=0.220; 
P=<0.0001), supplement use (β=-0.268; P<0.0001) and sun holiday (β=-0.180; 
P=0.010) remained significant predictors of vitamin D status (Table 4). 
 
Others blood biomarkers 
Mean ± SD concentrations of adjusted calcium and PTH are shown in Table 5. There 
were no significant differences in adjusted calcium or PTH concentrations across BMI 
categories. A significant negative correlation was observed between 25(OH)D and 
PTH concentrations (r= -0.343; P<0.0001) (Figure 3), but no apparent correlation 




In this study we found that pregnant women with obesity and overweight had 
significantly lower vitamin D status than women of normal weight in early pregnancy, 
irrespective of supplement use; BMI was found to be a significant predictor of vitamin 
D status. Other studies have reported similar findings (Perez-Lopez et al., 2011; 
McAree et al., 2013; Bartoszewicz et al., 2013) and in addition, some researchers have 
reported this difference even when dietary intake of vitamin D was significantly higher 
in women with obesity compared to women of normal weight (Karlsson et al., 2015). 
Low vitamin D status in obesity is thought to be due to sequestration in fat tissue. 
Physiological changes during pregnancy including weight gain, haemodilution and 
volumetric dilution are also postulated to influence vitamin D status (Drincic. et al., 
2012). However, haemodilution and weight gain during pregnancy are thought to have 
a similar effect on vitamin D status in pregnant women of normal weight and those 
with obesity (Karlsson, et al.,  2015), still very little is known on this issue.  
This study shows that whilst the overall mean vitamin D status was considered 
sufficient, there was still a high prevalence (45%) of vitamin D insufficiency (<50 
nmol/L) among women in early pregnancy living in Northern Ireland. These results 
are similar to a recent study of 144 pregnant women in Cork, Ireland (Callaghan et al., 
2018), which reported that whilst the mean vitamin D status was considered sufficient, 
44% were vitamin D insufficient (<50 nmol/L).  Other European studies have reported 
similar findings on a sufficient vitamin D status in pregnant women in the first 
trimester (Perez-Lopez et al., 2011; Bartoszewicz et al., 2013). Whilst other studies 
conducted at similar latitudes reported an insufficient vitamin D status among pregnant 
women during the first trimester (Haggarty et al., 2011; Savvido et al., 2012; McAree 
et al., 2013; Makgob et al., 2011). 
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In the current study, 62% of women reported taking a vitamin D containing 
supplement upon entering the study, which may explain the levels of sufficiency and 
why supplement users had significantly higher vitamin D status than non-supplement 
users, similar to the findings of Holmes et al. (2009). Pregnant women who were not 
taking a vitamin D supplement in early pregnancy were classified as vitamin D 
insufficient. Sufficiency, insufficiency and deficiency of vitamin D in non-supplement 
users was 40.7%, 29.7% and 29.7% respectively compared to supplement users 
63.3%, 33.3% and 3.4% respectively. Across BMI categories, there was no significant 
difference in the prevalence of vitamin D deficiency, insufficiency or sufficiency for 
either supplement or non-supplement users. 
Insufficiency of vitamin D was higher among pregnant women with obesity than in 
those who were overweight or normal weight (51.3% vs 49.4% vs 35% respectively). 
The level of vitamin D insufficiency increased among pregnant women who were not 
taking a supplement in early pregnancy from 48.1% to 62.5% to 65.5%, in those who 
were considered as normal weight, overweight and obese respectively. Previous 
studies have similarly reported that the prevalence of vitamin D deficiency is higher 
among pregnant women with obesity compared to non-obese pregnant women (Perez-
Lopez et al., 2011; McAree et al., 2013). This result shows the importance of vitamin 
D supplementation in early pregnancy for those women living in northern latitudes to 
help reach sufficient levels of vitamin D, particularly for those who are overweight or 
obese.  
In the current study, we found seasonal differences in the vitamin D status of pregnant 
women, with significantly lower vitamin D status in winter months compared to 
summer months and a corresponding higher rate of deficiency and insufficiency during 
winter months. Similar findings in Northern Ireland have been reported by Holmes et 
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al. (2009).  This has also been noted previously in a large prospective study of 995 
pregnant women in the first trimester at a similar UK latitude (Savvido et al., 2012). 
Vitamin D status of non-supplement users was highly influenced by season, where 
vitamin D was lower in non-supplement users in both winter and summer months. 
Vitamin D supplementation in early pregnancy is considered to be one of the factors 
associated with the change in season-corrected vitamin D, a negative association has 
been observed when comparing season-corrected 25(OH)D concentrations between 
women who never took supplements and those who previously had but discontinued 
during early pregnancy (Moon et al., 2015). Vitamin D status of pregnant women with 
obesity and overweight was also affected by season, particularly in winter months 
when compared to women of normal weight. Therefore, pregnant women with obesity 
and overweight are at risk of low vitamin D status particularly in winter months. 
Adequate vitamin D status during pregnancy is essential to prevent risks associated 
with vitamin D deficiency and insufficiency.   
BMI, season, sun holiday and supplement use were significant predictors of vitamin 
D status; this is similar to findings from a Scottish study in pregnant women at 19 
weeks gestation, where month of blood sampling, dietary vitamin D intake and vitamin 
D supplement use were predictors of vitamin D status (Haggarty et al., 2011). Previous 
research has indicated that these factors are also predictors of vitamin D status in non-
pregnant populations (Tsiaras and Weinstock, 2011). 
In this study maternal vitamin D status was significantly negatively correlated with 
PTH concentrations, similar to the findings of Callaghan et al. (2018). However, there 
was no association between maternal BMI and adjusted calcium or PTH 
concentrations. 
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This study has several strengths in that vitamin D status was assessed by quantifying 
25(OH)D concentrations using the gold-standard method of LC-MS/MS (Institute of 
Medicine, 2010). Furthermore, BMI and vitamin D were measured at the same time 
allowing the accurate assessment of the association between body weight and vitamin 
D status, with equal numbers of pregnant women across the BMI categories. 
Moreover, the blood sampling for vitamin D measurement occurred across all seasons 
allowing for the impact of seasonal variation to be investigated. The use of vitamin D 
containing supplements was recorded although we had no measure of dietary vitamin 
D intake in early pregnancy.  
 
Conclusion 
Pregnant women with overweight and obesity had significantly lower vitamin D status 
compared to pregnant women of normal weight in early pregnancy and BMI was found 
to be a significant negative predictor of vitamin D status. There was a high prevalence 
of vitamin D insufficiency among pregnant women living in Northern Ireland, and this 
was highest among non-supplement users in winter months. These findings are 
important for public health agencies when considering recommendations for vitamin 
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Table 1: Baseline characteristics in all pregnant women and across BMI 
categories in participants on the MO-VITD study. 
 All  
Normal 
weight  Overweight  Obese  P 
  n 239 n 80 n 79 n 80   
Age (yrs) 29.5 ± 5.2 29.9 ± 5.1 29.5 ± 5.5 29.2 ± 5.1 0.529 
Weight (kg) 74.5 ± 15.8 59.7 ± 6.6 72.4 ± 6.1 91.5 ± 12.5 <0.0001 
Height (m) 1.63 ± 0.61 1.63 ± 0.06 1.63 ± 0.06 1.63 ± 0.05 0.947 
BMI (kg/m2) 27.9 ± 5.5 22.3 ± 1.7a 27.1 ± 1.4b 34.2 ± 3.8c <0.0001 
Fat (%) 34.0 ± 6.8 27.6 ± 5.5a 34.7 ± 3.7b 39.6 ± 4.6c <0.0001 
Fat mass (kg) 26.5 ± 10.5 17.7 ± 7.9a 26.1 ± 6.2b 35.7 ± 8.2c <0.0001 
Fat free mass (kg) 48.0 ± 10.5 41.9 ± 7.1a 46.2 ± 5.7b 55.8 ± 12.2c <0.0001 
Fat mass index (kg/m2) 9.9 ± 3.8 6.6 ± 2.7a 9.7 ± 2.1b 13.3 ± 2.9c <0.0001 
Fat free mass index (kg/m2) 17.9 ± 3.6 15.7 ± 2.4a 17.3 ± 1.9b 20.8 ± 4.1c <0.0001 
Gestational weeks (wk) 12.8 ± 1.4 12.9 ± 1.3 12.8 ± 1.5 12.8 ± 1.3 0.945 
Blood pressure(mmHg)  
Systolic 119.9 ± 11.6 117.2 ± 11.9a 120.4 ± 12.2 122.2 ± 10.2b 0.011 
Diastolic 72.1 ± 8.9 70.6 ± 9.2 73.3 ± 9.3 72.4 ± 8.1 0.115 
Smoker n (%) 30 (12.7) 8 (10) 11 (13.8) 11 (14.1) 0.679 
Parity n(%)  
0 96 (40.7) 28 (35.4) 35 (44.3) 33 (42.3) 0.826 
1 82 (34.7) 30 (38) 25 (31.3) 27 (34.6)  
2+ 58 (24.6) 21 (26.6) 19 (24.1) 18 (23.1)  
Previous miscarriage n(%) 71 (29.7) 24 (30) 26 (32.9) 21 (26.3) 0.654 
Education level n(%)  
Secondary 74 (31.8) 16 (20.5) 25 (32.1 33 (42.9) 0.033 
Diploma 41 (17.6) 12 (15.4) 15 (19.2) 14 (18.2)  
Degree 76 (32.6) 32 (41) 24 (30.8) 20 (26)  
Postgraduate 30 (12.9) 16 (20.5) 8 (10.3) 6 (7.8)  
other 12 (5.2) 2 (2.6) 6 (7.7) 4 (5.2)  
Marital status n(%)  
Married 120 (50.8) 46 (57.5) 40 (50.6) 36 (45) 0.285 
Unmarried 117 (49.0) 34 (42.5) 39 (49.4) 44 (55)  
Regular medication n(%) 23 (9.6) 9 (11.3) 7 (8.8) 7 (8.8) 0.833 
Medical illnesses n(%) 22 (9.2) 8 (10) 5 (6.3) 9 (11.3) 0.537 
Vitamin D supplement n(%)  
Supplement user 147 (61.8) 53 (66.3) 46 (59.0) 48(60) 0.55 
Non-user 91 (38.2) 27 (33.8) 32 (41.0) 32 (40)  
Sun holiday past 6 mth n(%) 43(18.1) 13 (16.3) 12 (15.4) 18 (22.5) 0.512 
Sun bathing/bed 1 mth n(%) 18 (7.6) 7 (8.9) 6 (7.7) 5 (6.3) 0.782 
Data are presented as mean ± SD or n (%). 
BMI – body mass index according to WHO categorised as normal weight 18.5-24.9 / overweight ≥25.0 / obese ≥30.0 kg/m2. 
Fat mass index (kg/m2) Fat mass (kg) divided by height2 (m2), Fat free mass index (kg/m2) Fat free mass (kg) divided by 
height2 (m2). mth indicates month.                                                        
Differences between the BMI categories were assessed by ANOVA or Chi-squared test as appropriate, (P<0.05) considered 
significant. Columns with different superscript letters are significantly different from each other.  
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Table 2: Maternal 25(OH)D concentration across BMI categories in all and 
within supplement users and non-supplement users 
25(OH)D  
(nmol/L) All                             Normal weight             Overweight                  Obese                        P
All n=239 n=80 n=79 n=80 
 
 
52.0 ± 21.6 57.5 ± 23.1a 49.8 ± 20.4b 48.8 ± 20.3b 0.014 
Supplement user n= 147 n=53 n=46 n=48 
 
 
57.3 ± 17.7 62.4 ± 16.7a 54.4 ± 17.2b 54.4 ± 18.3b 0.045 
Non-supplement user n=91 n=27 n=32 n=32 
 
 
43.6 ± 24.6 47.9 ± 30.2 43.1 ± 23.2 40.3 ± 20.6 0.706 
P <0.0001 0.039 0.025 0.002 
 
Data are presented as mean ± SD. 
Differences of maternal 25(OH)D between BMI categories were assessed by ANOVA, differences between 
supplement users and non-supplement users assessed by independent sample t-test. (P<0.05) considered 








Table 3: Seasonal difference on maternal 25(OH)D concentration within 
supplement user and non-supplement user across BMI categories 
25(OH)D (nmol/L) All Normal weight Overweight Obese P 
Winter 
 
Supplement user (80) 54.4 18.5 (30) 61.1 18.2a (24) 49.0 16.0b (26) 51.6 19.4 0.035 
Non-supplement user (48) 39.1 24.9 (15) 43.7 30.8 (18) 40.5 24.0 (15) 32.8 18.9 0.474 




Supplement user (67) 60.9 16.2 (23) 64.3 14.9 (22) 60.3 16.9 (22) 57.9 16.8 0.420 
Non-supplement user (43) 48.7 23.7 (12) 53.4 30.0 (14) 46.6 22.7) (17) 47.1 20.4 0.729 
P 0.004 0.257 0.064 0.077   
Data are presented as (n) mean ± SD. 
Differences of maternal 25(OH)D between BMI categories were assessed by ANOVA, differences between 
supplement users and non-supplement users assessed by independent sample t-test. (P<0.05) considered 














Table 4: Multiple linear regression to identify predictors of maternal 25(OH)D 
concentrations at early pregnancy  





BMI categories -0.135 0.037 
 
-0.165 0.006 
Season* 0.168 0.009 
 
0.220 <0.0001 
Age 0.216 0.001 
 
0.099 0.107 
Supplement use -0.308 <0.0001 
 
-0.268 <0.0001 
Sun holiday -0.192 0.003 
 
-0.180 0.010 
Sunbed -0.165 0.011 
 
-0.057 0.400 
Parity 0.016 0.810 
   
Education 0.022 0.743       














Table 5: Maternal blood biomarkers in early pregnancy  
 
All           Normal weight        Overweight       Obese       P 
  n 239  n 80 n 79  n 80 
  
Adjusted calcium (mmol/L) 2.29 ±  0.11 2.28  ± 0.12 2.29  ± 0.10 2.31  ± 0.09 0.139 
Calcium (mmol/L) 2.29 ± 0.11 2.29 ± 0.13 2.29 ± 0.10 2.31 ± 0.10 0.196 
Parathyroid hormone (pg/ml) 21.6 ±  8.4 21.3 ±  7.5 20.7  ± 9.4 22.6  ± 8.3 0.383 
Data are presented as mean ± SD. 
Differences of maternal biomarkers between BMI categories were assessed by ANOVA (P<0.05) considered 
significant. 




Figure 1: Level of deficiency/ insufficiency and sufficiency of vitamin D in early 
pregnancy 
Differences between level of vitamin D deficiency, insufficiency and sufficiency among BMI categories were assessed by chi-











Figure 2: Seasonal differences on maternal 25(OH)D concentrations across BMI 
categories. 
























































Figure 3: Correlation between 25(OH)D concentrations at early pregnancy and 
(age, fat mass, PTH) 
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Chapter 5: 
The effect of supplementation of 10μg vs 20μg vitamin D3/d on vitamin 


















The level of maternal and infant adequacy in vitamin D status achievable by the 
current recommendation of 10µg/d remains controversial. Pregnant women who are 
overweight or obese at the beginning of pregnancy may be particularly vulnerable to 
low vitamin D status owing to the higher requirement and lower vitamin D status 
associated with obesity  
The aim of the current study was to assess the effect of supplementation of 10μg vs 
20μg vitamin D3/d throughout pregnancy on vitamin D status of normal weight, 
overweight and obese pregnant women and on the vitamin D status of cord blood of 
their infants. 
Data collected from a double-blind randomised vitamin D intervention study (MO-
VITD) were used. A total of 240 pregnant women were recruited throughout the year 
at antenatal clinics in Northern Ireland, with equal numbers in each BMI category 
(normal weight, overweight, obese). Pregnant women were assigned to receive 10µg 
or 20µg vitamin D from 12 weeks gestations until delivery. Non-fasting maternal 
blood samples were collected at 12, 28 and 34-36 weeks gestation and from cord after 
delivery and analysed for total serum 25(OH)D using liquid chromatography tandem 
mass spectrometry.  
There was a high prevalence of vitamin D insufficiency in the 1st trimester in both the 
10µg and 20µg groups (41.5 % and 48.8% respectively) with no statistical difference 
between treatment groups. Maternal 25(OH)D concentrations, increased from the 1st 
trimester to 3rd trimester in both the 10µg and 20µg groups, this increase was higher 
in the 20µg group (17.1 ± 24.7 and 28.8 ± 33.3 nmol/L, P=0.002). There was no overall 
statistical difference in cord blood 25(OH)D concentrations between the treatment 
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groups. In the 20µg group, maternal and cord blood 25(OH)D concentrations reached 
and maintained sufficiency as (≥50 nmol/L) throughout the pregnancy, even in those 
who started pregnancy with an insufficient status. In obese women who started 
pregnancy with an insufficient vitamin D status, the related cord blood 25(OH)D 
concentrations were deficient in both the 10µg and 20µg groups (19.4 ± 20.2 vs. 19.5 
± 9.4 nmol/L, P= 0.992) respectively. In contrast, obese women who started pregnancy 
with a sufficient status had 25(OH)D cord blood concentrations above deficiency and 
within the insufficiency range in both the treatment groups. 
Maternal vitamin D supplementation of 20µg/d is needed to reach and maintain 
maternal and cord vitamin D status ≥50 nmol/L during pregnancy in pregnant women 












Obesity is an additional risk factor for low vitamin D status for both the mother and 
infant. Previous studies have found a negative association between higher body weight 
and vitamin D deficiency during pregnancy (Perez-Lopez et al., 2011; Bartoszewicz 
et al., 2013). Many reasons have been proposed for this association including the fat-
solubility of vitamin D and its sequestration within adipose tissue (Holick et al., 2011; 
Hossein- nezhad et al., 2013); other have suggested it may be attributed to volumetric 
dilution or factors such as less sun exposure (Drincic et al., 2012; Pourshahidi, 2015). 
Furthermore, it has been shown that maternal obesity negatively influences both 
maternal and fetal vitamin D status with obese pregnant women having significantly 
lower vitamin D status compared to their non-obese counterparts (McAree et al., 
2013). It was observed among 1345 pregnant women living in Denmark that a 5-unit 
increase of BMI during winter and summer correlated to lower 25(OH)D of 4.2 
nmol/L and 2.85 nmol/L respectively (Andersen et al., 2013). The in-utero 
environment affects fetal development; maternal vitamin D supply is the main source 
of fetal vitamin D (Hollis et al., 1984) and vitamin D status of the neonate has been 
shown to be highly correlated with maternal vitamin D status (Dror et al., 2011; El 
Rifai et al., 2014; Godang et al., 2014) accounting for 60-80% of infants’ status at 
delivery (Hollis et al., 1984; Vieth et al., 2013). Vitamin D deficiency during 
pregnancy is associated with poor fetal and postnatal growth (Weinert et al., 2015; 
Leffelaar et al., 2010; Robinson et al., 2011). It has been observed that neonates of 
obese mothers had significantly lower vitamin D status in cord blood compared to 
neonates of normal weight mothers (Bodnar et al., 2007; Karras et al., 2013) despite 
no difference in maternal 25(OH)D status (Josefson et al., 2013). These findings are 
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suggestive of the potential need for a higher level of vitamin D supplementation for 
pregnant women who are overweight or obese.  
The effect of vitamin D supplementation on maternal and neonatal outcomes has been 
examined in previous systematic reviews (De-Regil et al., 2012& 2015; Harvey et al., 
2014; Perez-Lopez et al., 2015; Thorne-Lyman and Fawzi 2012), however a dearth of 
knowledge remains as to how maternal body weight affects this relationship. Previous 
studies have not accounted for the influence of maternal body weight on vitamin D 
status. In a UK study by Yu et al., 2009, a single oral dose of 5000 µg/d vitamin D was 
compared to a daily supplement of 20µg/d vitamin D from 27 weeks until delivery and 
a group that received no treatment. The supplementation groups had significantly 
higher vitamin D status at 34 weeks compared to the no treatment group, however the 
authors did not account for the possible effect of maternal BMI. More recently in 2016, 
Cooper et al., conducted a multicentre study where pregnant women were randomly 
assigned to either 25µg/d vitamin D3 or matched placebo from 14 weeks gestation 
until delivery. Vitamin D status was significantly higher in the supplement group 
compared to placebo at 34 weeks gestation, however maternal BMI at baseline was 
higher in the placebo group compared to the supplement group. Information regarding 
the relationship between maternal weight and vitamin D status remains scarce, 
therefore the aim of the current study was to assess the effect of supplementation of 
10μg vs 20μg vitamin D3/d throughout pregnancy on vitamin D status of normal 
weight, overweight and obese pregnant women and on the cord blood of their infants.  
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Methods 
Study design (Figure 1) 
A double-blind randomised vitamin D intervention study (MO-VITD), conducted and 
reported according to consort guideline (Consort, 2010). Two-hundred and forty 
pregnant women received either 10μg or 20μg vitamin D from 12 weeks gestation 
through to delivery.  
 
Participants 
This study recruited pregnant women to the ‘Association between Maternal Body 
Weight and Vitamin D Status (MO-VITD) Study’, which was carried out within the 
Nutrition Innovation Centre for Food and Health (NICHE) at Ulster University and 
the Western Health and Social Care Trust (WHSCT) in Northern Ireland. Pregnant 
women (n=240, with equal numbers of normal weight, overweight and obese) were 
recruited between January 2016 and August 2017 during their first antenatal visit. At 
the booking appointment (approximately 9-10 weeks gestation), all pregnant women 
in the WHSCT area received an information sheet from their health care provider 
(HCP) with a detailed study outline and contact details of the lead researcher if any 
further details were required.  The HCP also verbally informed the potential participant 
about the study. At the hospital clinic when women attended for their 12-week 
antenatal scan, the researcher was present to answer any further questions and to take 
written informed consent from eligible participants.  
The inclusion criteria were: pregnant women of at least 12 weeks gestation, aged ≥18 
years, BMI ≥18.5 kg/m², without current pregnancy related complications and having 
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a singleton pregnancy. Exclusion criteria included, aged <18 years, BMI <18.5kg/m2, 
participants with multiple pregnancy, those currently involved in another research 
study, participants with a history of gastrointestinal, hepatic, renal, vascular or 
haematological disorders. In addition, participants who have had in vitro fertilisation 
(IVF) treatment, participants with a history of NTD affected pregnancies and pregnant 
women with active thyroid disease (e.g., Graves, Hashimoto or thyroiditis) were 
excluded. 
All participants provided written informed consent according to the Declaration of 
Helsinki. The study was reviewed by the Biomedical Sciences Ethics Filter 
Committee, Ulster University 15/0041 and approved by Office for Research Ethics 
Committees (ORECNI) 15/NI/0068 and by WHSCT (WT 14/49). The study was 
registered at the ClinicalTrials.gov ID: NCT02713009.  
 
Sample size 
A sample size of 94 in each treatment group was calculated to provide 90% power at 
a significance level of p<0.005 in vitamin D status. This was based on a previous study 
by Hollis et al, 2011. Based on Hollis et al., 2011 and to account for potential dropouts, 
(those who discontinue the study, suffer miscarriage or pregnancy complications or 
poorly comply with the study protocol) the sample size was increased by 25% to give 






Participants were randomised and stratified by BMI using Minim randomisation 
software, by an independent researcher, and randomly assigned to receive either 10μg 
or 20μg vitamin D from 12 weeks gestation through to delivery (119 participants were 
given two tablets, one multivitamin tablet (containing 10μg/vitamin D) plus a 0μg 
vitamin D (placebo) tablet and 121 participants were given two tablets, one 
multivitamin tablet (containing 10μg/vitamin D) plus a 10μg vitamin D tablet). 
10μg is the current UK recommendation for pregnant women (SCAN, 2016); the 
multivitamin used in the study contained 10μg. Whereas 20μg was based on a previous 
study by Holmes et al., 2009, where the vitamin D status of non-supplement using 
pregnant women with obesity was 25 nmol/L; in order to rise this status to a level of 
sufficiency (>50nmol/L), it was calculated that 20μg/d was required, as approximately 
1μg of vitamin D may increase status by 1.2 nmol/L. 
 
Intervention  
The multivitamins (Vitabiotics, Pregnancare®) were supplied from Vitabiotics, and 
vitamin D3 and placebo from (Sona
® Nutrition). The placebo and vitamin D tablets 
were matched for size, colour and texture. The tablets were provided to the participants 
in two batches comprising of weekly pill boxes, by the researcher at their 
appointments; batch one from week 12 to 28 weeks gestation and batch two from 28 
to 40 weeks gestation. Participants were contacted by the researcher twice between 12 
and 28 weeks gestation and again between 28 to 34 weeks gestation to check 
compliance and answer any questions the participant had. Following the second visit 
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participants returned the pill boxes; all unused tablets were counted and recorded. This 
procedure was repeated at the third visit and following this, any remaining pill boxes 
were returned via a free post envelope after the birth. Compliance was defined as 
supplement consumption > 75%. 
 
Data collection 
First antenatal visit  
Anthropometry and body composition 
At the first antenatal visit around (12 weeks gestation), anthropometric and body 
composition measurements were taken including height (using a stadiometer), weight, 
fat mass (kg) and fat free mass (kg) (using TANITA, MC-780MA scale). BMI was 
calculated as kg/m2 (World Health Organisation, 2004). All measurements were 
carried out by trained researchers in a private environment within the clinic setting.  
 
Health and Lifestyle information 
All participants completed a Health and Lifestyle Questionnaire at the first antenatal 
visit, which recorded information on age, social demographics, medication, 
supplementation use and sun exposure, including sun bed/bathing use and whether 
participants had been on a sun holiday within the previous 6 months. In addition, 
details from maternal notes were recorded including weeks gestation, parity, blood 




Participants attended follow-up appointments at 28 and 34 weeks gestation. 
Anthropometric and body composition measurements were repeated as per the initial 
visit. Information from maternal notes was recorded including weeks gestation, blood 
pressure, growth chart for the fetus, routine blood and urine sample results during 
pregnancy by the researcher at each visit. Infants anthropometric measures at birth 
(weight, length, head circumference) and other measures relevant to the health status 
of the mother and child were recorded from maternal notes and paediatric charts after 
delivery by the researcher. 
 
Dietary intake 
At the second trimester visit, all participants completed a validated Food Frequency 
Questionnaire (FFQ) to assess vitamin D intake from foods (Weir et al., 2016). The 
FFQ were assessed by portion size of the food and how often they consumed the food 
based on variety of foods which contribute to dietary vitamin D intake (milk and dairy, 
cereal products, meat and fish, eggs, cakes and confectionery, other fortified 
foods/drinks and dietary supplements). 
 
Blood sample analysis 
Non-fasting blood samples were collected at 12, 28 and 34-36 weeks gestation by a 
fully trained phlebotomist and cord blood samples were collected at delivery by the 
midwife on duty. A total of 20 ml (2x8ml serum tubes and 1x4ml plasma tube) of 
blood was collected and kept chilled and processed within 3 hours of collection 
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(centrifugation at 3000 rpm for 15 minutes).  Plasma and serum aliquots were stored 
at -80°C until batch analysis. Stored serum samples were used for vitamin D analysis. 
This was performed using liquid chromatography tandem mass spectrometry (LC-
MS/MS) by quantifying and summing 25-hydroxyvitamin D2 (25(OH)D2) and 25-
hydroxyvitamin D3 (25(OH)D3) to give total 25-hydroxyvitamin D (25(OH)D) 
concentrations (Chromsystems Instruments and Chemicals GmbH, Gräfelfing, 
Germany; MassChrom 25-OH-Vitamin D3/D2 and API 4000 LC-MS/MS; AB SCIEX, 
Washington, DC, USA). Vitamin D status was classified into categories of sufficiency 
according to SACN guidelines and defined as deficient (25(OH)D <25nmol/L); 
insufficient (25(OH)D 25-50nmol/L) or sufficient (25(OH)D >50nmol/L) (SACN, 
2016). Plasma intact parathyroid hormone (PTH) concentrations was measured using 
a commercially available enzyme-linked immunosorbent assay (MD Biosciences Inc., 
Minnesota, USA). Samples were batch analysed in the Biochemistry Department of 
St James's Hospital (Dublin, Ireland). 
Serum concentrations of calcium and albumin were measured using an automated 
clinical chemistry system (Ilab 650 Clinical Chemistry System, WERFEN). Albumin-
adjusted calcium was calculated using the following formulae: 
Adjusted calcium = measured total calcium+0.02(40-albumin) 
Or for albumin greater than 45g/L: 






The statistical analyses were performed using SPSS (Statistical Package for the Social 
Sciences software, Version 22; IBM). Data were assessed for normality using 
Kolmogorov-Smirnov test. Data were presented as mean ± SD. Intention to treat 
analysis was conducted by carrying forward the last available measurement e.g., 
vitamin D status missing at second visit was input with the vitamin D status measured 
at the baseline visit. Repeated measures ANOVA was used to compare the effect of 
10μg and 20μg supplementation, adjusted for age, BMI group, supplement use and 
season at baseline. Differences between 10 μg and 20μg groups in 25(OH)D were 
assessed by ANCOVA adjusted for age, BMI, supplement use at baseline and seasons 
in each trimester. Differences between 10μg and 20μg treatment groups for adjusted 
calcium and PTH were also assessed by ANCOVA adjusted for age, BMI and 
supplement use at baseline. 
Independent-samples t-test was used to assess differences in maternal characteristics 
between treatment groups. Chi-Square tests were performed to determine associations 
between the category of vitamin D sufficiency and other categorical variables 
including smoking, education level, marital status, parity, medication use, dietary 
supplement use, recent sun holiday, sunbed/bathing use and season. Bivariate 
correlations were performed between 25(OH)D concentrations and age, body 
composition measures, biochemical measures and blood pressure. In addition, 
multivariate-adjusted multiple regression models were used to assess determinants of 
vitamin D status. Differences between 10μg and 20μg treatment groups in infants’ 
characteristics were assessed by ANCOVA adjusted for BMI group and categorical 
variables including mode of delivery, baby weight and gender were assessed by Chi-




240 pregnant women completed the baseline visit (119 in 10µg group and 121 in 20µg 
group); samples were available for all but one participant from the 10µg group who 
withdrew from the study (personal reasons). A total of 74 participants withdrew from 
the study after baseline (37 in 10µg group and 37 in 20µg group) and the dropout 
according to BMI category in the 10µg group was n 13 normal weight, n 14 
overweight, n 9 obese and in the 20µg group was n 10 normal weight, n 14 overweight, 
n 14 obese, with no significant difference observed between BMI categories in each 
treatment group for those who dropped out. A total 158 participants completed the 
second trimester visit and provided blood samples (78 in 10µg group and 80 in 20µg 
group); 4 women in each group did not provide samples due to sickness or inability to 
attend the appointment. At the third trimester visit, 153 participants completed study 
measurements and provided blood samples (73 in 10µg group and 80 in 20µg group); 
9 women in the 10µg group did not provide blood samples (n=5 unable to attend the 
appointment and n=4 due to preterm delivery). In the 20µg group 4 women did not 
provide blood samples (n=1 due to sickness, n=1 due to preterm delivery, n=2 due to 
inability to attend the appointment; details of reasons for withdrawal are explained in 
Figure 2). Compliance with the intervention was high with no difference between 







A total of 239 pregnant women were included in this analysis, 118 in the 10 µg/d group 
and 121 in the 20µg/d group. There were no significant differences at baseline for 
anthropometric characteristics, weeks’ gestation, blood pressure, education, 
medication use, use of supplements containing vitamin D, vitamin D dietary intake 
and season of enrolment between the 10µg and 20µg treatment groups (Table1). 
 
Infants characteristics 
A total of 164 infants (81 in the 10µg group and 83 in the 20µg group) were born to 
mothers who completed the intervention. At delivery there were no statistical 
differences in gestational age or mode of delivery between the 10µg and 20µg 
treatment groups.  Nor were there any differences between birth weight, length, apgar 
scores or gender in infants born in each treatment group. Infants born to mothers in 
the 10µg group had significantly lower head circumference compared to infants born 
to mothers in the 20µg group (34.9 ± 1.5 vs. 35.7 ± 2.7 cm, P= 0.020) (Table 6).  
 
Maternal vitamin D status 
Maternal 25(OH)D concentrations in each trimester are shown in Table 2. Maternal 
25(OH)D concentrations increased from the 1st trimester to 3rd trimester in both the 
10µg and 20µg groups, with a higher increase in the 20µg group (P<0.0001). The 
mean ± SD increase was 17.1 ± 24.7 and 28.8 ± 33.3 nmol/L, P=0.002, in the 10µg 
and 20µg groups respectively, after adjustment for age, BMI, vitamin D supplement 
use at baseline and season.  
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Maternal 25(OH)D concentrations at the baseline visit were not significantly different 
between the 10µg and 20µg groups; 52.2 ± 22.9 vs. 52.0 ± 20.5 nmol/L, P=0.655. At 
the 2nd and 3rd trimester visits, 25(OH)D concentrations were significantly lower in 
the 10µg group compared with the 20µg group (trimester 2: 62.8 ± 26.3 vs. 73.6 ± 
31.6 nmol/L, P= 0.005; trimester 3: 69.3 ± 30.7 vs. 80.8 ± 37.1 nmol/L, P= 0.012) 
after adjustment for age, BMI, vitamin D supplement use at baseline and season.  
Maternal 25(OH)D concentrations in the 1st trimester (baseline) were not significantly 
different between the 10µg and 20µg groups among normal weight, overweight and 
obese women (Table 3). In the 2nd and 3rd trimesters 25(OH)D concentrations of 
normal weight women were significantly lower in the 10µg group compared with the 
20µg group (64.3 ± 25.8 vs. 84.1 ± 30.4 nmol/L, P= 0.012; 71.3 ± 30.4 vs. 94.3 ± 36.2 
nmol/L, P= 0.018) after adjustment for age, vitamin D supplement use at baseline and 
season. There were no observed differences in 25(OH)D concentrations in the 2nd and 
3rd trimesters between treatment groups in either overweight or obese women.  
Maternal 25(OH)D concentrations across BMI categories in each trimester for both 
the 10µg and 20µg groups are presented in Table 4. There were no statistical 
significant differences in maternal 25(OH)D concentrations across BMI categories in 
any trimester in the 10µg group. Whereas, in the 20µg group, maternal 25(OH)D 
concentrations were significantly lower in pregnant women with obesity compared 
with women of normal weight in the 2nd trimester and 3rd trimester (64.7 ± 30.9 vs. 
84.1 ± 30.4 nmol/L, P=0.037; 67.7 ± 34.5 vs. 94.3 ± 36.2 nmol/L, P=0.014) after 
adjustment for age, vitamin D supplement use at baseline and season.  
The prevalence of insufficiency (<50 nmol/L) and sufficiency (≥50 nmol/L) in both 
the 10µg and 20µg groups in each trimester are presented in Table 5. There were no 
230
differences in the levels of insufficiency/sufficiency between the 10µg and 20µg 
groups in any trimester; nor was there a difference in insufficiency/sufficiency when 
assessed by BMI category.  
Figure 3A presents 25(OH)D concentrations in each trimester for the 10µg and 20 µg 
groups, split by those who had a baseline 25(OH)D concentration <50nmol/L vs. 
≥50nmol/L. Pregnant women who started pregnancy with an insufficient 25(OH)D 
concentration remained insufficient in 25(OH)D throughout pregnancy in the 10µg 
group however, in the 20µg group women who started pregnancy classed as 
insufficient reached 25(OH)D sufficiency in the 2nd and 3rd trimesters. Whereas, 
pregnant women who started pregnancy with a sufficient 25(OH)D concentration, 
maintained sufficiency throughout pregnancy in both the 10µg and 20µg groups.  
When split by BMI category, similar findings were obtained in the normal weight, 
overweight and obese categories. 
 
Cord vitamin D status 
Sixty-two cord blood samples were collected (31 samples in each of the 10 and 20µg 
groups) (Table 2). Cord blood 25(OH)D concentrations were not statistically different 
between infants born to mothers in the 10µg vs. 20µg groups (35.5 ± 15.1 vs. 42.2 ± 
19.7 nmol/L, P=0.208). Cord blood 25(OH)D concentrations were positively 
correlated with maternal 25(OH)D concentrations in the 1st, 2nd and 3rd trimesters 
(r=552, P<0.0001; r=585, P<0.0001; r=784, P<0.0001) respectively. There was no 
statistical difference in levels of cord blood insufficiency/sufficiency between the 
10µg and 20µg groups (Table 5). Furthermore, cord blood 25(OH)D concentrations 
were significantly lower in infants born to mothers with obesity in the 20µg group 
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compared to infants born to mothers of normal weight (28.8 ± 16.9 vs. 52.1 ± 17.3 
nmol/L, P=0.027) after adjustment for season of delivery (Table 4).  
When the mother started pregnancy with an insufficient status, corresponding mean 
cord blood 25(OH)D concentrations were found to be insufficient in infants born to 
mothers in both the 10µg and 20µg groups (31.2 ± 17.0 vs. 26.3 ± 12.0 nmol/L, 
P=0.461) respectively. Whereas, when the mother had a sufficient status at the 
beginning of pregnancy, sufficient cord blood 25(OH)D concentrations (based on 
mean) were found in infants born to mothers in 20µg group but not in infants born to 
mothers in 10µg group (53.7 ± 15.9 vs. 36.8 ± 14.7 nmol/L, P=0.001) respectively, 
(Figure 3 A). 
Similar trends which were dependent on maternal insufficiency/sufficiency in early 
pregnancy were observed in the cord blood 25(OH)D concentrations of infants born 
to normal weight and overweight pregnant women (Figures 3 B, C). However, in 
women with obesity who started pregnancy with an insufficient status, cord blood 
results were found to be classified as deficient regardless of 10µg vs. 20µg treatment 
(19.4 ± 20.2 vs. 19.5 ± 9.4 nmol/L, P= 0.992). In contrast, obese women who started 
pregnancy as sufficient had cord blood results above deficiency and within the 
insufficiency in both the 10µg vs. 20µg treatment groups (Figure 3 D). 
When 3rd trimester maternal 25(OH)D concentrations were related to cord blood 
25(OH)D concentrations, women who had an insufficient status in late pregnancy 
were found to have cord blood levels classified as deficient, regardless of 10µg vs. 
20µg treatment (12.7 ± 2.6 vs. 23.2 ± 16.7 nmol/L, P=0.460). In contrast, when 3rd 
trimester maternal 25(OH)D concentrations were sufficient, corresponding cord blood 
25(OH)D concentrations were classified as insufficient (and out of the deficiency 
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category) in both the 10µg vs. 20µg treatment groups (37.1 ± 14.3 vs. 44.3 ± 19.2 
nmol/L, P=0.118). 
There was no difference in the percentage placental transfer of maternal 25(OH)D 
concentrations in the 3rd trimester to the cord blood 25(OH)D concentration between 
the 10µg and 20µg groups after adjustment for season of delivery (41% vs.42%, 
P=0.807) respectively; nor were there any differences in placental transfer of 
25(OH)D between the 10µg and 20µg groups among pregnant women of normal 
weight, overweight and obesity.  
Pregnant women with obesity in the 10µg group who had an insufficient 25(OH)D 
concentration (<50 nmol/L) in the 1st trimester transferred a lower 25(OH)D 
concentration to their infants compared with women who received 20µg vitamin D 
(21.5 % vs. 32.8%, P=0.046). 
Vitamin D supplement use at baseline and vitamin D dietary intake assessed in the 2nd 
trimester from a validated vitamin D FFQ were found to be significant predictors of 
maternal 25(OH)D percentage change (from 1st to 3rd trimester) in adjusted regression 
models (β= 0.181, P=0.005; β=-0.144, P=0.024) respectively.  
Maternal adjusted calcium and PTH concentrations are shown in Table 2. There were 
no differences in these blood biomarkers over the time of the intervention between the 
10µg and 20µg treatment groups after adjustment for age, BMI and vitamin D 
supplement use at baseline. There were no associations found between maternal 
adjusted calcium concentrations and maternal 25(OH)D concentrations in any 
trimester. In the 1st and 3rd trimesters maternal PTH concentrations were negatively 
correlated with maternal 25(OH)D concentrations (r=-0.343, P<0.0001; r=-0.130, 
P=0.045). Maternal 25(OH)D concentrations in the 3rd trimester positively correlated 
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There is no global consensus as to what constitutes adequate vitamin D 
supplementation during pregnancy; the current UK recommendation of 10µg/d of 
vitamin D for all pregnant and lactating women has been set with the aim of preventing 
maternal and infant deficiency (SACN, 2016). When we assessed the vitamin D status 
at the group level of 239 pregnant women, both 10µg and 20µg of vitamin D/d during 
pregnancy seemed to increase vitamin D status to a sufficient status (≥50 nmol/L) for 
the duration of pregnancy. A recent study by O'Callaghan et al., 2018 compared 3 
supplement groups of vitamin D, placebo, 10µg and 20 µg/d and reported similar 
findings. Although, in our study, we showed that the increase in vitamin D status was 
significantly higher in the 20µg group compared with the 10µg group. There was no 
observed difference in the related cord blood vitamin D status between the 10µg and 
20µg treatment groups, both were classed as being an insufficient status (<50 nmol/L). 
However, the definition of adequate or optimal vitamin D status for maternal health is 
controversial, and currently there are no known requirements or thresholds for 25(OH) 
D concentrations in cord blood samples indicative of improved infant health outcomes.   
Previous studies have shown a negative association between maternal BMI and 
maternal vitamin D status (Perez-Lopez et al., 2011; Bartoszewicz et al., 2013) 
however, based on current knowledge no studies have assessed the effect of vitamin 
D supplementation on pregnant women in different BMI categories. Therefore, this 
study shows the treatment effect of vitamin D supplementation of both 10µg/d and 20 
µg/d on pregnant women across different BMI categories. Normal weight pregnant 
women in the 20µg/d group had significantly increased maternal and cord vitamin D 
status post intervention compared to normal weight pregnant women in 10µg/d group. 
There were no observed differences in vitamin D status in the 2nd and 3rd trimesters 
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between treatment groups in either overweight or obese women. This shows that 
pregnant women of normal weight had a higher response to a higher dose (20µg) of 
vitamin D compared to pregnant women who were overweight and obese. In the 20µg 
supplementation group, pregnant women who were classified as obese had 
significantly lower vitamin D status in the 2nd and 3rd trimesters and in corresponding 
cord blood compared with pregnant women of normal weight; no significant 
difference was observed in vitamin D status in the 1st trimester. This observed 
difference could be related to sequestration of vitamin D in adipose tissue, with obese 
participants typically carrying more adipose tissue than their normal weight or 
overweight counterparts. Other physiological changes during pregnancy including 
weight gain, haemodilution and volumetric dilution which are also postulated to 
influence vitamin D status (Drincic et al., 2012). Haemodilution and weight gain 
during pregnancy are thought to have a similar effect on vitamin D status in pregnant 
women across different BMI categories (Karlsson et al., 2015), however a dearth of 
knowledge remains on this issue.  
Women who commenced pregnancy with insufficient vitamin D status failed to reach 
sufficiency throughout pregnancy in the 10µg/d group, which shows that the current 
recommendation is inadequate to reach a sufficient status in those who start pregnancy 
with a low vitamin D status. In our study we showed that 41.5% and 48.8% of women 
had an insufficient status on entering pregnancy in the 10µg and 20µg groups, and 
even with reported supplement use, 40.8% and 57.6% of women in the 10µg and 20µg 
groups, were still classified as insufficient. It has been noted previously that over 90% 
of pregnant women living in the same latitude, had an insufficient vitamin D status 
even with supplement use (Holmes et al., 2009). Given our large population of 
pregnant women, our findings can be considered reflective of the current vitamin D 
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status of women in early pregnancy, who, even when adherent to the current 
recommendation of 10µg/d, may not reach a sufficient vitamin D status at any stage 
during pregnancy. Although, we have shown that as per the aim of the current SACN 
recommendation, 10µg/d of vitamin D supplementation during pregnancy is enough 
to prevent pregnant women and their infant from vitamin D deficiency (<25 nmol/L), 
however is not enough to ensure maternal or cord sufficiency. Pregnant women who 
started pregnancy with a sufficient vitamin D status remained sufficient throughout 
pregnancy in both the10µg and 20µg groups. Cord blood vitamin D concentrations 
only reached a sufficient status in pregnant women taking 20µg/d and not in those 
women taking 10µg/d. Whilst these findings may be viewed as encouraging for the 
10µg SACN supplementation strategy, over 45% of women in this cohort would not 
reach these levels of maternal sufficiency, as they started pregnancy with an 
insufficient status.  In addition, even when starting pregnancy with a sufficient status, 
the 10µg SACN supplementation strategy is inadequate to achieve a sufficient 25(OH) 
cord concentration.  
 Previous studies have reported that 10µg/d of vitamin D may prevent pregnant women 
from vitamin D deficiency (Hollis et al., 2011; Asemi et al., 2013), and whilst this 
may have been the case in these studies, many factors can affect the measurement of 
vitamin D status which may account for some of the variance observed between 
studies even when the same supplementation dose is used, these include latitude, 
vitamin D status at the baseline of the study, dietary intake and study design.  
Similar to finding at the total group level, findings in normal weight and overweight 
pregnant women showed that 10µg/d of vitamin D supplementation during pregnancy 
is enough to prevent pregnant women and their infant from vitamin D deficiency (<25 
nmol/L) however is not enough to ensure maternal or cord sufficiency. Pregnant 
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women with obesity who started pregnancy with an insufficient vitamin D status had 
deficient (<25 nmol/L) cord blood concentrations in both the 10µg and 20µg groups 
despite mothers having a sufficient vitamin D status in 3rd trimester, this was not 
observed in mothers who were either normal weight or overweight. This result 
supported the previous findings that neonates of obese mothers have significantly 
lower cord vitamin D status compared to neonates of normal weight mothers (Bodnar 
et al., 2007; Karras et al., 2013) despite no differences in maternal 25(OH)D (Josefson 
et al., 2013). This result again reinforces our finding that the current recommendation 
of 10µg vitamin D during pregnancy is inadequate particularly based on the high 
prevalence of vitamin D insufficiency and on the current high prevalence of maternal 
obesity in UK populations. The potentially putting infants born to mothers with 
obesity at high risk for vitamin D deficiency and poor in-utero bone development 
(Weinert et al., 2015; Leffelaar et al., 2010; Robinson et al., 2011). 
Cord blood vitamin D concentrations are usually 60-80% of maternal vitamin D values 
at delivery (Hollis et al., 1984; Vieth et al., 2013). However, the current study found 
cord vitamin D concentrations to be 41% and 42% of maternal vitamin D in late 
pregnancy, with no difference between the treatment groups. We did find that the 
percentage of placental transfer was significantly lower among pregnant women with 
obesity who started pregnancy with insufficient vitamin D status and received 10µg/d 
compared with pregnant women with obesity who started pregnancy also with 
insufficient vitamin D status and received 20µg/d (21.5% and 32.8% P=0.046). 
The overall mean vitamin D status for both treatment groups at baseline was 
considered sufficient, yet there was still a high prevalence of vitamin D insufficiency; 
similar to findings from a recent study of 144 pregnant women in Cork, Ireland 
(O'Callaghan et al., 2018). In our study, after supplementation in the 3rd trimester the 
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prevalence of vitamin D insufficiency dropped from 41.5% and 48.8% to 27.1% and 
24.8% in the 10µg and 20µg groups respectively, compared to 5% and 2% in 
O'Callaghan et al., 2018 study. The higher prevalence of insufficiency in the 3rd 
trimester observed in the current study may be due to a number of  reasons, firstly 
participants in current study received exactly 10µg or 20µg daily, which is different 
to the O'Callaghan et al., 2018 study, as they allowed participants to continue with 
their own antenatal supplement regime, allowing for possible variation in the 
multivitamin type and vitamin D amount within supplements. In addition, we had 
equal numbers with BMI categories and within treatment groups whereas O'Callaghan 
et al., 2018 had more normal weight women in the 20µg group and overweight in the 
10µg group. We demonstrated that normal weight women had a higher response in 
vitamin D change in the 20µg group compared to the overweight and obese on this 
supplement dose, therefore the high numbers of normal weight in the 20µg treatment 
group in the O'Callaghan et al., 2018 study may have contributed to their higher status 
and lower prevalence of insufficiency.  
To account for seasonal variation, recruitment of our participants was ongoing 
throughout the year, across all seasons, winter (October-March) and summer (April-
September). All statistical analysis was adjusted for season. A previous UK study 
conducted in across different cities (Southampton, Oxford and Sheffield) of 1134 
pregnant women showed that a higher dose (25µg) of vitamin D was enough to prevent 
seasonal decline of maternal vitamin D status and maintain concentrations (≥ 50 
nmol/L) however, the mean maternal BMI at baseline considered as normal which not 
reflect other maternal BMI groups also cord vitamin D status was not assessed to 
ensure adequate vitamin D supplement to prevent infant vitamin D deficiency (Cooper 
et al., 2016). 
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Maternal adjusted calcium and parathyroid hormone concentrations remained 
unchanged throughout pregnancy in both the 10µg and 20µg groups with no 
differences observed between treatment groups. A negative correlation between 
maternal PTH and maternal vitamin D status in the 1st and 3rd trimester was observed 
this is expected with vitamin D metabolism; O'Callaghan et al., 2018, reported similar 
findings. 
Infants characteristics were not different between the 10µg and 20µg groups however; 
head circumference was higher in infants born to mothers in the 20µg group compared 
to infants born to mothers in the 10µg group. Maternal vitamin D status in the 3rd 
trimester was positively correlated with infant weight and head circumference, similar 
results were observed by Gernand et al., 2013, which might explain that higher vitamin 
D status during pregnancy associated with better growth of infant. 
This study has a number of strengths, including that vitamin D status was assessed by 
quantifying 25(OH)D concentrations using the gold-standard method of LC-MS/MS 
(Institute of Medicine, 2010). Furthermore, BMI and vitamin D were measured at the 
same time to accurately assess the association between body weight and vitamin D 
status, with equal numbers of women across the BMI categories. Moreover, the blood 
sampling for vitamin D measurement occurred across all seasons allowing for the 
impact of seasonal variation to be investigated. Vitamin D was assessed at three time 
points throughout pregnancy and in cord blood samples at delivery. Dietary vitamin 
D intake was assessed using a validated vitamin D FFQ. In addition, there was a large 
sample size, and a high rate of compliance in both intervention groups. There was no 
difference in the maternal characteristics and maternal vitamin D status at baseline, 
which help to summarise the results of the intervention without any confounders. 
There are some limitations in this study, including the relatively high dropout rate with 
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30% of pregnant women failing to complete the study however, the power calculation 
had accounted for a high dropout rate and differences were still observed in the current 




These findings demonstrate that the current recommendation of 10µg/d is inadequate 
to ensure sufficient vitamin D status throughout pregnancy for women living in 
Northern Ireland, particularly for those who start pregnancy with a low vitamin D 
status. This risk is further increased in obese women who enter pregnancy with a low 
vitamin D status. Cord blood from obese women who enter pregnancy with a low 
vitamin D status was vitamin D deficient, potentially putting infants at high risk for 
vitamin D deficiency and poor in-utero bone development. This research highlights 
the need for revised maternal policy on vitamin D recommendations during pregnancy, 
particularly considering our findings on BMI and the implications for related cord 
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Figure 1: Flow diagram of study design 
* Anthropometric and body composition measurements were taken and including height (using a stadiometer), 
weight, fat mass (kg) and fat free mass (kg) (using TANITA, MC-780MA scale). 
** Infants anthropometric measures at birth (weight, length, head circumference) and other measures relevant to 
the health status of the mother and child. (WHSCT) Western Health and Social Care Trust.  
Inclusion criteria 
 Pregnant women age ≥18 years  
 Singleton pregnancy - BMI >18.5 kg/m²  
 No current pregnancy related complications 
 At least 12 weeks gestation 
 Pregnant women  currently taking vitamin D and have 








and 10μg D3 
Recruitment 
N= 240 pregnant women recruited at clinics in WHSCT area 
Baseline visit (12 weeks gestation) 
 Consent completion 
 Maternal blood sample 
 Anthropometry and body composition measurements*  
 Health and Lifestyle Questionnaire 
 
 
Second trimester visit (28 weeks gestation) 
 Anthropometry and body composition  measurements*  
 Maternal blood sample 
 Vitamin D Food Frequency Questionnaire  
 
Third trimester visit (34-36 weeks gestation) 
 Anthropometry and body composition  measurements*  
 Maternal blood sample 
 
Delivery 
 Cord blood sample  





































Figure 2. Flow diagram of study participants 
 
*Sickness (n 2 in 10µg group, n 2 in 20µg group), unable to make appointment (n 2 in 10µg group, n 2 in 20µg 
group).     
**Sickness (n 1 in 20µg group), unable to make appointment (n 5 in 10µg group, n 2 in 20µg group), preterm 






Baseline visit (12 weeks gestation) 
 
n 240 
10µg group        
    
 n 119 
20µg group    
      
  n 121 
Second trimester visit (28 weeks gestation) 
 
n 166 
10µg group         n 82                                    
No samples obtained n 4*     
Samples available for analysis 
n 78  
20µg group        n 84                                         
No samples obtained n 4*    
Samples available for analysis    
n 80    
Third trimester visit (34-36 weeks gestation) 
 
n 166 
10µg group          n 82                                    
No samples obtained n 9**     
Samples available for analysis  
n 73 
20µg group        n 84                                         
No samples obtained n 4**    
Samples available for analysis    
n 80    
Cord samples available 
 
n 62 
10µg group          n 31                                     20µg group        n 31                                        
10µg group , dropout n 37                                                   
-Withdraw without reason n 20                                                              
-Sickness n 13                                                                                                                                                                                                                                                       
-Stopped taking supplements n 2                                                                                                                                                     
-Preterm delivery n1                                                            
-Decided not to continue and 
requested disposal off all data and 
samples n 1                                                                                                                                                                                                                                                                                               
 
20µg group , dropout n 37                                  
-Withdraw without reason n 14                                                         
-Sickness n 12                                                                                       
-Stopped taking supplements n 8                                                                  
-Miscarriage n 3                                                                                                                                                                                                                                                                                                                              
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Table 1: Maternal characteristics in 10 µg and 20 µg treatment groups. 
  
 
10 µg 20 µg P 
 n 118 n 121 
 
Age (yrs) 29.7 ± 5.1 29.5 ± 5.5 0.810 
Weight (kg) 74.7 ± 15.9 74.4 ± 15.9 0.880 
Height (m) 1.63 ± 0.06 1.63 ± 0.06 0.703 
BMI (kg/m2) 28.1 ± 5.7 27.8 ± 5.4 0.678 
Fat (%) 34.0 ± 6.4 34.0 ± 7.3 0.982 
Fat mass (kg) 26.5 ± 10.5 26.6 ± 10.6 0.928 
Fat free mass (kg) 48.2 ± 6.7 47.8 ± 6.8 0.617 
Fat mass index (kg/m2) 9.9 ± 3.8 9.9 ± 3.8 0.944 
Fat free mass index (kg/m2) 18.3 ± 3.0 17.9 ± 2.1 0.191 
Gestational weeks (wk) 13.0 ± 1.4 12.8 ± 1.4 0.363 
Blood pressure (mmHg)   
Systolic 119.3 ± 11.1 120.5 ± 11.6 0.415 
Diastolic 71.8 ± 8.5 72.7 ± 9.0 0.403 
Smoker n (%) 16 (13.7) 14 (11.7) 0.642 
Parity n(%)   
0 53 (45.3) 43 (36.1) 0.175 
1 34 (29.1) 48 (40.3)  
2+ 30 (25.6) 28 (23.5)  
Previous miscarriage n(%) 41 (34.7) 30 (24.8) 0.092 
Education level n(%)   
Secondary 38 (32.8) 36 (30.8) 0.939 
Diploma 18 (15.5) 23 (19.7)  
Degree 38 (32.8) 38 (32.5)  
Postgraduate 16 (13.8) 14 (12.0)  
other 6 (5.2) 6 (5.1)  
Marital status n(%)   
Married 60 (50.8) 62 (51.2) 0.952 
Unmarried 58 (49.2) 59 (48.8)  
Regular medication n(%) 15 (12.7) 8 (6.6) 0.110 
Medical illnesses n(%) 13 (11.0) 9 (7.4) 0.339 
Vitamin D supplement use n(%) 
  
User 66 (55.9) 81 (66.9) 0.080 
Non-user 52 (44.1) 40 (33.1)  
Sun holiday past 6 months n(%) 20 (16.9) 23 (19.2) 0.657 
Sun bathing/sunbed last month n(%) 7 (6.0) 11 (9.2) 0.355 
Season at enrolment n (%)    
Winter (October-March) 61 (47.7) 67 (52.3) 0.569 
Summer (April-September) 57 (51.4) 54 (48.6)  
Vitamin D dietary intake (µg/d)* 4.3 ± 2.2 4.3 ± 2.8 0.978 
Data are presented as Mean ± SD or n (%). BMI – body mass index (kg/m2) was calculated as weight (kg) divided by height2 
(m2) (WHO). Fat mass index (kg/m2) Fat mass (kg) divided by height2 (m2). Fat free mass index (kg/m2) Fat free mass (kg) 
divided by height2 (m2). *Vitamin D dietary intake assessed form validated vitamin D FFQ.  Differences between group 10 
µg and 20 µg groups were assessed by Independent sample t-test or Chi-squared test as appropriate, (P< 0.05) considered 
significant                                                              
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Table 2: Intention to treat analysis of pregnant women on maternal 25(OH)D, adjusted calcium and PTH and cord 25(OH)D, 
cord adjusted calcium. 
 1
st trimester  2
nd trimester  3



















  P*  
 10 µg  
n 31  
 20 µg 
n 31 P 
25(OH)D 
(nmol/L) 
52.2 ± 22.9 52.0 ± 20.5 0.655  62.8 ± 26.3 73.6 ± 31.6 0.005  69.3 ± 30.7 80.8 ± 37.1 0.012  <0.0001  35.5 ± 15.1 42.2 ± 19.7 0.208 
Adjusted calcium 
(mmol/L) 
2.29 ± 0.10 2.30 ± 0.11 0.614  2.27 ± 0.11 2.29 ± 0.08 0.127  2.27 ± 0.11 2.28 ± 0.10 0.769  0.580  2.6 ± 0.23 2.6 ± 0.25 0.618 
Parathyroid 
hormone (PTH) 
21.2 ± 7.8 21.9 ± 9.0 0.441  23.4 ± 9.1 22.8 ± 8.2 0.643  23.8 ± 9.3 23.5 ± 9.0 0.789     0.296     
Data presented as mean ± SD. P Differences between 10 µg and 20 µg groups in 25(OH)D were assessed by ANCOVA adjusted age, BMI, supplement use at 
baseline and seasons in each trimester and cord for the adjusted calcium and (PTH) only adjusted age, BMI and supplement use at baseline, (P< 0.05) 
considered significant. P* obtained from repeated measure ANOVA, comparing the effect of treatment group adjustment for age, BMI group, supplement use 












Table 3: Differences in vitamin D status between 10 µg and 20 µg groups in each BMI category.     
 1
st trimester  2
nd trimester  3
rd trimester  Cord  
 10 µg 20 µg P 10 µg 20 µg P 10 µg 20 µg P 10 µg 20 µg P 
25(OH)D (nmol/L)            
ALL 52.2± 22.9 52.0 ± 20.5 0.671 62.8 ± 26.3 73.6± 31.6 0.006 69.3 ± 30.7 80.8 ± 37.1 0.012 35.5 ± 15.1 42.2 ± 19.7 0.184 
Normal weight 55.9 ± 26.3 59.2 ± 19.8 0.987 64.3 ± 25.8 84.1 ± 30.4 0.012 71.3 ± 30.4 94.3 ± 36.2 0.018 34.9 ± 14.5 52.1 ± 17.3 0.030 
Overweight 51.0 ± 22.2 48.7 ± 18.7 0.697 64.9 ± 27.7 71.7 ± 31.2 
0.267 
69.7 ± 29.5 80.0 ± 36.4 0.136 37.5 ± 8.5 40.1 ± 19.3 0.540 
Obese 49.7 ± 19.7 48.0 ± 21.2 0.711 59.2 ± 25.7 64.7 ± 30.9 0.402 66.9 ± 32.7 67.7 ± 34.5 0.739 34.5 ± 20.3 28.8 ± 16.9 0.942 
Data presented as mean ± SD. P Differences between 10 µg and 20 µg groups were assessed by ANCOVA adjusted Age, supplement use at baseline and seasons in 
















  All Normal weight Overweight Obese P 
 
All Normal weight Overweight Obese P 
25(OH)D nmol/L 
           
1st trimester n 118 n 39 n 39 n 40 
  
n 121 n 41 n 40 n 40 
 
 
52.2 ± 22.9* 55.9 ± 26.3* 51.0 ± 22.2* 49.7 ± 19.7* 0.358 
 
52.0 ± 20.5* 59.2 ± 19.8* 48.7 ± 18.7* 48.0 ± 21.2* 0.072 
2nd trimester n 118 n 39 n 39 n 40 
  
n 121 n 41 n 40 n 40 
 
 
62.8 ± 26.3# 64.3 ± 25.8 64.9 ± 27.7 59.2 ± 25.7 0.548 
 
73.6 ± 31.6# 84.1 ± 30.4a# 71.7 ± 31.2# 64.7 ± 30.9b# 0.037 
3rd trimester n 118 n 39 n 39 n 40 
  
n 121 n 41 n 40 n 40 
 
 
69.3 ± 30.7# 71.3 ± 30.4# 69.7 ± 29.5# 66.9 ± 32.7# 0.692 
 
80.8 ± 37.1# 94.3 ± 36.2a# 80.0 ± 36.4# 67.7 ± 34.5b# 0.014 
Cord  n 31 n 11 n 9 n 11 
  
n 31 n 13 n 10 n 8 
 
 
35.5 ± 15.1 34.9 ± 14.5 37.5 ± 8.5 34.5 ± 20.3 0.609 
 
42.2 ± 19.7 52.1 ± 17.3a 40.1 ± 19.3 28.8 ± 16.9b 0.027 
P* <0.0001 0.037 0.005 0.029   
 
<0.0001 <0.0001 <0.0001 0.025 
 
Data presented as mean ± SD.  P Differences between the BMI categories were assessed by ANCOVA adjustments for age, supplement use at baseline and seasons in each 
trimester. In cord were assessed by ANCOVA adjustments for season of delivery (P< 0.05) considered significant. P* Differences between 25(OH)D in each trimester were 
assessed by ANCOVA adjusted for  age, supplement use at baseline, BMI group and season at baseline and for each category of BMI adjustments for age, supplement use at 
baseline and season at baseline. Different superscript letters are significantly different between BMI categories, different superscript simples are significantly different 




Table 5: Prevalence of maternal 25(OH)D insufficiency and sufficiency in each trimester and in cord for 10µg and 20µg groups. 
  
 1
st trimester  2
nd trimester  3
rd trimester  Cord  
  10 µg 20 µg P 10 µg 20 µg P 10 µg 20 µg P 10 µg 20 µg P 
All             
Insufficient <50 nmol/L 49 (41.5) 59 (48.8) 0.261 38 (32.2) 31 (25.6) 0.261 32 (27.1) 30 (24.8) 0.682 24 (77.4) 17 (54.8) 0.060 
Sufficient >50 nmol/L 69 (58.5) 62 (51.2)  80 (67.8) 90 (74.4)  86 (72.9) 91 (75.2)  7 (22.6) 14 (54.2)  
Normal weight              
Insufficient <50 nmol/L 14 (35.9) 14 (34.1) 0.870 13 (33.3) 6 (14.6) 0.049 10 (25.6) 6 (14.6) 0.219 9 (81.8) 5 (38.5) 0.032 
Sufficient >50 nmol/L 25 (64.1) 27 (65.9)  26 (66.7) 35 (85.4)  29 (74.4) 35 (85.4)  2 (18.2) 8 (61.5)  
Overweight              
Insufficient <50 nmol/L 17 (43.6) 22 (55.0) 0.311 11 (28.2) 11 (27.5) 0.944 10 (25.6) 10 (25.0) 0.948 8 (88.9) 6 (60) 0.153 
Sufficient >50 nmol/L 22 (56.4) 18 (45.0)  28 (71.8) 29 (72.5)  29 (74.4) 30 (75.0)  1 (11.1) 4 (40)  
Obese               
Insufficient <50 nmol/L 18 (45.0) 23 (57.5) 0.263 14 (35.0) 28 (35.0) 1.000 12 (30.0) 14 (35.0) 0.633 7 (63.6) 6 (75) 0.599 
Sufficient >50 nmol/L 22 (55.0) 17 (42.5)   26 (65.0) 26 (65.0)   28 (70.0) 26 (65.0)   4 (36.4) 2 (25)   
Data are presented as n (%). Differences in maternal classifications of insufficiency and sufficiency between 10 µg and 20 µg groups were assessed by Chi-squared test, (P< 0.05) considered significant.  







Table 6: Infants characteristics born to mothers who completed the 
intervention.  
 10 µg 20 µg P 
 n 81    n 83    
Gestation at delivery (wk) 39.6 ± 2.1 39.8 ± 1.6 0.528 
Mode of delivery    
Vaginal delivery 41 (50.6) 38 (45.8) 0.550 
Caesarean section 33 (40.7) 36 (43.4)  
Forceps 6 (7.4) 5 (6.0)  
Vacuum 1 (1.2) 4 (4.8)  
Apgar    
1 minute* 8.4 ± 1.4 8.5 ± 1.1 0.678 
5 minutes* 8.9 ± 1.0 9.0 ± 0.3 0.479 
Anthropometric    
Baby weight (gm) 3492.7 ± 487.7 3628.9 ± 559.6 0.092 
             Low birth weight n (%) 3 (3.7) 3 (3.6) 0.500 
             Normal birth weight n 
(%) 67 (82.7) 63 (75.9)  
             Macrosomia n (%) 11 (13.6) 17 (20.5)  
Birth length (cm)* 52.5 ± 3.3 52.9 ± 3.5 0.378 
Head circumference (cm)* 34.9 ± 1.5 35.7 ± 2.7 0.020 
Gender    
Male 37 (45.7) 43 (51.8) 0.432 
Female 44 (54.3) 40 (48.2)  
Data are presented as Mean ± SD or n (%).                                                                                
Apgar score is a test generally done at one and five minutes after birth to assess the health of new born children 
immediately after birth, Scores 7 and above are generally normal, 4 to 6 fairly low, and 3 and below are generally 
regarded as critically low. Birth weight defined by WHO- Low birth weight <2500g and macrosomia >4000g.  P 
Differences between 10 µg and 20 µg groups were assessed by ANCOVA adjusted for BMI group or Chi-squared test 
as appropriate, (P< 0.05) considered significant. * Only n 81 of infant measures in control group available for 
analysis. 




Figure 3 A.  25(OH)D concentrations in 10µg and 20µg groups in all pregnant women throughout pregnancy and in cord for those who 
started pregnancy with insufficient 25(OH)D concentrations <50 nmol/L and sufficient 25(OH)D concentrations ≥50 nmol/L.   Indicated 
to significant difference P (<0.05) between 10µg and 20µg groups who started pregnancy with insufficient (<50 nmol/L) and between 
10µg and 20µg groups who started pregnancy with sufficient (≥50 nmol/L) were assessed by independent t-test. 
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Figure 3 B.  25(OH)D concentrations in 10 µg and 20 µg groups in pregnant women of normal weight throughout pregnancy and in 
cord for those who started pregnancy with insufficient 25(OH)D concentrations <50 nmol/L and sufficient 25(OH)D concentrations ≥50 
nmol/L.   Indicated to significant difference P (<0.05) between 10µg and 20µg groups who started pregnancy with insufficient (<50 






Figure 3 C.  25(OH)D concentrations in 10 µg and 20 µg groups in pregnant women with overweight throughout pregnancy and in cord 
for those who started pregnancy with insufficient 25(OH)D concentrations <50 nmol/L and sufficient 25(OH)D concentrations ≥50 









Figure 3 D.  25(OH)D concentrations in 10 µg and 20 µg groups in pregnant women with overweight throughout pregnancy and in cord 
for those who started pregnancy with insufficient 25(OH)D concentrations <50 nmol/L and sufficient 25(OH)D concentrations ≥50 






The overall aim of this thesis was to investigate the association between maternal body 
weight and vitamin D status throughout pregnancy. The prevalence of maternal 
obesity is increasing, with one in five women of reproductive age in the UK being 
classed as obese (Poston et el., 2016; Devlieger et al., 2016). The prevalence of 
vitamin D deficiency (<25 nmol/L) during pregnancy is largely unknown as the 
routine measurement of vitamin D is not part of standard antenatal care. A limited 
number of studies have reported on the prevalence of vitamin D deficiency to range 
from 13% to 64% (Yu et al., 2009) and over 90% of pregnant women living in 
Northern Ireland have been reported to be vitamin D insufficient (<50 nmol/L), even 
with the use of vitamin D supplements (Holmes et al., 2009). Previous studies have 
shown a negative association between maternal BMI and maternal vitamin D status 
(Perez-Lopez et al., 2011; Bartoszewicz et al., 2013). The complications of maternal 
obesity during pregnancy are similar to those reported as associated with vitamin D 
deficiency including increased risk of developing gestational diabetes mellitus 
(GDM), pre-eclampsia, having a preterm delivery and requiring a caesarean section. 
The adequacy of the current UK recommendation of 10µg/d (SACN, 2016) remains 
controversial, particularly in those who are overweight or obese, owing to the higher 
requirement and lower vitamin D status associated with obesity.  
The main findings of this thesis are as follows: Chapter 2, the systematic review 
explored current knowledge on the association between maternal obesity and vitamin 
D status of mothers and their infants. In studies across the globe evidence shows that 
obese or severely obese pregnant women have consistently lower vitamin D status 
compared to non-obese pregnant women and maternal BMI is negatively associated 
with maternal vitamin D status. Infant vitamin D stores are directly related to maternal 
stores; studies report that vitamin D status is lower in infants born to obese mothers 
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compared to infants born to normal weight mothers. Maternal obesity was negatively 
associated with maternal and infant vitamin D status, with potential implications for 
both maternal and child health. Based on the systematic review it seems that public 
health advice on vitamin D supplementation during pregnancy should consider the 
implications of pre-pregnancy BMI. Findings from Chapter 3 &4 further supported 
the existing literature regarding the association between body weight and vitamin D 
status during pregnancy. Chapter 3 showed that in early pregnancy, women with 
obesity had significantly lower vitamin D status than those who were normal weight, 
this was evident particularly during the winter months. These data from the FASSTT 
trial collected in 2006, where women were not taking vitamin D supplements during 
pregnancy, showed that 60% of pregnant women living in Northern Ireland were 
considered vitamin D insufficient at 14 and 36 weeks gestation.  Chapter 4 showed 
that pregnant women classed as overweight and obese had significantly lower vitamin 
D status compared to pregnant women of normal weight in early pregnancy, despite 
62% of women reporting to take a vitamin D containing supplement. Maternal BMI 
was found to be a significant negative predictor of vitamin D status. There was a high 
prevalence of vitamin D insufficiency with over 45% of pregnant women living in 
Northern Ireland considered insufficient, and this was highest among non-supplement 
users in winter months. The awareness of the importance of vitamin D 
supplementation may have increased over the time between the two cohorts in 
Chapter 3 & 4, which likely contributed to the increased vitamin D status from 
insufficiency in Chapter 3 to sufficiency in Chapter 4. Chapter 5 discussed the 
findings from a double-blind randomised vitamin D intervention study (MO-VITD) 
which assessed the effect of supplementation of 10μg vs. 20μg vitamin D3/d 
throughout pregnancy on vitamin D status of normal weight, overweight and obese 
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pregnant women and on the cord blood of their infants. Maternal vitamin D status, 
increased from the 1st trimester to 3rd trimester in both the 10µg and 20µg groups, this 
increase was higher in the 20µg group. There was no overall difference in cord vitamin 
D status between the treatment groups. Vitamin D supplementation of 10µg/d is 
adequate to prevent pregnant women and their infant from vitamin D deficiency (<25 
nmol/L) however is not enough to ensure maternal or cord sufficiency when women 
started pregnancy with insufficient vitamin D status. In this cohort 41.5% and 48.8% 
of pregnant women started pregnancy with insufficient status in the 10µg vs. 20µg 
treatment groups. Currently in the UK vitamin D status is not assessed during 
pregnancy, meaning these at-risk mothers remain unidentified. Recommendations 
advise all pregnant women to take 10μg/d of vitamin D however this is inadequate for 
those commencing pregnancy with the lowest vitamin D status. In the 20µg group, 
maternal and cord 25(OH)D concentrations reached and maintained sufficiency 
throughout the pregnancy, even in those who started pregnancy with an insufficient 
status. However, when taking pre-pregnancy BMI into account, this was not achieved 
across all BMI categories. In obese women who started pregnancy with an insufficient 
vitamin D status, the related cord blood vitamin D status was deficient in both the 
10µg and 20µg groups. In contrast, obese women who started pregnancy as sufficient 
had cord blood results above deficiency and within the insufficiency range in both the 
treatment groups. In the 20µg group, pregnant women with obesity had lower vitamin 
D status in the second and third trimester and in cord compared to women of normal 
weight. Infants born to mothers with obesity who started pregnancy with insufficient 
vitamin D status are at higher risk of low vitamin D status (<25 nmol/L). This further 
highlights the need for vitamin D status to be measured as part of routine antenatal 
care, enabling HCPs to identify mothers most at risk of deficiency. 
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In chapter 2 measures of BMI were reported to be taken either pre-pregnancy or 
throughout pregnancy. In contrast to this, in the studies included in chapter 3, chapter 
4 and chapter 5 all BMI measures were taken during early pregnancy at 12 and 14 
weeks gestation with blood sampling for the analysis of vitamin D being carried out 
at the same appointment. This allowed for the accurate assessment of the association 
between body weight and vitamin D status and is one of the considerable strengths of 
this work. 
Circulating 25(OH)D concentration is the most reliable biomarker for the 
measurement of vitamin D status, therefore it was used to establish vitamin D status 
in all blood samples in chapter 3, chapter 4 and chapter 5.  The Institute of Medicine 
(IOM) has defined serum 25(OH) D concentrations greater than 50nmol/L as 
sufficient for bone health (Institute of Medicine, 2010). The cut-off point for 
deficiency has been defined as <25 nmol/L (SACN, 2016) or  <30 nmol/L (IOM, 2011) 
and some researchers have argued that concentrations as high as >75 nmol/L are 
necessary for functions of vitamin D beyond bone health (Holick et al., 2011). 
However, pregnancy specific vitamin D guidelines outlining required intake are 
needed to prevent adverse outcomes. In this thesis the cut-off point for deficiency was 
defined as 25(OH)D <25 nmol/L, insufficiency 25-50 nmol/L and sufficiency ≥50 
nmol/L, however further research in this area is urgently needed. 
Seasonal variations are known to influence vitamin D status during pregnancy to 
account for this the studies were ongoing across all seasons. In chapter 3 it was 
observed that during the winter months’ obese mothers had significantly lower vitamin 
D status compared to their normal weight or overweight counterparts this difference 
was not observed during the summer months. In Chapter 4 when examining baseline 
measures it was reported that vitamin D status in early pregnancy was significantly 
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lower in pregnant women with overweight and obesity compared to women of normal 
weight in winter months, but not in summer months. Vitamin D status of pregnant 
women with obesity who were also non-supplement users was significantly lower than 
supplement users with obesity, in winter months. In chapter 5 when assessing the 
maternal percentage change of vitamin D, there was no difference in the baseline 
season in the group as a whole or among pregnant women in different BMI categories 
in both the 10µg and 20µg groups. These results demonstrate the additive effect that 
seasonal variability can have, particularly when coupled with a higher BMI and 
absence of supplement use compounding the risk for these women. Based on the 
geographical location in the northern latitude of the cohort studied in this thesis, 
vitamin D supplementation is required during pregnancy particularly during winter 
months and in those who have higher BMI to prevent vitamin D deficiency and 
implications related to maternal and infant outcomes. Season is a known contributor 
to having a lower vitamin D status, however this effect is further exacerbated in those 
with a higher BMI putting them at greater risk of vitamin D deficiency.  
Season was the only significant predictor of vitamin D status in both early and late 
pregnancy (chapter 3 & chapter 4), maternal BMI, supplement use and having been 
on a sun holiday were significant predictors of vitamin D status only in early 
pregnancy. However, in chapter 5 season was not found to be a predictor of vitamin 
D percentage change during pregnancy. 
Numerous different factors affect vitamin D status such as vitamin D supplement use, 
sun holidays and sun bed use; we able to account for the influence of these factors in 
chapter 4 and in chapter 5, however in chapter 3 only information on 
supplementation use was available. 
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Results reported in chapters 4 and chapter 5, may have implications for policies on 
vitamin D supplementation during pregnancy as the current UK recommendation of 
10µg/d, was not enough to prevent the high prevalence of vitamin D insufficiency 
found in early and late pregnancy. We also observed that the current recommendation 
of 10µg/d is not enough to ensure sufficient status in pregnant women with insufficient 
vitamin D status at early pregnancy; 10µg/d is adequate to prevent vitamin D 
deficiency but not enough to bring maternal and cord concentrations to sufficiency. 
Findings from this thesis would suggest that those planning a pregnancy should 
consider taking a vitamin D supplement in order to reach a sufficient status before 
conception. Due to the high prevalence of insufficiency in those who reported 
supplement use during early pregnancy, it may be that 20µg vitamin D is required to 
reach a sufficient pre-pregnancy status; further research is needed in this area.  
In contrast, 20µg/d was able to increase maternal and cord vitamin D concentrations 
to sufficient status. The current study would suggest that a maternal vitamin D 
supplement of 20µg/d is needed to reach and maintain maternal and cord vitamin D 
status ≥50 nmol/L during pregnancy in all pregnant women living in Northern Ireland.  
As we highlighted in this research, maternal BMI was negatively associated with 
vitamin D status during pregnancy, this was observed in non-supplement user and 
those taking 10µg/d supplements (chapter 3 & chapter 4). Furthermore, among 
pregnant women taking 20µg/d in the second and third trimesters, obese pregnant 
women had lower vitamin D status than normal weight women. Moreover, we found 
that the cord vitamin D status was affected by maternal BMI; obese pregnant women 
had lower vitamin D cord status compared with the cord status of normal weight 
women in those who had taken 20µg/d supplements.  Infants of obese women who 
enter pregnancy with a low vitamin D status had vitamin D deficiency even if the 
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mothers had taken 10 µg/d or 20µg/d, potentially putting infants at high risk for 
vitamin D deficiency and poor in-utero bone development. These findings are 
important for public health agencies reinforcing the need to consider maternal BMI 
when implementing recommendations for vitamin D supplementation. 
The mechanisms behind lower maternal and cord vitamin D concentrations in women 
with higher BMI is not clear yet, it has been thought to be due to possible sequestration 
of vitamin D in adipose tissue. However further investigation is needed in this area to 
elucidate the mechanisms by which vitamin D is utilised in vivo during pregnancy 
particularly in women across BMI categories. In addition, the impact of maternal 
obesity and low vitamin D status during pregnancy on infants’ bone health and 
outcomes is not yet fully investigated. Research in this area is required to identify an 
adequate vitamin D supplement dose, appropriate for use during pregnancy.  
Key findings 
 Pregnant women with obesity had lower vitamin D status than normal weight 
women in early and late pregnancy.  
 Vitamin D deficiency was prevalent during winter in pregnant women and this 
was particularly evident in those with maternal obesity and non-supplement 
users. 
 Maternal BMI was inversely correlated with maternal vitamin D status during 
pregnancy. 
 Attaining sufficient vitamin D status in pregnancy through dietary 
supplementation is vital for the mother and child. 
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 10µg/d of vitamin D supplementation during pregnancy is not enough to bring 
women who had an insufficient vitamin D status in early pregnancy to 
sufficient status throughout pregnancy. 
 20µg/d of vitamin D supplementation during pregnancy is required to increase 
maternal and cord vitamin D to sufficient status. 
 
 
This thesis highlights areas for further investigations: 
1. Investigation on the mechanisms of vitamin D metabolism during pregnancy 
on pregnant women with obesity compared to pregnant women of normal 
weight. 
2. Further investigation of vitamin D transfer during pregnancy to the fetus 
from pregnant women with obesity compared to pregnant women of normal 
weight. 
3. A need for studies to define thresholds for cord and infant vitamin D status 
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Impact of maternal body weight on vitamin D status during 
pregnancy 
 Background: 
Vitamin D is involved in calcium and phosphate homeostasis and is essential for the 
maintenance of bone health. Severe vitamin D deficiency results in rickets in 
children and osteomalacia in adults (Bouvard et al., 2011; Christakos et al., 2011). 
Low vitamin D status has been implicated in the pathogenesis of a number of 
conditions including cardiovascular, autoimmune and inflammatory diseases and a 
number of cancers (Bouvard et al., 2011; Christakos et al., 2011). Vitamin D is a fat-
soluble vitamin which is produced by the body after exposure to sunlight. Sunlight 
provides approximately 90% of vitamin D and the remaining 10% is provided by food 
such as fatty fish, egg yolks, liver, mushrooms and fish-liver oils (Holick et al., 2007; 
2008). Many factors can limit vitamin D synthesis from sun exposure, such as 
latitude, season, sunscreen use, societal factors, pollution, weather, age, skin colour 
and body composition. One study has highlighted that the main cause of vitamin D 
deficiency in Ireland is its latitude which is between 51-55°N (Hill et al., 2004); this 
leads to reduced sunlight exposure for at least 6 months of the year during 
(autumn/winter) which time, vitamin D synthesis is negligible and individuals rely on 
stores (built up during the previous summer) as well as dietary sources. 
The most robust biomarker for the measurement of vitamin D status is serum 25-
hydroxyvitamin D (25(OH) D) concentrations, (Institute of Medicine, 2011) with 
concentrations greater than 50 nmol/L (or 20 ng/mL) defined as sufficient vitamin D 
status (Institute of Medicine, 2010). 
Vitamin D deficiency (25(OH) D <30 nmol/L) and insufficiency (25(OH)D <50 
nmol/L) is prevalent world-wide in many populations (Department of Health, 2011) 
with a higher prevalence in individuals considered at-risk (infants, elderly, pregnant 
women) (Bandeira 2006; Holick2007a). Indeed, many studies have reported vitamin 
D deficiency and insufficiency in pregnant women in many nations across the world 
(Dawodu et al., 2013). In Northern Ireland, it has been reported that 96% of 
pregnant women were vitamin D insufficient and insufficiency was prevalent even 
among those women who were supplement users (Holmes et al., 2009).  Due to risk 
of bacterial exposure, food such as liver and eggs are advised to be avoided during 
pregnancy (Food Standards Agency, 2008), thus reducing the opportunity for the 
consumption of vitamin D rich food sources during this critical period of 
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development. Vitamin D is essential for maintaining normal bone health of the 
developing child (Bodnar et al., 2007) and mothers vitamin D status during 
pregnancy, which is directly correlated with offspring vitamin D status, has been 
shown to be a predictor of bone mineral density in the offspring later in life (Javaid et 
al 2006).  
Studies have also highlighted that low maternal vitamin D status is a strong risk 
factor for conditions such as pre-eclampsia (Robinson et al., 2011; Bodnar et al., 
2007), gestational diabetes (Wagner et al., 2012), hypertension (Wagner et al., 
2012) and pre-term delivery (Dawodu et al., 2011). Furthermore, rickets, skeletal 
problems, type 1 diabetes, schizophrenia, and asthma are adverse health outcomes 
of infants born to mothers with a low vitamin D status during pregnancy (Holick 
2006; McGrath 2001). Despite the high prevalence of vitamin D deficiency in 
pregnancy and its possible short and long-term consequences, the criteria for 
defining an optimal intake and status during pregnancy remains controversial (Holick 
et al., 2011; Wagner et al., 2012). In the UK, it is currently recommended that all 
pregnant and breastfeeding women should take a daily supplement of 10 μg of 
vitamin D (Food Standards Agency, 2008).  
As previously mentioned, body composition is a determinant of vitamin D status.  
Observational and intervention studies have reported that those who are obese or 
overweight may need 2 to 5 times more vitamin D to reach a sufficient level when 
compared with lean individuals (Holick et al., 2011; Holick et al., 2007; Hossein-
nezhad et al., 2013; Jorde et al., 2010;Lee et al., 2009). Vitamin D is fat-soluble and 
therefore may be sequestered in the larger pool of adipose tissue in overweight and 
obese individuals (Holick et al., 2011; Holick et al., 2007; Hossein-nezhad et al., 
2013). In a study by Karani et al. (2013) it was shown that a higher BMI was 
associated with a lower vitamin D status in both men and women of various ages. 
Furthermore, another study has shown that cord blood 25(OH)D concentrations are 
significantly lower in infants born to obese mothers compared to infants born to lean 
mothers (Bodnar et al., 2007). This was further supported in 2013, in a study which 
demonstrated that at the same concentration of serum vitamin D, obese pregnant 
women transfer less 25(OH)D to the infant than normal-weight pregnant 
women(Jami et al., 2013) and the authors suggested that to transfer sufficient levels 
of vitamin D to the offspring, obese mothers may require a higher amount of vitamin 
D supplement than lean mothers, owing to reduced bioavailability and sequestration 
of 25(OH)D in adipose tissue (Jami et al., 2013). 
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We hypothesise that overweight and obese pregnant women have a lower vitamin D 
status than their leaner counterparts at the beginning of pregnancy and may need a 
higher daily supplementation level of vitamin D to achieve a sufficient status.  
Therefore the primary aim of this randomised controlled intervention study is to 
assess the impact of 10 μg vs 20 μg/day of vitamin D on vitamin D status in normal 




See (Figure 1) for a flow diagram of the study process. 
Study Design 
Double Blinded Randomised Controlled Intervention Study.  
Study participants 




• Pregnant women 
• Age ≥18years  
• BMI >18.5 kg/m² 
• Without current pregnancy related complications  
• At least 12 weeks gestation 
• Have a singleton pregnancy (as confirmed at first scan) 
• Pregnant women who are currently taking vitamin D and have had a sun 
holiday will be included in this study. All participants will agree to 
discontinue any current supplementation and will be provided with a 
multivitamin for the duration of pregnancy. 
             
Exclusion Criteria 
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• Aged <18 years  
• Pregnancy BMI <18.5kg/m2 
• Participants with multiple pregnancy 
• Participants currently involved in another research study 
• Participants with a history of gastrointestinal, hepatic, renal, vascular or                     
haematological disorders. 
• Participants who have had in vitro fertilisation (IVF) treatment 
• Participants with a history of NTD affected pregnancies 
• Pregnant women with active thyroid disease (e.g., Graves, Hashimoto or 
thyroiditis) 




At the booking appointment (approximately 9-10 weeks gestation), all pregnant 
women in the Western Trust Area will be given an information sheet with details of 
the study including contact details of the lead researcher should they wish to know 
more about the study. The midwife or the health care professional (HCP) will give a 
brief outline of the study and inform the potential participant that a researcher will be 
at the hospital clinic when they attend for their 12 week scan, to answer any further 
questions and to take consent, if they wish to participate in the research. The 
researcher will ensure that all participants meet the inclusion criteria and are fully 
aware of the requirements of the research. The total number of participants will be 
N=240, normal weight, overweight and obese pregnant women at least 12 weeks 
gestation. Using minim randomisation software and stratified by BMI, participants 
will be randomised by an independent person (clinical trials manager at Ulster 
University) to receive either 10μg or 20μg of vitamin D from 12 weeks gestation 
through to delivery. All participants will be given a pregnancy multivitamin which 
contains 10μg vitamin D. Participants will be randomised to receive a separate 
supplement of placebo (0μg) or 10μg vitamin D. Therefore all participants will 
receive 2 capsules to consume daily: a pregnancy multivitamin plus placebo (0μg) 
or a pregnancy multivitamin plus 10μg vitamin D. The placebo capsule and 10μg 
vitamin D will be matched for size, colour and texture. 
Blood sampling: 
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The study will have 4 sampling time-points; 12 weeks gestation, 28 weeks gestation, 
36 weeks gestation and a cord blood sample will be collected after delivery. At each 
time point a total of 20 ml (2x8ml serum tube and 1x4ml plasma tube) of blood will 
be collected. In addition, a 20 ml of cord blood sample will be obtained at delivery.  
All blood samples will be taken by a fully trained phlebotomist and the cord blood 
sample will be collected by the midwife on duty at the delivery. All midwives have 
been trained in the collection of cord blood samples. 
All blood samples will be analysed for vitamin D status, 25 hydroxyvitamin D 
(25(OH) D) and other markers of vitamin D metabolism will also be measured, such 
as 1, 25 di hydroxyl vitamin D (1, 25(OH)2 D), serum calcium and plasma 
parathyroid hormone concentrations (PTH).  C - reactive protein (CRP), insulin, 
glucose, lipid parameters and bone turnover markers e.g. (serum alkaline 
phosphatase, bone specific alkaline phosphatase, osteocalcin, serum crosslops, 
tartrate-resistant acid phosphatase). 
Also, blood samples will be analysed for pro- and anti-inflammatory cytokines and 
vascular markers e.g. (IL-6, IL-8, IL-10, TNF- α, IFN- γ, CRP, ICAM-1, VCAM-1). 
DNA will be analysed by removing the buffy coat from blood samples to analyse 




Bioelectrical impedance will be used for the measurement of body composition. At 
each time point (12, 28 and 36 weeks) maternal anthropometric and body 
composition measures (weight / height / BMI/ lean tissue / body fat/ TBW) will be 
taken and recorded. In addition, details from the projected growth chart for the 
foetus, routine blood and urine sample results during pregnancy will be taken from 
maternal notes. 
Infants anthropometric measures at birth (weight / length/ head circumference) and 
other measures relevant to the health status of the mother and child will be recorded 
from maternal notes and paediatric charts.  
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All measurements will be carried out by trained researchers in a private 
environment. A data collection sheet will be used to record this information on which 
each subject will be identifiable only by an ID number. 
Questionnaires: 
Participants will be asked to complete a Health and Lifestyle Questionnaire at 12 
weeks gestation and at 28 week gestations participants will be asked to complete a 
Food Frequency Questionnaire to assess vitamin D intake from foods. 
A four day food diary will be used for the collection of dietary intake data. At the 28 
week appointment, all participants will be given a food diary and detailed verbal and 
written instructions on how to complete the food diary. The food diary will be 
completed on 2 weekdays and 2 weekend days. 
During each phase between appointments (12-28 weeks and 28-36weeks), 
participants will be contacted twice via telephone to evaluate how adherence to the 
study is being managed.  
 
Data Analysis: 
The Statistical analysis package for the social sciences (SPSS version 21) will be 
used to analyse all data collected during the study.  Data will be examined for 
normality using the Kolmogorov-Smirnov test and where necessary, data may be 
log-transformed. Depending on the normality of data parametric or non-parametric 
equivalents will be used. 
Primary outcome: 
One Way ANCOVA will be used to assess the effects of 10 and 20μg/d vitamin D 
during pregnancy among lean, overweight and obese pregnant women using 
intention-to-treat analysis. 
Secondary outcomes: 
Regression analyses will be used to assess the relationships between vitamin D 
status and (BMI/ Age/ Infant anthropometric measurements/ mode of delivery/ 
inflammatory responses/ bone turnover markers and lipid parameters).P values 
<0.05 will be considered significant. 
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All participants will be given a unique study identification code for identification 
purposes so that anonymity is protected at all times. All participant data will be 
stored on password protected computers. Hard copy personal data will be stored in 
locked cabinets under the custodial care of the principal investigator. Researchers 
will hold all information and data collected in confidence and all efforts will be made 
to ensure participants will not be identified (except as might be required by law or in 
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* Anthropometry and body composition measurements (weight/height/BMI/lean tissue/fat tissue/TBW)  
** Duration of gestation, mode of delivery, birth weight/ Length /Head circumference, APGAR scores       
 
Inclusion criteria 
 Pregnant women age ≥18 years  
 Singleton pregnancy - BMI >18.5 kg/m²  
 No current pregnancy related complications 
 At least 12 weeks gestation 
 Pregnant women who are currently taking vitamin 




 Pregnant women aged <18 years 
 Multiple pregnancy 
 Pregnancy BMI <18kg/ m² 
 History of gastrointestinal, hepatic, renal, 
vascular, haematological disorders 
 In vitro fertilisation (IVF)  
 History of NTD affected pregnancies 
 Currently involved in another research study 
 Active thyroid disease (e.g., Graves,) 







Receive multivitamin and placebo 0μg D3 
 
(Treatment group) 
Receive multivitamin and 10μg D3 
12 week gestation 
36 week gestation 
Sampling point 4 
- Cord blood sample  




Sampling point 1 
 Consent completion 
 Maternal blood sample 
 Anthropometry and body composition measurements*  
 Health and Lifestyle Questionnaire 
 
 
Sampling point 2 
- Anthropometry and body composition  measurements*  
- Maternal blood sample 
- Vitamin D Food Frequency Questionnaire  
- A four day food diary 
 
28 week gestation 
Sampling point 3 
         - Anthropometry and body composition  measurements* 
         - Maternal blood sample 
Delivery 
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Date seen:     /  /                                           Health and Social Care No:  
           d  d        m  m         y   y 
 






           
  Name   (last)  
             (first)   
   
 
Date of brith  - -   Age:  
 
Address          
          
  
 
Telephone Number Home:  -   Work:  -   
 







1. Education level: 
 
 Primary                                    Secondary                          Diploma                                    
 Degree                                     Postgraduate                     Other………………                       
 
2.  Marital status: 
 
  Single (never married)                                    Married  
 Separated                                                        Divorced                                     Wido 
Health and Lifestyle Questionnaire  
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1.  Do you take any medications on a regular basis?                                Yes No  
 




          Name 
Dose please state 
         number of pills  
       or capsules or 
 teaspoons consumed 
How often do you take these? 
Daily 
Once/ twice/ three times 
Weekly Monthly Less often 
      
      
      
 
 
2.  Do you suffer from any medical illnesses?                                                        Yes  No  
             






1.  Do you take any vitamins, minerals, fish oils or other food supplements? Yes No  
 





          Name 
Dose please state 
         number of pills  
       or capsules or 
 teaspoons consumed 
How often do you take these? 
Daily 
once/ twice/ three times 
Weekly Monthly Less often 
      
      
      
 




1c. What are the reasons for taken supplements? 
 
               Preventive Therapeutic (prescribed by your doctor) 
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Sun exposure Information: 
 
1.  Have you been on a sun or ski holiday in past 6 months?        Yes   No  
 
2.  Have you been sunbathing or used a sunbed in the last months?                Yes No  
 
2a. If yes, have how many times per month did you use a sunbed  
2b. If yes, have how long did each session last     miuntes  
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normal weight women (1.95 vs. 0.66 µg/day; P=0.010). 
     The findings of this study are in agreement with other European research and 
demonstrate that maternal dietary vitamin D intakes are low. Maternal obesity is 
shown to be associated with dietary vitamin D intake. These findings support the 
guidelines for vitamin D supplementation during pregnancy.  
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